methotrexate has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 912 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 229 (25.11) | 18.7374 |
| 1990's | 346 (37.94) | 18.2507 |
| 2000's | 173 (18.97) | 29.6817 |
| 2010's | 112 (12.28) | 24.3611 |
| 2020's | 52 (5.70) | 2.80 |
| Authors | Studies |
|---|---|
| Andis, SL; Gates, SB; Gossett, LS; Habeck, LL; Mendelsohn, LG; Schultz, RM; Self, TD; Shackelford, KA; Shih, C; Theobald, KS; Worzalla, JF | 1 |
| Batchelor, T; Song, KW | 1 |
| Balikov, DA; Betz, BL; Cani, AK; Chinnaiyan, AM; Devisetty, LV; Hu, K; Liu, CJ; Rao, RC; Tomlins, SA; Venneti, S | 1 |
| Grommes, C; Schaff, LR | 1 |
| Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
| Azumi, M; Fujihara, T; Mizobuchi, Y; Nakajima, K; Takagi, Y | 1 |
| Feng, Z; Gao, J; Gao, X; Hua, L; Nie, X; Sun, Y; Wang, M | 1 |
| Alinari, L; Baiocchi, RA; Bond, DA; Brammer, J; Christian, BA; Dotson, E; Epperla, N; Fleming, M; Huang, Y; Maddocks, K; Reneau, J; Sawalha, Y | 1 |
| Chukwueke, U; Grommes, C; Nayak, L | 1 |
| Barraclough, A; Gregory, GP; Hamad, N; Keane, C; Ku, M; Lee, YY; Swain, F; Talaulikar, D; Tatarczuch, M; Wight, J | 1 |
| Deng, X; Luo, X; Wang, X; Zhang, Q; Zhang, Y; Zhu, Y | 1 |
| Fortin Ensign, SP; Gathers, D; Mrugala, MM; Wiedmeier, JE | 1 |
| Delhiwala, K | 1 |
| Chaudhry, QU; Ghafoor, T; Hussain, F; Mahmood, SK; Rehman, J | 1 |
| Fujita, M; Nakao, T; Okuda, T; Takahashi, JC; Yoshioka, H | 1 |
| Bernhardt, MB; Brown, AL; El-Mallawany, NK; Grim, AT; Ozuah, NW; Scheurer, ME | 1 |
| Cao, A; Chen, H; Chen, L; Du, P; Geng, D; Liu, X; Shen, L; Wu, X | 1 |
| Chang, Q; Chen, H; Chen, T; Chen, Y; Geng, D; Jiang, T; Lei, J; Li, J; Li, W; Li, XQ; Li, Y; Lin, S; Liu, Y; Lu, D; Lyu, L; Mao, Y; Qiu, X; Song, Y; Wang, B; Wang, Y; Wang, Z; Wu, J; Yu, JT; Zhang, X; Zhuang, D | 1 |
| Nagane, M | 1 |
| Baehring, JM; Kaulen, LD | 1 |
| Al-Athamen, K; Barrett, O; Gourevitch, A; Gozlan, A; Grinbaum, U; Kaisman-Elbaz, T; Levi, E; Peles, I; Porges, T; Rabinovich, A; Zektser, M | 1 |
| Cheng, CL; Fang, WQ; Hou, HA; Lin, CP; Ma, WL; Tien, HF; Tsai, CH; Yeh, PT | 1 |
| Absi, A; Aga, SS; Al-Mansour, M; Alharbi, Z; Alhwaity, AS; Almasrahi, A; Almufti, R; Alnejadi, W; Hussain, S; Khan, MA; Saif, SA | 1 |
| Andayani, YD; Andriani, M; Diansari, Y; Djamaludin, N; Syahrir, M; Wirdah, A | 1 |
| Mishra, P; Moharana, B; Palanisamy, S; Parija, S | 1 |
| Inazuka, M; Kushihara, Y; Otani, R; Shinoura, N; Yamada, R | 1 |
| Hayano, A; Hondoh, H; Ikenaka, K; Kano, Y; Takashima, Y; Yamanaka, R; Yoshimura, T | 1 |
| Chen, H; Liu, Z; Xu, J; Yang, J; Yang, Y | 1 |
| Pan, E; Singh, PK | 1 |
| Alchawaf, A; Buckley, H; Culligan, DJ; Cwynarski, K; Eyre, TA; Fourali, S; Fox, CP; Horan, M; Kassam, S; Kelsey, P; Lim, YJ; Linton, K; Martinez-Calle, N; McCulloch, R; McKay, P; Ngu, L; Osborne, W; Poynton, E; Rafferty, M; Rowntree, C; Scott, G; Smith, J; Wright, J; Yallop, D | 1 |
| Fukunaga, A; Inano, S; Kitano, T; Okamoto, Y; Shibata, S; Tabata, S; Takiuchi, Y; Yamamoto, K | 1 |
| Liu, F; Xun, Y; Yang, A; Yang, H; You, H | 1 |
| Fukai, J; Hamano, M; Hondoh, H; Iwadate, Y; Kajiwara, K; Kobayashi, T; Takashima, Y; Yamanaka, R | 1 |
| Zhang, Y; Zhou, DB | 1 |
| Alañá, M; Barbero-Bordallo, N; Barceló, MI; Barón, M; Bobillo, S; Bruna, J; Caballero, AC; Cacabelos, P; Caldú Agud, R; Camro, I; Dlouhy, I; Encuentra, M; Erro, ME; Estela, J; Gállego Pérez-Larraya, J; García Molina, E; García-Catalán, G; Gómez-Vicente, L; Graus, F; Huertas, N; Ibáñez-Juliá, MJ; Lado, T; Martínez, P; Mercadal, S; Muntañola, A; Salar, A; Sancho, JM; Solé-Rodríguez, M; Velasco, R; Vidal, N | 1 |
| George, J; Goncalves, PH; Jaffe, ES; Little, RF; Lurain, K; Martin, S; Pittaluga, S; Polizzotto, MN; Ramaswami, R; Steinberg, SM; Tamula, MA; Uldrick, TS; Wang, HW; Widell, A; Wolters, PL; Yarchoan, R; Yuan, CM | 1 |
| Juul-Jensen, K; Larsen, TS; Møller, MB; Pedersen, CB; Poulsen, FR; Schulz, MK; Sommer-Sørensen, R | 1 |
| Dhingra, H; Kalra, M; Mahajan, A | 1 |
| Annessi, V; Ascani, S; De Marco, L; Manzini, L; Martiniani, R; Martino, G; Parente, P; Sanguedolce, F; Zanelli, M; Zizzo, M | 1 |
| Grommes, C; Holdhoff, M; Kaley, TJ; Mrugala, MM; Nayak, L; Perez-Heydrich, C; Swinnen, LJ | 1 |
| Ballester, LY; Choi, HA; Dono, A; Esquenazi, Y; Hasbun, R; Husein, N; Ybarra, C | 1 |
| Ding, N; Gao, L; Gao, LH; Wang, XB; Wang, Z; Yang, YY; Zhang, LP | 1 |
| Bairey, O; Shargian-Alon, L; Siegal, T | 1 |
| Grommes, C | 1 |
| Du, H; Xiao, H; Ye, X; Yu, J; Zhang, L | 1 |
| Hojo, H; Ikeda, S; Koyama, D; Ohta, M; Sukegawa, M; Suzuki, M; Tsunoda, S | 1 |
| Akashi, K; Asaoku, H; Ayano, M; Fujisaki, T; Harada, T; Iwasaki, H; Kato, K; Kohno, K; Mitoma, H; Miyamoto, T; Miyamura, T; Miyoshi, H; Mori, Y; Muta, T; Niiro, H; Ohshima, K; Oryoji, K; Oshiro, Y; Sakamoto, A; Sawabe, T; Takase, K; Takeshita, M; Urata, S; Yamamoto, H; Yoshimoto, G | 1 |
| Agrawal, S; Krawczyk, M; Makuch, S; Nowak, M; Pastuch-Gawołek, G; Szeja, W; Wiśniewski, J; Woźniak, M | 1 |
| Hou, HA; Hsu, CJ; Hsu, WF; Lee, YJ; Lin, CP; Yeh, PT | 1 |
| Anikhindi, SA; Arora, A; Bansal, N; Gupta, P; Kumar, A; Sharma, P; Singla, V; Walinjkar, S | 1 |
| Liu, Y; Wang, Y; Wei, W; Xu, X; Zhou, N | 1 |
| Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B | 1 |
| Kim, N; Kim, SJ; Kim, WS; Lim, DH; Yoon, SE | 1 |
| Adlington, J; Auer, D; Bessell, EM; Bishton, MJ; Byrne, P; Figueroa, R; Fox, CP; Grainge, MJ; James, E; Kaji, FA; Martinez-Calle, N; O'Donoghue, M; Paine, S; Smith, S; Sovani, V | 1 |
| Glass, J | 1 |
| Cerio, R | 1 |
| Ahn, YC; Kim, K; Kim, SJ; Kim, WS; Lim, DH; Park, JS; Park, W | 1 |
| Jin, J; Mao, L; Wang, H; Wang, L; Wang, M; Wei, J | 1 |
| Gelder, TV; Han, Y; Matic, M; Ruan, JS; Wu, H; Xie, RX; Yang, L | 1 |
| Batchelor, TT; Han, CH | 1 |
| Adams, HJA; Kwee, TC | 1 |
| Gondi, V; Lukas, RV; Raizer, JJ; Stupp, R | 1 |
| Haydaroglu Sahin, H; Mete, A; Pehlivan, M | 1 |
| Cui, Y; Du, Y; Lin, S; Mei, S; Ren, X; Shi, X; Yu, K; Zeng, C; Zhao, Z | 1 |
| Bijttebier, P; D'Hooge, R; Danckaerts, M; Deprez, S; Elens, I; Labarque, V; Lemiere, J; Uyttebroeck, A; Van Gool, S | 1 |
| Clavert, A; Farhi, J; Hamel, JF; Hunault-Berger, M; Laribi, K; Mercier, M; Moles-Moreau, MP; Orvain, C; Rousselet, MC; Sutra Del Galy, A; Tanguy-Schmidt, A | 1 |
| Tian, J; Wang, X; Wang, Z; Yang, Y | 1 |
| Beume, LA; Hosp, JA; Klingler, JH; Marks, R; Rauer, S; Staszewski, O; Urbach, H; Weiller, C; Wolf, K | 1 |
| Gowarty, JL; Herrington, JD; Patel, IJ | 1 |
| Adhikari, N; Baghmar, S; Bakhshi, S; Batra, A; Biswas, A; Garg, A; Gogia, A; Kumar, L; Mohanti, BK; Patekar, M; Raina, V; Sahoo, RK; Sharma, A; Sharma, MC; Thulkar, S; Vishnubhatla, S | 1 |
| Bi, X; Chen, C; Chen, H; Cui, J; Jiang, W; Li, ZM; Liu, P; Nie, M; Sun, P; Wang, Y; Xia, Y; Yan, S; Yang, H; Zhang, XW | 1 |
| Aaroe, AE; Nevel, KS | 1 |
| Hayano, A; Takashima, Y; Yamanaka, R | 1 |
| Bandke, D; Boehm, A; Brandner-Kokalj, T; Dieckmann, K; Dumser, M; Hackl, M; Hager-Seifert, A; Hainfellner, A; Hainfellner, JA; Haybaeck, J; Hoenigschnabl, S; Hoffermann, M; Hutterer, M; Iglseder, S; Jaeger, U; Kaufmann, H; Kiesel, B; Kitzwoegerer, M; Kleindienst, W; Krenosz, KJ; Marosi, C; Mayrbaeurl, B; Moser, P; Neuhauser, M; Oberndorfer, S; Payer, F; Pichler, J; Preusser, M; Reiner-Concin, A; Roetzer, T; Stockhammer, G; Stultschnig, M; Thomé, C; Unterluggauer, JJ; Weis, S; Widhalm, G; Woehrer, A; Wuertz, F | 1 |
| Al-Darraji, AF; Al-Hadad, S; Al-Jadiry, MF; Foà, R; Mohamed, S; Moleti, ML; Piciocchi, A; Shateh, WA; Testi, AM; Uccini, S | 1 |
| Carbajales, M; Fernández, B; Fernández, R; Labeaga, Y; Pampín, R; Rodríguez, B | 1 |
| Bertoni, F; Mian, M; Mondello, P | 1 |
| Castellino, A; Chiappella, A; Nicolosi, M; Novo, M; Santambrogio, E; Vassallo, F; Vitolo, U | 1 |
| Brenner, A; Butler, MJ; Faivre, G; Le, I | 1 |
| Affinita, MC; Buffardi, S; Casale, F; D'Angelo, V; Di Martino, M; Di Pinto, D; Francese, M; Iannotta, A; Indolfi, C; Indolfi, P; Pecoraro, G; Poggi, V; Pota, E; Ramaglia, M | 1 |
| Fang, BM; Jiang, JH; Xu, YH | 1 |
| Chi, HS; Huh, J; Jang, S; Kim, S; Lee, K; Park, CJ; Park, CS; Park, JS; Park, SJ; Suh, C; Yoon, DH | 1 |
| Avivi, I; Efrati, E; Krivoy, N; Zuckerman, T | 1 |
| Cairo, MS; Galardy, PJ; Goldman, S; Harrison, L; Hochberg, J; Perkins, SL | 1 |
| Mamoudou, AD; Mikkelsen, TS; Schroeder, H; Tuckuviene, R; Wehner, PS | 1 |
| Chen, XY; Li, JY; Mao, JQ; Pan, BH; Song, H; Tang, YM; Xu, WQ; Zhang, LY | 1 |
| Benevolo, G; Chiappella, A; Vitolo, U | 1 |
| Mao, J; Shen, H; Song, H; Tang, Y; Xu, W; Zhang, L; Zhao, F | 1 |
| Chen, XH; Gao, L; Kong, PY; Liu, Y; Peng, XG; Sun, AH; Zeng, DF; Zhang, C; Zhang, X | 1 |
| Atta, J; Brandts, C; Brodt, HR; Kann, G; Kiderlen, T; Stephan, C; Wolf, T | 1 |
| Ikegami, S; Iwadate, Y; Matsutani, T; Saeki, N; Shinozaki, N; Suganami, A; Tamura, Y; Yamanaka, R | 1 |
| Hashida, N; Nakai, K; Nishida, K; Saitoh, N | 1 |
| Abrey, L; Bayraktar, S; DeAngelis, LM; Hosein, PJ; Lossos, C; Lossos, IS; Natkunam, Y; Raizer, J; Schiff, D; Sutton Posthumus, J; Tibshirani, RJ; Weinzierl, E; Younes, SF | 1 |
| Ayad, MW; El Naggar, AA; El Naggar, M | 1 |
| Hatakeyama, N; Hori, T; Igarashi, K; Mizue, N; Suzuki, N; Tsutsumi, H; Yamamoto, M | 1 |
| Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
| Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B | 1 |
| Bee, PC; Chang, KM; Gan, GG; Lian, LH; Mohamed, Z; Ong, TC; Suthandiram, S; Zain, SM | 1 |
| Fujimoto, J; Fujita, N; Fukano, R; Gosho, M; Horibe, K; Inada, H; Kobayashi, R; Koh, K; Mitsui, T; Mori, T; Nakazawa, A; Saito, A; Sunami, S; Takimoto, T; Tanaka, F; Tsurusawa, M | 1 |
| Bazine, A; Bellefqih, S; Benjaafar, N; Diakité, A; El Kacimi, H; Kebdani, T; Khalil, J; Mezouri, I | 1 |
| Agis, H; Berghoff, AS; Bojic, M; Kalhs, P; Preusser, M; Rabitsch, W; Sperr, WR; Troch, M; Widhalm, G; Wöhrer, A | 1 |
| Abrey, LE; Baser, RE; Correa, DD; DeAngelis, LM; Faivre, G; Gavrilovic, IT; Grommes, CC; Kaley, TJ; Matasar, MJ; Moskowitz, CH; Nolan, C; Omuro, A; Panageas, KS; Pentsova, E; Sauter, CS | 1 |
| Abou Mourad, Y; Barnett, MJ; Broady, RC; Connors, JM; Forrest, DL; Gascoyne, RD; Gerrie, AS; Hogge, DE; Karsan, A; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Savage, KJ; Sehn, LH; Shepherd, JD; Slack, GW; Song, KW; Sun, H; Sutherland, HJ; Toze, CL; Villa, D | 1 |
| Anasetti, C; Ayala, E; Figueroa, J; Kharfan-Dabaja, MA; Kim, J; Locke, F; Nishihori, T; Perkins, J; Riches, M; Yue, B | 1 |
| Echizen, N; Inoue, M; Keino, H; Nagane, M; Okada, AA; Takayama, N; Watanabe, T | 1 |
| Bandoh, S; Dobashi, H; Imataki, O; Izumikawa, M; Kameda, T; Morimoto, H; Nakashima, S; Shimada, H; Susaki, K; Takeuchi, Y | 1 |
| Inagaki, A; Komatsu, H; Morozumi, I; Ogura, H; Sato, Y; Suga, N; Suzuki, S; Wakita, A; Yamada, K | 1 |
| Abarah, W; Choquet, S; Coso, D; Damaj, G; Diouf, M; Dupuis, J; Gac, AC; Garidi, R; Ghesquières, H; Gressin, R; Houillier, C; Ivanoff, S; Marjanovic, Z; Morschhauseur, F; Parcelier, A; Soussain, C; Troussard, X; Ysaebert, L | 1 |
| Connors, JM; Gerrie, AS; Kansara, R; Savage, KJ; Sehn, LH; Shenkier, TN; Villa, D | 1 |
| Gordon, LI; Nieto, K; Raizer, J | 1 |
| Bakhshi, S; Dhawan, D; Gupta, YK; Pathania, S; Thomas, MK; Tiwari, P; Vishnubhatla, S | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Alnahhas, I; Malkin, M | 1 |
| Fischer, T; Koehler, M; Schalk, E; Zeremski, V | 1 |
| Cheong, JW; Cho, H; Chung, H; Jang, JE; Kim, JS; Kim, SJ; Kim, Y; Kim, YR; Lee, JY; Min, YH; Park, H | 1 |
| Cen, J; Qian, L; Shen, J; Yin, W; Zhou, C | 1 |
| Annibali, O; Avvisati, G; Cavallari, I; Cenfra, N; Chiodi, F; Cimino, G; Mecarocci, S; Mega, S; Rago, A; Sarlo, C; Tomassini, S | 1 |
| Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E | 1 |
| Geng, H; Ji, LH; Luo, W; Ma, J; Ma, XJ; Xiong, H; Yin, QC; Yin, YJ; Yu, L | 1 |
| Deng, XF; Wang, XX; Zhang, Q; Zhang, Y; Zhu, YZ | 1 |
| Cho, SG; Eom, KS; Jeon, YW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Yoon, JH | 1 |
| Bentz, M; Binder, M; Deckert, M; Edinger, M; Egerer, G; Finke, J; Fricker, H; Frickhofen, N; Fritsch, K; Hader, C; Hau, P; Hirt, C; Ihorst, G; Illerhaus, G; Kasenda, B; Keller, U; Lamprecht, M; Möhle, R; Pfreundschuh, M; Röth, A; Schorb, E; Stilgenbauer, S; Valk, E; von Baumgarten, L; Wolf, HH | 1 |
| Baars, JW; Bromberg, JEC; Doorduijn, JK; Enting, RH; Kersten, MJ; Lugtenburg, PJ; MacKenzie, MA; Poortmans, P; Schaafsma, MR; Schouten, HC; Spoelstra, FM; van den Bent, MJ; van der Holt, B; van Imhoff, GW | 1 |
| Carnevale, J; Rubenstein, JL | 1 |
| Belhabri, A; Biron, P; Blay, JY; Chassagne-Clément, C; Ducray, F; Faurie, P; Ferlay, C; Fossard, G; Ghesquières, H; Jouanneau, E; Nicolas-Virelizier, E; Rey, P; Sebban, C; Sunyack, MP; Thiesse, P | 1 |
| Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG | 1 |
| Barber, M; Buchbinder, R; Giles, G; Hall, S; Harkness, A; Heuzenroeder, L; Jolley, D; Lewis, D; Littlejohn, G; Miller, MH; Ryan, PF; Wluka, AE | 1 |
| Zucca, E | 1 |
| Feilmeier, MR; Lossos, IS; Malumbres, R; Murray, TG; Schefler, AC | 1 |
| Abrey, LE; Ben-Porat, LS; DeAngelis, LM; Ekenel, M; Iwamoto, FM; Panageas, KS; Yahalom, J | 1 |
| Ladicka, M; Lakota, J; Vranovsky, A | 1 |
| Cai, QQ; Gao, Y; Huang, HQ; Li, S; Liao, H; Lin, XB; Xia, ZJ; Zhou, NN | 1 |
| Deckert, M; Feuerhake, F; Finke, J; Ihorst, G; Illerhaus, G; Marks, R; Müller, F; Ostertag, C | 1 |
| Fijnheer, R; Haverman, JF; Sinniqe, HA; van Poppel, PC | 1 |
| Hong, JT; Hong, YK; Kim, IS; Lee, KS; Lee, SW; Son, BC; Sung, JH; Yang, SH | 1 |
| Aurer, I; Labar, B; Mitrović, Z; Mrsić, M; Nemet, D; Nola, M; Radman, I; Santek, F; Sertić, D; Serventi-Seiwerth, R; Stern-Padovan, R | 1 |
| Aksoylar, S; Cetingul, N; Cinar, M; Eroglu, Z; Gumus, S; Kantar, M; Kosova, B; Tetik, A; Topcuoglu, N; Toroslu, E; Zafer, N | 1 |
| Angelov, L; Barnett, GH; Bell, S; Doolittle, ND; Ference, S; Haluska, M; Hedrick, NA; Jahnke, K; Kraemer, DF; Lacy, CA; McGregor, J; Neuwelt, EA; Peereboom, DM; Shalom, E; Siegal, T; Sorenson, L; Stevens, G; Tyson, RM | 1 |
| Balme, B; Dalle, S; Fontaine, J; Petrella, T; Ronger-Savle, S; Thomas, L; Traullé, C | 1 |
| Lee, SL; Mouzakes, J; Neskey, D | 1 |
| Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E | 1 |
| Aondio, GM; Avvisati, G; Balzarotti, M; Brandes, AA; Cabras, MG; Caligaris-Cappio, F; Cavalli, F; Corazzelli, G; Fabbri, A; Fajardo, J; Ferreri, AJ; Foppoli, M; Frezzato, M; Gomez, H; Guarini, A; Ilariucci, F; Martelli, M; Pangalis, GA; Picozzi, P; Pinotti, G; Ponzoni, M; Reni, M; Rigacci, L; Rossi, G; Soffietti, R; Stelitano, C; Uhlmann, C; Vallisa, D; Vezzulli, P; Zaja, F; Zoppegno, L; Zucca, E | 1 |
| Anoop, P; Bain, BJ; Dearden, CE; Matutes, E; Osuji, N; Ravindranathan, G; Wotherspoon, A | 1 |
| Czumbil, L; Gyánó, G; Iványi, JL; Marton, E; Plander, M; Tóth, C | 1 |
| Dührsen, U; Hüttmann, A; Jöckel, KH; Müller, S | 1 |
| Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
| Dalhoff, K; Hedeland, RL; Hvidt, K; Lausen, B; Nersting, J; Rosthøj, S; Schmiegelow, K | 1 |
| Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
| El Bary, NA; El Mageed, HA; Ghany, AA; Hashem, T; Metwally, H | 1 |
| Chen, A; Liu, J; Wang, H; Wu, D; Xiang, H | 1 |
| Arai, A; Ishiwata, Y; Miura, O; Mochizuki, M; Nakauchi, Y; Shibata, S; Shibuya, Y; Sugita, S; Takase, H; Yasuhara, M | 1 |
| Abrey, LE | 2 |
| Behm, FG; Graham, K; Hale, GA; Howard, SC; Hudson, MM; Kaste, S; Krasin, MJ; Kun, LE; Lowe, E; Mahmoud, H; Metzger, ML; Onciu, M; Pui, CH; Razzouk, BI; Rencher, R; Ribeiro, RC; Sandlund, JT; Zhou, Y | 1 |
| Aghakhani, R; Alavi, S; Arzanian, MT; Gharib, A; Goudarzipour, K; Jadali, F; Rezaei, N; Shamsian, BS | 1 |
| Davis, J; Lossos, IS; Markoe, A; Murray, T; Stefanovic, A | 1 |
| Cavalli, F; Ferreri, AJ; Illerhaus, G; Zucca, E | 1 |
| Bromberg, JE; Doorduijn, J; Enting, R; Poortmans, P; Schuurmans, M; Seute, T; Taphoorn, MJ; van den Bent, MJ; van Imhoff, G; van Norden, Y | 1 |
| Ballman, KV; Brown, PD; Carrero, XW; Colgan, JP; Fitch, TR; Gilbert, MR; Habermann, TM; Hawkins, RB; Kurtin, PJ; Laack, NN; Morton, RF; O'Fallon, JR; O'Neill, BP; Pajon, ER; Scheithauer, BW; Windschitl, HE | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Mo, N; Muthu, S; O'Sullivan, M | 1 |
| Alfonso, R; Miralles, J; Moragón, M; Onrubia, J; Pérez-Crespo, M; Requena, L; Sevila, A | 1 |
| Finke, J; Fritsch, K; Hader, C; Haug, S; Haug, V; Ihorst, G; Illerhaus, G; Kasenda, B; Nikkhah, G; Prinz, M | 1 |
| Baidoo, L; Barrie, AM; Binion, DG; El Mourabet, M; Hashash, JG; Issa, M; Katz, JA; Levesque, MC; Regueiro, M; Schwartz, MB; Sun, NH; Swoger, JM | 1 |
| Alaoui-Slimani, K; Biron, P; Blay, JY; Chassagne-Clement, C; de la Fouchardiere, A; de Prijck, B; Delannoy, A; Devidas, A; Ferlay, C; Ghesquières, H; Ketterer, N; Lepretre, S; Provencher, S; Sebban, C; Thyss, A; Tilly, H | 1 |
| Macharia, WM | 1 |
| Graber, JJ; Omuro, A | 1 |
| Bourcier, T; Gaucher, D; Nikolitch, K; Saleh, M; Speeg, C | 1 |
| Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
| Ferreri, AJ; Huitema, AD; Illerhaus, G; Joerger, M | 1 |
| Birnbaum, T; Stadler, EA; Straube, A; von Baumgarten, L | 1 |
| Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
| Lin, S; Wang, C; Wang, L; Zhang, J | 1 |
| Peereboom, DM; Xie, H | 1 |
| Deangelis, LM; Omuro, A; Welch, MR | 1 |
| Zyrina, GV | 1 |
| Glas, M; Herrlinger, U; Schäfer, N | 1 |
| Bassi, E; Bergonzi, M; Coriani, C; Federico, M; Gobbi, PG; Merli, F | 1 |
| Bergner, N; Engert, A; Illerhaus, G; Monsef, I; Skoetz, N | 1 |
| Ahn, HS; Kang, HJ; Kim, H; Lee, JW; Park, JD; Park, KD; Shin, HY; Yoon, JH | 1 |
| Advani, R; Auerback, G; Batchelor, T; Cha, S; Chen, L; Damon, LE; Drappatz, J; Gerstner, E; Hwang, J; Kadoch, C; Krouwer, H; Li, J; Lowell, C; Munster, P; Rubenstein, JL; Shuman, MA | 1 |
| Fukano, R; Inada, H; Ishii, E; Itonaga, N; Kawakami, K; Kawano, Y; Kikuchi, M; Matsuzaki, A; Moritake, H; Nagatoshi, Y; Nakayama, H; Okamura, J; Suenobu, S; Suminoe, A; Yanai, F | 1 |
| Aranow, C; Askanase, A; Bae, SC; Barr, SG; Bernatsky, S; Blanco, I; Boivin, JF; Clarke, AE; Costenbader, KH; Criswell, LA; Dooley, MA; Dreyer, L; Edworthy, SM; Feldman, CH; Fortin, PR; Ginzler, EM; Gladman, DD; Gordon, C; Isenberg, D; Jacobsen, S; Joseph, L; Kamen, DL; Manzi, S; Nived, O; Patel, NM; Peschken, CA; Petri, MA; Rahman, A; Ramsey-Goldman, R; Romero-Diaz, J; Ruiz-Irastorza, G; St Pierre, Y; Sturfelt, GK; Urowitz, MB; Wallace, DJ; Witte, T; Yelin, E | 1 |
| Birnbaum, T; Bochmann, K; Straube, A; von Baumgarten, L | 1 |
| Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Tomita, N | 1 |
| Fukuno, K; Goto, H; Hara, T; Kanemura, N; Kasahara, S; Moriwaki, H; Oyama, M; Sawada, M; Shimizu, M; Takami, T; Tsurumi, H; Yamada, T; Yoshikawa, T | 1 |
| Aebi, S; Calderoni, A | 1 |
| Aurer, I; Bogdanić, V; Duraković, N; Kovacević-Metelko, J; Labar, B; Mikulić, M; Mrsić, M; Nemet, D; Radman, I; Sertić, D; Zupancić-Salek, S | 1 |
| Angrilli, F; Di Lorenzo, R; Di Marzio, A; Fioritoni, G; Liberatore, E; Pennese, E | 1 |
| Bevan, J; Homer, D; Jobanputra, P; Maggs, F | 1 |
| Southcott, BM; Stewart, AJ | 1 |
| Jackson, AS; Lightman, S; Pavesio, C; Plowman, PN; Taylor, A | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
| Cantonetti, M; De Renzo, A; De Vivo, A; Falini, B; Gherlinzoni, F; Guardigni, L; Lauria, F; Lauta, VM; Mandelli, F; Martelli, M; Mazza, P; Meloni, G; Molinari, AL; Moretti, L; Pescarmona, E; Pileri, SA; Rizzo, M; Storti, S; Tura, S; Zinzani, PL | 1 |
| Baehring, JM; Hochberg, FH; Longtine, J | 1 |
| Chua, SL; Januszewicz, EH; Prince, HM; Seymour, JF; Streater, J; Wolf, MM | 1 |
| Crombie, C; Harvey, T; Kirkpatrick, P; Roman, M; Sharma, P; Smith, A; St Heaps, L | 1 |
| Fischer, DH; Mason, JO | 1 |
| Amess, J; Cornelius, V; Delves, T; Fitzgibbon, J; Last, KW; Lister, TA; Norton, A; Rohatiner, AZ; Sieniawska, C; Wilson, A | 1 |
| Fukushima, T; Katayama, Y; Komine, C; Watanabe, T; Yokoyama, T; Yoshino, A | 1 |
| Contentin, N; Dominique, S; Dubruille, V; Le Guillou, F; Nouvet, G; Tilly, H | 1 |
| Benner, A; Goerner, M; Ho, AD; Hoepfner, S; Luft, T; Weber-Nordt, R | 1 |
| Boccadoro, M; Caracciolo, D; Cuttica, A; Dell'Aquila, M; Di Nicola, M; Gianni, AM; Ladetto, M; Magni, M; Marinone, C; Pileri, A; Rosace, M; Tarella, C; Zallio, F | 1 |
| Mead, G; Woodcock, J; Young, C | 1 |
| Filippa, DA; Mora, J; Qin, J; Wollner, N | 1 |
| PITNEY, WR | 1 |
| GEYER, S; KLEMM, J; SCHLEGEL, D | 1 |
| FEIWEL, M; MUNRO, DD | 1 |
| ARIEL, IM; GALEY, D; RESNICK, MI | 1 |
| ESTRIN, J; PENG, BK; WEINBERG, SR; WESOLOWSKI, S | 1 |
| SULLIVAN, RD; ZUREK, WZ | 1 |
| HUTCHISON, JL | 1 |
| BOWERMAN, DL; GREENHOUSE, AH; NEUBUERGER, KT | 1 |
| ANKER, HS; RENNERT, OM | 1 |
| ANDERSON, RE; MORROW, LB | 1 |
| Bahceci, E; Cooper, DL; Seropian, S | 1 |
| Akimoto, T; Hasegawa, M; Hayakawa, K; Ishikawa, H; Mitsuhashi, N; Nakano, T; Niibe, H; Sakurai, H; Tamaki, Y; Tamura, M | 1 |
| Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A | 1 |
| Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
| Ardashev, VN; Korotkiĭ, AN; Mazurov, VI; Seriakov, AP; Ushakov, II | 1 |
| Davidson, KL; Devaney, MB; Dunlop, DJ; Johnson, PR; Mackie, MJ; Rogers, SY; Thomas, RV; Tighe, JE | 1 |
| Ambrosetti, A; Cabras, MG; Di Vito, F; Fioritoni, G; Gabbas, A; Gallamini, A; Gallo, E; Gargantini, L; Gottin, L; Lazzarino, M; Menestrina, F; Morra, E; Orlandi, E; Palestro, M; Pasini, F; Paulli, M; Pizzolo, G; Pizzuti, M; Rossi, G; Secchi, S; Tarella, C; Tecchio, C; Todeschini, G; Vitolo, U | 1 |
| Tardif, Y; Tourville, E | 1 |
| Acar, S; Albayrak, D; Aliyazicioglu, Y; Dagdemir, A; Kanber, Y; Yildirim, H | 1 |
| Alzieu, C; Bardou, VJ; Charbonnier, A; Cohen, R; Costello, RT; de Colella, JM; Gastaut, JA; Lepeu, G; Nezri, M; Olive, D; Poizot-Martin, I; Xerri, L; Zerazhi, H | 1 |
| Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK | 1 |
| O'Neill, BP | 1 |
| Abrey, LE; Correa, DD; DeAngelis, LM; Glass, A; Shi, W; Thaler, H | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Aleksza, M; Gergely, L; Illés, A; Ponyi, A; Sipka, S; Szegedi, G; Váróczy, L | 1 |
| Bessell, EM; Graus, F; Lewis, SA; Lopez-Guillermo, A; Petit, J; Verger, E; Villa, S | 1 |
| Michaud, K; Wolfe, F | 1 |
| Harney, J; Pope, A; Short, SC | 1 |
| Tanaka, R; Yamanaka, R | 1 |
| Batchelor, TT; Betensky, RA; Chon, B; Grossman, SA; Hochberg, FH; Lesser, GJ; Nabors, LB; Plotkin, SR | 1 |
| Acquatella, G; Carneiro, M; García, R; Gómez, R; Hernández, M; Insausti, CL; Nouel, A; Santos, S | 1 |
| Arbion, F; Autret, A; Benboubker, L; Bonnaud, I; Cottier, JP; de Toffol, B; Debiais, S; Destrieux, C; Saudeau, D | 1 |
| Al-Izzi, M; Constantinou, J; McNicholas, TA; Nitkunan, T | 1 |
| Adamson, PC; Balis, FM; Boron, M; Castle, V; Cole, DE; Hermann, RC; Hinton, S; Ivy, P; Jayaprakash, N; Moertel, CL; Moussa, A; Muraszko, K; O'Brien, M; Poplack, D; Reaman, G; Shalabi, A; Trueworthy, R; Widemann, BC | 1 |
| Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ | 1 |
| Chan, CC; Kim, SK; Wallace, DJ | 1 |
| Alterini, R; Bernardi, F; Bosi, A; Carrai, V; Longo, G; Nassi, L; Rigacci, L | 1 |
| Alexopoulou, A; Archimandritis, AJ; Dourakis, SP; Georgousi, KK | 1 |
| Bertrand, Y; Boutard, P; Dresse, MF; Ferster, A; Lutz, P; Maes, P; Mazingue, F; Munzer, M; Norton, L; Otten, J; Philippe, N; Philippet, P; Plantaz, D; Plouvier, E; Robert, A; Sirvent, N; Suciu, S; Thyss, A; Uyttebroeck, A; van der Werff Ten Bosch, J; Vilmer, E; Waterkeyn, C | 1 |
| Frigerio, L; Garavaglia, E; Mangili, G; Montoli, S; Panacci, N; Ponzoni, M; Taccagni, G | 1 |
| Bravo, M; Carmona, L; Heredia, F; Majlis, A; Pierotic, M | 1 |
| Rao, PS | 1 |
| Bay, A; Caksen, H; Etlik, O; Oner, AF; Yilmaz, C | 1 |
| Dichgans, J; Hebart, H; Herrlinger, U; Kanz, L; Weller, M | 1 |
| Gu, J; Hua, Y; Lu, XT; Yang, LH; Zhao, WH | 1 |
| Benedetti, F; Cantini, M; Crippa, C; Draisci, M; Pasini, F; Pizzolo, G; Tecchio, C; Todeschini, G | 1 |
| García, I; Lugo, Z; Navas, R; Rojas-Morales, T; Santana, Y; Viera, N; Zambrano, O | 1 |
| Burkhardt, B; Mann, G; Niggli, F; Oschlies, I; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Zimmermann, M | 1 |
| Ardeshna, KM; Burton, C; Cheung, CW; Hoskin, PJ; Linch, DC; Smith, P | 1 |
| Dzhumabaeva, BT; Frank, GA; Gemdzhian, EG; Gotman, LN; Kaplanskaia, IB; Kravchenko, SK; Kremenetskaia, AM; Shavlokhov, VS; Vishnevskaia, ES | 1 |
| Andreu, JL; Salas-Antón, C; Tutor-Ureta, P; Yebra-Bango, M | 1 |
| Heslop, HE | 1 |
| Konopka, L; Pawelski, S | 1 |
| Diehl, V; Engert, A; Reiser, M; Rödel, S | 1 |
| Azzi, N; Christophe, C; Damry, N; Dan, B; Ferster, A; Ziereisen, F | 1 |
| Anzai, Y; Ohta, S; Sakaue, Y; Taga, T; Takeuchi, Y | 1 |
| Fujimaki, K; Fujisawa, S; Fujita, H; Harano, H; Hashimoto, C; Ishigatsubo, Y; Kanamori, H; Kodama, F; Koharazawa, H; Maruta, A; Motomura, S; Sakai, R; Tomita, N | 1 |
| Demlova, R; Dusek, L; Sterba, J; Valik, D | 1 |
| Gardner, J; Gonen, M; Heaney, M; O'Connor, OA; Sirotnak, F; Smith, EA; Teruya-Feldstein, J; Toner, LE; Vrhovac, R | 1 |
| Ikizoglu, G; Kaya, TI; Tiftik, N; Tursen, U; Yalcin, A | 1 |
| Boran, BO; Boran, P; Oktem, S; Tokuc, G | 1 |
| Mackie, GC; Pohlen, JM | 1 |
| Artibani, W; Boscolo Berto, R; El Mazloum, R; Fassina, A; Gottardo, F | 1 |
| Bo, J; DA, WM; Li, HH; Wang, QS; Wang, SH; Wu, XX; Yu, L; Zhao, Y | 1 |
| Baldini, L; Balzarotti, M; Bernardi, M; Bobbio, F; Brandes, AA; Caligaris Cappio, F; Corazzelli, G; Dell'Oro, S; Ferreri, AJ; Foppoli, M; Ilariucci, F; Montanari, M; Picozzi, P; Ponzoni, M; Reni, M; Spina, M; Stelitano, C; Tosoni, A; Zaja, F | 1 |
| Hayes, CW; Kalantarian, B; Kennedy, JW; Turner, L; Wong, LK | 1 |
| Whelan, P | 1 |
| Arlotta, A; Larocca, LM; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
| Counsel, P; Khangure, M | 1 |
| Inamura, K; Kakuta, K; Matano, S; Munemoto, S; Nishijima, H; Okamura, T; Satoh, S; Sugimoto, T | 1 |
| Forero, A; Lobuglio, A; Meredith, R; Nabors, B; Shah, JJ; Shen, S; Yester, M | 1 |
| Allard, A; Bachelez, H; Dauendorffer, JN; Rivet, J | 1 |
| Aydin, K; Baysal, T; Caliskan, U; Energin, Ml; Koksal, Y; Unal, E | 1 |
| DiMaggio, C; Fahey, JB | 1 |
| Digumarti, R; Rajappa, SJ; Uppin, SG | 1 |
| Batchelor, T; Gerstner, E | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ | 1 |
| Akutsu, M; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kobayashi, H; Masuda, Y; Muroi, K; Nagashima, T; Ohmine, K; Ozawa, K; Shirai, T; Takagi, S; Tsunoda, S; Ueda, M; Ueda, T | 1 |
| Cerno, M; Damiani, D; Fanin, R; Geromin, A; Grimaz, S; Rinaldi, C; Skert, C; Sperotto, A | 1 |
| Abrey, LE; Mohile, NA | 1 |
| Fujii, M; Kaiga, T; Kanamori, N; Kobayashi, M; Kochi, M; Takahashi, T; Takayama, T | 1 |
| Fujimaki, K; Higashihara, M; Hotta, T; Ishigatsubo, Y; Kanamori, H; Kishi, K; Miyazaki, K; Miyazaki, T; Ohsaka, M; Sakai, R; Shirasugi, Y; Tamaru, J; Yamazaki, E; Yoshiba, F | 1 |
| Belanger, R; Doolittle, ND; Haluska, M; Hedrick, NA; Jahnke, K; Lacy, CA; Nance, RW; Neuwelt, EA; Ryan, DA; Tyson, RM; Varallyay, C | 1 |
| Karantanis, D; Lowe, VJ; Mullan, BP; Nathan, MA; O'eill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
| Baker, A; Hadzic, N; Height, S; Messahel, B; Mycroft, J; Pinkerton, CR; Pritchard-Jones, K; Taj, MM | 1 |
| Chowers, I; Frenkel, S; Pe'er, J; Shalom, E; Siegal, T; Vicuna-Kojchen, J | 1 |
| Frenkel, S; Hendler, K; Pe'er, J; Shalom, E; Siegal, T | 1 |
| Fischer, L; Kiewe, P; Korfel, A; Martus, P; Thiel, E | 1 |
| Canellos, GP | 1 |
| McElfresh, AE | 1 |
| Chapman, AL; Klein, RM; Torres, J; Tung, HN | 1 |
| Rassiga, AL | 1 |
| Anger, G; Herold, M; Höche, D; Kästner, R; Rüdiger, KD; Wutke, K | 1 |
| Coleman, M; Gordon, B; Hollister, D; Silver, RT | 1 |
| Anderson, JR; Chilcote, RR; Coccia, P; Exelby, P; Hammond, D; Jenkin, DT; Kersey, J; Kushner, J; Meadows, AT; Siegel, S; Wilson, JF | 1 |
| Frei, E | 1 |
| Mathe, G | 1 |
| Barnwell, R; Berard, CW; Edwards, BK; Jaffe, ES; Janus, C; Magrath, IT; Miliauskas, J; Morris, K; Spiegel, R | 1 |
| Bednár, M; Bostík, J; Chudomel, V; Motycka, K | 1 |
| Bussanich, N; Gudauskas, G; Rootman, J | 1 |
| Abdyldaev, RA; Finogenova, IA; Kruglova, GV; Tarasiuk, SV | 1 |
| Hattori, K; Ito, H; Kamei, T; Takeda, I; Tatsuno, I; Yamazaki, T | 1 |
| Brown, NO; Hayes, AA; MacEwen, EG; Passe, S; Patnaik, AK | 1 |
| Balcarová, A; Dyr, JE; Motycka, K; Slavík, K; Vodrázka, Z | 1 |
| Dyr, JE; Macáková, A; Motycka, K; Slavík, K | 1 |
| Ojeda, VJ | 1 |
| Tisman, G; Wu, SJ | 1 |
| Burke, JS; Cohen, JR; Coleman, CN; Rosenberg, SA | 1 |
| Balcarová, A; Kubín, M; Motycka, K; Slavík, K; Spacek, P | 1 |
| Raich, PC | 1 |
| Liffers, R | 1 |
| Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R | 1 |
| Daly, PA; Love, WC; McAdam, B; Murphy, M; Smith, T | 1 |
| Andoh, A; Bamba, T; Fujiyama, Y; Hodohara, K; Hosoda, S; Inoue, T; Kitoh, K; Niwakawa, M | 1 |
| Leonard, RC; Mao, JH; Prescott, RJ; White, JM | 1 |
| Allegranza, A; Boiardi, A; Broggi, G; Salmaggi, A; Silvani, A; Valentini, S | 1 |
| Ezaki, K; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
| Akman, N; Bilir, M; Ferhanoğlu, B; Soysal, T | 1 |
| Ambrosetti, A; Cetto, GL; Meneghini, V; Pasini, F; Perona, G; Sabbioni, R; Santo, A; Todeschini, G | 1 |
| Cooper, IA; Dart, G; Ding, JC; Firkin, FC; Fox, RM; Matthews, J; Matthews, JP; Robertson, TI; Stone, JM; Wolf, MM | 1 |
| Allen, PK; Cabanillas, FF; Fuller, LM; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Swan, F; Tucker, SL; Velasquez, WS | 1 |
| Blaise, D; De Laurenzi, A; Goldstone, AH; Laurenzi A [corrected to De Laurenzi, A]; Pearce, R; Proctor, SJ; Sweetenham, JW; Taghipour, G | 1 |
| Byrne, A; Carney, DN; Corbally, N; Dervan, PA; Grogan, L | 1 |
| Coltman, CA; Dahlberg, S; Fisher, RI; Gaynor, ER; Glick, JH; Grogan, TM; Miller, TP; Mize, EM; Oken, MM | 2 |
| Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
| Ajchenbaum-Cymbalista, F; Bauduer, F; Delmas-Marsalet, B; Delmer, A; Marie, JP; Rio, B; Ruskoné-Fourmestraux, A; Zittoun, R | 1 |
| Bastion, Y; Baumelou, E; Bouabdallah, K; Delannoy, A; Dupriez, B; Haioun, C; Herbrecht, R; Morel, P; Nouvel, C; Tilly, H | 1 |
| Chisesi, T; Congiu, AM; Contu, A; Coser, P; Porcellini, A; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Vespignani, M | 1 |
| Kanamori, H; Kodama, F; Maruta, A; Matsuzaki, M; Mohri, H; Motomura, S; Okubo, T; Tanabe, J | 1 |
| Baldini, L; Butti, C; Cassi, E; Ceriani, A; Confalonieri, C; De Paoli, A; Lombardi, F; Montalbetti, L; Pisoni, GB; Scandolaro, L | 1 |
| Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C | 1 |
| Allan, SE; Andrade, CA; Carriço, MK; Costa, MA; Dobbin, JA; Froimtchuk, MJ; Gil, RA; Martino, JL; Olivatto, LO; Rabinowits, M | 1 |
| Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR | 1 |
| DeVita, VT; Duffey, PL; Fisher, RI; Hubbard, SM; Jaffe, ES; Longo, DL; Raffeld, M; Wittes, RE; Young, RC | 1 |
| Fisher, RI | 1 |
| Hirano, M | 1 |
| Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M | 1 |
| Andersen, J; Cassileth, PA; Colgan, J; Glick, J; Gordon, LI; O'Connell, M; Resnick, GD | 1 |
| Cooper, I; Laidlaw, CR; Page, FJ; Stone, JM | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Begley, CG; Boyd, AW; Grigg, AP; Lickliter, JD; Szer, J | 1 |
| Advani, SH; Dinshaw, KA; Gopal, R; Nair, R; Saikia, TK; Soman, CS | 1 |
| Grünewald, T; Jautzke, G; Pohle, HD; Ruf, B; Schürmann, D; Weiss, R | 1 |
| Hahn, J; Herndier, B; Kaplan, LD; McGrath, MS; Meeker, TC; Ng, V; Shiramizu, B; Volberding, PA | 1 |
| Amadori, S; Bocchia, M; Falini, B; Fiacchini, M; Martelli, M; Martelli, MF; Mazza, P; Papa, G; Pileri, S; Zinzani, PL | 1 |
| Fujimoto, N; Higuchi, M; Kawamura, M; Kuni-Eda, Y; Kurosawa, M; Maekawa, I; Morioka, M; Ohmura, T; Okabe, M; Suzuki, S | 1 |
| Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
| Biron, P; Blay, JY; Bouffet, E; Bouhour, D; Brunat-Mentigny, M; Carrie, C; Philip, T | 1 |
| Heinz, R; Hopfinger, G; Koller, E; Pittermann, E; Schneider, B | 1 |
| Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M | 1 |
| Xu, T | 1 |
| Asakawa, H; Higano, S; Imaizumi, M; Matsumoto, K; Sakamoto, K; Sato, A; Tada, K; Takahashi, S | 1 |
| Cohen, MD; Luthra, HS; Menke, DM; Moder, KG; Tefferi, A | 1 |
| Brocq, O; Carli, P; Chagnon, A; de Jaureguiberry, JP; Jaubert, D; Marlier, S; Paris, JF | 1 |
| Hryniuk, W | 1 |
| Bonnem, E; Levine, A; Melendez, D; Rarick, M; Shelton, B; Thompson, J; Walsh, C; Wernz, JC; Willson, E | 1 |
| Brower, M; Dudgeon, DJ | 1 |
| Dujardin, P; Fuzibet, JG; Garnier, G; Pesce, A; Schneider, S; Taillan, B | 1 |
| Hagemeister, FB | 1 |
| Almagro, M; Corrales, A; Herranz, MT; Martí, J; Molina, MA; Redondo, E | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Waits, TM; Wolff, SN | 1 |
| Sawada, U | 1 |
| Craig, JI; Cuthbert, RJ; Ludlam, CA | 1 |
| Ang, PT; Chua, EJ; Ong, YW; Sng, I; Soh, LT | 2 |
| DeVita, VT; Longo, DL; Young, RC | 1 |
| Chan, TK; Lam, WK; Liang, RH; Ngan, HY | 1 |
| Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M | 1 |
| Müller, U; Stahel, RA | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM | 1 |
| Ezoe, A; Fujisaki, Y; Hayashi, S; Kohda, K; Nakazawa, O; Takayanagi, N; Takeda, M; Takimoto, R; Tsuji, A; Tsuji, Y | 1 |
| Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H | 1 |
| Endo, T; Hayakawa, H; Kawaguchi, N; Tei, H; Yashima, M | 1 |
| Hattori, N; Kaya, H; Matano, S; Mochizuki, Y; Nakamura, S; Okabe, Y; Okumura, H; Otake, S; Takeshima, M; Yoshida, T | 1 |
| Bevan, DH; Dalgleish, AG; Evans, TR; Harmer, CL; Mansi, JL | 1 |
| Fujimoto, T; Kikuchi, M; Shimizu, H; Takaue, Y; Takeda, T; Utsumi, J | 1 |
| Andersson, BS; Bellare, N; Gajewski, JL; Giralt, SA; Khouri, IF; McCarthy, P; Mehra, R; Nath, R; Przepiorka, D; van Besien, KW | 1 |
| Kadin, M; Kersey, JH; King, D; Krailo, MD; Meadows, AT; Morse, M; Rosenstock, J; Steinherz, PG; Tubergen, DG | 1 |
| Balla, G; Békési, A; Kovács, I; Oláh, VA; Tóth, A | 1 |
| Reiter, A | 1 |
| Baron, D; Koreichi, A; Le Goff, P; Saraux, A | 1 |
| Cambier, N; Cony-Makhoul, P; Delmer, A; François, S; Harousseau, JL; Leprisé, PY; Ostronoff, M; Patte, C; Rigal-Huguet, F; Soussain, C | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Abate, G; Corazzelli, G; D'Andrea, P; Fimiani, P; Gailli, E; Iaccarino, G; Marcacci, G; Monda, VM; Tafuto, S | 1 |
| Katou, H; Kuwabara, H; Miyaguchi, M; Sakai, S; Sakamoto, H; Yamauchi, A | 1 |
| Aglietta, M; Bondesan, P; Caracciolo, D; Falda, M; Gallo, E; Gavarotti, P; Locatelli, F; Novarino, A; Paolino, F; Sanavio, F | 1 |
| Green, JA; Pendleton, N | 1 |
| Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG | 1 |
| Arrighini, A; Carli, M; Cordero di Montezemolo, L; Fears, TR; Fossati Bellani, F; Garrè, ML; Guazzelli, C; Jankovic, M; Rosso, P; Terracini, B | 1 |
| Butler, RW; Finlay, JL; Hill, JM; Meyers, PA; Steinherz, PG | 1 |
| Cano, J; Carcassonne, Y; Catalin, J; Lejeune, C; Monjanel-Mouterde, S; Payet, B; Tubiana-Mathieu, N | 1 |
| Brown, CV; Miller, JH | 1 |
| Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
| Brown, AE; Crown, JP; Gulati, SC; Jurcic, JG; Koll, B; Yahalom, J | 1 |
| Baxter, JD; DiNubile, MJ | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Bowman, WP; Buchanan, GR; Griffin, TC; Winick, NJ | 1 |
| Ebina, K; Kowada, M; Mineura, K; Sasajima, T; Sawataishi, J; Sugawara, A | 1 |
| Dhondt, JL; Farriaux, JP; Hayte, JM; Mazingue, F; Millot, F | 1 |
| Oguro, M; Sakai, C; Takagi, T | 1 |
| Beck, O; Björk, O; Hayder, S; Peterson, C; Skoglund, KA; Söderhäll, S; Wennberg, M | 1 |
| Argüello, A; Barrantes, JC; Barrantes, M; García, I; Jiménez, R; Lobo-Sanahuja, F | 1 |
| Castanet, J; Dujardin, P; Ferrari, E; Fuzibet, JG; Garnier, G; Pesce, A; Taillan, B | 1 |
| Golding, R; Hoekstra, OS; Ossenkoppele, GJ; Teule, GJ; van Lingen, A | 1 |
| Broekmans, FJ; Schutter, EM; Swartjes, JM; Van der Valk, P | 1 |
| Ashida, T; Ayabe, T; Maekawa, I; Namiki, M; Shibata, Y; Taruishi, M | 1 |
| Benard, BA; Heimans, JJ; Huijgens, PC; Ossenkoppele, GJ; Postma, TJ | 1 |
| Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Ganesan, TS; Gregory, W; Johnson, PW; Matthews, J; Richards, MA; Rohatiner, AZ; Whelan, JS | 1 |
| Engels, B; Hartmann-Klosterkötter, U; Heider, A; Kress, M; Niederle, N | 1 |
| Smith, PJ; Stevens, M; Tiedemann, K; Toogood, IR | 1 |
| Dorigo, A; Kwan, YL; Mansberg, R | 1 |
| Cobeta-Garcia, JC; Fontova-Garrofé, R; Ruiz-Jimeno, MT | 1 |
| Akatsuka, J; Furukawa, T; Nakazawa, S; Nishimura, K; Ohira, M; Okawa, Y; Sugita, K; Tsuchida, M | 1 |
| Castanet, J; Dujardin, P; Ferrari, E; Garnier, G; Pesce, A; Taillan, B | 1 |
| Bergeron, C; Chatel, M; Darcel, F; Edan, C; Faivre, J; Jouan, H; Le Moine, P; Le Prise-Fleury, E; Patte, C; Tass, P | 1 |
| Gerhartz, HH; Walther, J; Wilmanns, W | 1 |
| Oguro, M; Sakai, C; Sampi, K; Sawada, U; Takagi, T | 1 |
| Anderson, JR; Chilcote, RR; Coccia, PF; Exelby, PR; Jenkin, RD; Kjeldsberg, CR; Meadows, AT; Siegel, S; Sposto, R; Wilson, JF | 1 |
| Andersen, JW; Hines, JD; Mann, R; Mazza, JJ; Neiman, RS; O'Connell, MJ; Oken, MM | 1 |
| Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
| Bolognesi, A; Ferreri, AJ; Reni, M; Verusio, C; Villa, E | 1 |
| Cheng, AL | 1 |
| Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
| Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R | 1 |
| Cawley, JC; Clough, JV; Davies, JM; Nash, JR; Parry, H; Phillips, JK; Sherlaw-Johnson, C | 1 |
| Fuzimoto, N; Higuchi, M; Itaya, T; Kawamura, M; Maekawa, I; Morioka, M; Nishi, K; Ohmura, T; Okabe, M; Suzuki, S | 1 |
| Bower, M; Brock, C; Gulliford, T; Newlands, ES; O'Reilly, SM; Smith, DB | 1 |
| de Smet, MD; Kohler, DR; Nussenblatt, RB; Smith, J; Stark-Vancs, V; Wittes, R | 1 |
| Adde, MA; Arndt, C; Gootenberg, J; Horak, ID; Magrath, IT; Neely, JE; Nieder, ML; Seibel, NL; Shad, AT; Venzon, DJ; Weintraub, M | 1 |
| Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
| Bessell, EM; Firth, JL; Graus, F; Hope, DT; Lopez-Guillermo, A; Moloney, AJ; Punt, JA; Villa, S | 1 |
| Berg, GE; Johansson, BR; Klingenstierna, HA; Landys, KE; Ridell, BS; Torgerson, JS | 1 |
| Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H | 1 |
| Calabresi, F; De Sanctis, V; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Meloni, G; Papa, G; Tura, S; Vignetti, M; Zinzani, PL | 1 |
| Crowther, D; Deakin, DP; Harris, M; Morgenstern, GR; Pettengell, R; Radford, JA; Ryder, D; Scarffe, JH; Wilkinson, PM; Woll, PJ | 1 |
| Enblad, G; Glimelius, B; Hagberg, H | 1 |
| Bijnens, L; De Wolf-Peeters, C; Hagenbeek, A; Meerwaldt, JH; Noordijk, EM; Pittaluga, S; Somers, R; Teodorovic, I; Thomas, J | 1 |
| Kisseberth, WC; London, CA; MacEwen, EG; Moore, FM; Obradovich, JE; Ritter, MA; Vail, DM | 1 |
| Behm, F; Berard, C; Bowman, WP; Carroll, A; Cook, B; Griffin, T; Head, D; Link, M; Murphy, S; Pullen, J; Shuster, JJ | 1 |
| Anderson, J; Cassileth, P; Glick, J; Gordon, LI; Habermann, TM; Schilder, RJ; Winter, JN | 1 |
| Cher, L; Glass, J; Harsh, GR; Hochberg, FH | 1 |
| Bodenstein, H; Dietzfelbinger, H; Eimermacher, H; Engert, A; Freund, M; Herrmann, R; Hiddemann, W; Kreuser, ED; Landys, K; Nahler, M; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stauder, R; Stein, H; Tiemann, M; Tirier, C; Trümper, L; Unterhalt, M | 1 |
| Anderson, NR; Lokich, JJ; Moore, CL | 2 |
| Anderson, L; Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; MacLennan, KA; Milligan, DW; Newland, AC; Stevenson, PA; Vaughan Hudson, B; Vaughan Hudson, G; Wood, JK | 1 |
| Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M | 1 |
| Jensen, MK; Skejø, HP | 1 |
| Fisher, RI; Gaynor, ER | 2 |
| Usman, AR; Yunus, MB | 1 |
| Nowacki, P; Zyluk, B | 1 |
| Fujisawa, S; Fukawa, H; Hattori, M; Kanamori, H; Kodama, F; Maruta, A; Motomura, S; Mouri, H; Okubo, T; Sakai, R; Taguchi, J; Tanabe, J; Tomita, N | 1 |
| al-Mulhim, FA; al-Nabhan, AA; Bunyan, RF; Ibrahim, EM; Ibrahim, RE | 1 |
| Carletti, S; Frondizi, D; Maira, G; Mastronardi, L; Spera, C | 1 |
| Chong, R; Goh, YT; Lee, LH; Ng, HS; Tan, P; Wong, GC | 1 |
| Andersen, J; Bauer, KD; Fisher, RI; Gordon, LI; Jiang, S; Neiman, RS; Oken, MM; Variakojis, D; Winter, JN | 1 |
| Fryze, C; Grzelec, H; Nowacki, P; Zdziarska, B | 1 |
| Dietrich, CF; Heyd, R; Jacobi, V; Kirchner, J; Seipelt, G | 1 |
| Fujimoto, T | 1 |
| Chiodo, F; Coronado, O; Costigliola, P; Gherlinzoni, F; Gritti, F; Mazza, P; Mazzetti, M; Raise, E; Tosi, P; Tura, S; Visani, G | 1 |
| Alcalá, A; Bladé, J; Estapé, J; Faura, MV; Fontanillas, M; García-Conde, J; Hernández-Nieto, L; Llorente, A; López-Guillermo, A; Maldonado, J; Montserrat, E; Viñolas, N; Zubizarreta, A | 1 |
| Ben Othman, T; Binet, JL; Fardeau, C; Gerber, S; Leblond, V; Lehoang, P; Merle-Béral, H; Reux, I; Soussain, C; Sutton, L | 1 |
| Gomi, K; Izuno, I; Oguchi, M; Sasaki, S; Shikama, N; Sone, S; Takei, K | 1 |
| Bologna, C; Jorgensen, C; Picot, MC; Sany, J; Verdier, R; Viu, P | 1 |
| Avanzini, P; Baldini, L; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Guffanti, A; Maiolo, AT; Pieresca, C; Silingardi, V | 1 |
| Bergström, SR; Glimelius, BL; Nyman, RS; Rehn, SM; Rodriguez, M | 1 |
| Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
| Aumann, V; Dörffel, W; Kluba, U; Mittler, U; Mohnike, K; Timme, J; Vorwerk, P | 1 |
| Connors, JM; Gascoyne, RD; Klimo, P; Lee, AY; O'Reilly, SE | 1 |
| Adamson, PC; Balis, FM; Montello, MJ; Murphy, RF; O'Brien, M; Sorensen, JM; Widemann, BC | 1 |
| Cooley, TP; Dezube, BJ; Herndier, B; Huang, J; Kaplan, LD; Levine, AM; Northfelt, DW; Straus, DJ; Testa, MA; Tulpule, A; Von Roenn, J | 1 |
| Cooper, IA; Fox, RM; Matthews, JP; Robertson, TI; Stone, J; Wolf, M | 1 |
| Kamieńska, E | 1 |
| Lundberg, LG; Samuelsson, J | 1 |
| Kremer, JM | 1 |
| Georgescu, L; Paget, SA; Quinn, GC; Schwartzman, S | 1 |
| Basser, R; Fox, R; Goss, G; Grigg, A; Szer, J | 1 |
| Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C | 1 |
| Angus, B; Cameron, DA; Cook, MK; Dawes, PJ; Dawson, AA; Evans, RG; Galloway, MJ; Harris, AL; Heppleston, A; Horne, CH; Krajewski, AS; Lennard, AL; Leonard, RC; Lessells, AM; Lucraft, HH; MacGillivray, JB; Mackie, MJ; Parker, AC; Prescott, RJ; Proctor, SJ; Roberts, JT; Taylor, PR; Thompson, WD; White, JM | 1 |
| Berard, CW; Bowman, WP; Brecher, ML; Coppes, MJ; Link, MP; Murphy, SB; Schwenn, MR; Shuster, JJ | 1 |
| Hallahan, D; Mundt, AJ; Williams, SF | 1 |
| Bessho, F; Iga, T; Matsushita, Y; Moriwaki, K; Sawada, Y; Yamamoto, K | 1 |
| Sparano, J | 1 |
| Berard, CW; Donaldson, SS; Link, MP; Murphy, SB; Shuster, JJ | 1 |
| Magrath, I | 1 |
| Cassileth, P; Cooper, BW; Fernandez, H; Kutteh, L; Lazarus, HM; Miller, KB; Morelli, J; Pecora, AL; Roitman, D; Schenkein, DP; Stadtmauer, E | 1 |
| Evans, WE; Harrison, PL; Lascombes, F; Mahmoud, HH; Mondesir, JM; Pui, CH; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT; Struxiano, A | 1 |
| Bargay, J; Brunet, S; Caballero, D; de la Rubia, J; de la Serna, J; Domingo-Albós, A; Espigado, I; Figuera, A; García Conde, J; Hernández, F; Mataix, R; Moraleda, J; Ojeda, E; Pérez-Oteiza, J; Petit, J; Rozman, C; Sierra, J; Solano, C; Torrabadella, M; Urbano-Ispizua, A; Vivancos, P | 1 |
| Farese, VL; Girard, PM; Jacomet, C; Lebrette, MG; Monfort, L; Rozenbaum, W | 1 |
| Katai, H; Kinoshita, T; Maruyama, K; Matsuno, Y; Sano, T; Sasako, M; Takenaka, T | 1 |
| Joensuu, H; Muhonen, T; Ristamäki, R; Teerenhovi, L; Villikka, K | 1 |
| Chamberlain, MC; Kormanik, PA | 1 |
| Ferracini, R | 1 |
| Braun, J; Dalhoff, K; Hannemann, J; Hornei, B | 1 |
| Zyluk, B | 1 |
| Baccarani, M; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Sperotto, A; Stocchi, R | 1 |
| Bettelheim, P; Ehrengruber, A; Fridrik, MA; Geit, M; Höpfel, I; Leisch, F; Simma, R; Wahl, G | 1 |
| Alvarez Alvarez, C; García García, S | 1 |
| Camoriano, JK; Habermann, TM; Kurtin, PJ; Schroeder, G; Witzig, TE | 1 |
| Bleyer, WA | 1 |
| Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O | 1 |
| Albertini, P; Ascani, S; Bendandi, M; Buzzi, M; Gherlinzoni, F; Magagnoli, M; Pileri, S; Sabattini, E; Tura, S; Zinzani, PL | 1 |
| Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R | 1 |
| Asami, K; Eguchi, H; Hatae, Y; Hirota, T; Iwai, A; Katano, N; Koizumi, S; Kono, Y; Matusita, T; Miyawaki, T; Mugisima, H; Nakayama, M; Nisikawa, K; Osima, K; Sekine, I; Simokawa, T; Suzumiya, J; Tanaka, A; Tsuchiya, T; Tsurusawa, M; Utumi, J; Yamamoto, Y; Yamamura, Y; Yanase, T; Yokota, S | 1 |
| Bairey, O; Blickstein, D; Epstein, O; Gabbay, U; Lahav, J; Prokocimer, M; Shaklai, M; Stark, P | 1 |
| Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Pharo, A; Smeland, EB | 1 |
| Bianco, AR; Biondi, E; Lauria, R; Matano, E; Montesarchio, V; Morabito, A; Pagliarulo, C; Palmieri, G; Rea, A; Tagliaferri, P | 1 |
| Urasiński, I; Wichert, K; Zdziarska, B; Zuk, E | 1 |
| Cabanillas, F; Dong, K; Hagemeister, FB; McLaughlin, P; Moon, T; Rodriguez, MA; Rodriguez-Diaz Pavón, J; Romaguera, JE | 1 |
| Akiba, H; Harabuchi, Y; Hareyama, M; Hinoda, Y; Hirokawa, N; Kataura, A; Koito, K; Morita, K; Nagakura, H; Oouchi, A; Sakata, K; Satoh, M; Tamakawa, M | 1 |
| Bailey, NP; Barnard, DL; Bessell, EM; Child, JA; Cullen, MH; Dunn, J; Farish, J; Fletcher, J; Grieve, RJ; Jack, A; Norfolk, D; Simmons, AV; Stack, C; Stuart, NS; Woodroffe, CM | 1 |
| Bloor, AJ; Marcus, RE; Seale, JR | 1 |
| Korfel, A; Thiel, E | 1 |
| Guttormsen, AB; Lønning, PE; Mella, O; Refsum, H; Ueland, PM | 1 |
| Bando, K; Hasegawa, Y; Ohyama, S; Shirayma, H; Taniguti, M | 1 |
| Hoshino, T; Iwamoto, T; Kuroko, K; Nishida, S; Shirai, C | 1 |
| Ben-Bassat, I; Chetrit, A; Dreiher, J; Raamami, P; Raanani, P; Shpilberg, O | 1 |
| Adam, Z; Hájek, R; Hejlová, N; Klabusay, M; Korístek, Z; Krahulcová, E; Král, Z; Mayer, J; Müllerová, I; Navrátil, M; Penka, M; Tomíska, M; Vásová, I; Vodvárka, P; Vorlícek, J | 1 |
| Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
| Bigazzi, C; Bocchia, M; Forconi, F; Lauria, F; Marotta, G | 1 |
| Cabanillas, F; Champlin, R; Claxton, D; Giralt, S; Hagemeister, F; Kantarjian, H; Khouri, IF; Korbling, M; Palmer, JL; Przepiorka, D; Pugh, WC; Rodriguez, A; Romaguera, J; Samuels, B; Younes, A | 1 |
| Arnold, R; Flath, B; Gottschalk, S; Lehmann, R; Massenkeil, G; Späth-Schwalbe, E | 1 |
| Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
| Dobashi, N; Kuraishi, Y; Usui, N | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Dräger, LM; Huijgens, PC; Jonkhoff, AR; Schuurhuis, GJ; Teule, GJ; Van Leeuwen-Stok, EA; Visser-Platier, AW | 1 |
| Mora, J; Wollner, N | 1 |
| Boiardi, A; Broggi, G; Fariselli, L; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Bauters, F; Detourmignies, L; Dupriez, B; Fenaux, P; Jouet, JP; Morel, P; Plantier-Colcher, I; Simon, M | 1 |
| Hanai, M; Horie, T; Irie, T; Kaneita, Y; Kura, Y; Mochimaru, J; Sato, Y; Sawada, U; Yamazaki, T; Yasukawa, K | 1 |
| Castillo, M; Mukherji, SK; Stone, JA | 1 |
| Biberoğlu, G; Hasanoğlu, A; Oğuz, A; Timlioğlu, O; Uluoğlu, C | 1 |
| Cream, JJ; Farrell, AM; Francis, N; Henry, K; Mitchell, DN; Newlands, ES; Woodrow, D | 1 |
| Ariyoshi, K; Kameda, N; Kamei, T; Katsuki, K; Shinohara, K; Takeda, K; Yamada, T | 1 |
| Brocchieri, A; Grignani, G; Maiolo, A; Merlo, EM; Tua, A | 1 |
| Berger, F; Blanc, M; Chevrel, G; Felman, C; Jeanneret, J; Miossec, P; Tebib, J | 1 |
| Baumelou, E; Caubarrere, I; Couderc, LJ; Epardeau, B; Frachon, I; Hermine, O; Stelianides, S; Stern, M | 1 |
| Bergna, MI; Cánepa, C; Gardenal, L; Gil, MA; Italiano, C; Klein, G; Malacalza, J; Mansilla, E; Marin, GH; Mendez, MC; Menna, ME; Orlando, S; Perez, M; Piccinelli, G; Saba, S | 1 |
| Hishima, T; Inokuma, S; Kono, H; Maeda, Y; Matsuzaki, Y; Nakayama, H; Yamazaki, J | 1 |
| Akimov, MA; Gershanovich, ML | 1 |
| Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F | 1 |
| Cassileth, PA; Flynn, P; Ghosh, C; Glick, J; Gordon, LI; Habermann, TM; Weller, E; Winter, JN; Young, M | 1 |
| Anticoli Borza, P; Bendandi, M; Bocchia, M; Cellini, C; De Renzo, A; Gherlinzoni, F; Gobbi, M; Lauta, VM; Magagnoli, M; Mandelli, F; Martelli, M; Palombi, F; Pavone, E; Ronconi, F; Scaramucci, L; Stefoni, V; Storti, S; Tura, S; Zaja, F; Zinzani, PL | 1 |
| Dubey, SP; Kaleh, LK; Morewaya, JT; Sengupta, SK | 1 |
| Damek, D; Guha-Thakurta, N; Hochberg, FH; Pollack, C | 1 |
| Akerman, M; Anderson, H; Cavallin-Ståhl, E; Dictor, M; Hagberg, H; Jerkeman, M; Johnson, A; Kaasa, S; Kvaløy, S; Sundström, C | 1 |
| Abate, G; Bianco, AR; Catalano, G; D'Aprile, M; Dammacco, F; De Lena, M; De Vita, F; Lauta, VM; Lorusso, V; Lucarelli, G; Mantovani, G; Marzullo, F; Palmieri, G; Polimeno, G | 1 |
| Chihara, K; Inoue, R; Iwata, N; Kajimoto, Y; Matsui, T; Matsuoka, H; Natazuka, T; Shimoyama, M; Tamekane, A | 1 |
| Hattori, T; Matsuda, M; Seki, S; Tabata, K | 1 |
| Hatano, Y; Kume, M; Miura, AB; Miura, I | 1 |
| Ascari, E; Avanzini, P; Baldini, L; Broglia, C; Ghirardelli, ML; Gobbi, PG; Loni, C; Quarta, G; Silingardi, V; Stelitano, C | 1 |
| Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; Maclennan, KA; Milligan, D; Newland, AC; Smith, P; Stevenson, PA; Vaughan, B; Vaughan, G; Wood, JK | 1 |
| Armata, J; Bogusławska-Jaworska, J; Bubała, H; Dłuzniewska, A; Kazanowska, B; Kowalczyk, J; Kołecki, P; Matysiak, M; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopyło, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G | 1 |
| Caracciolo, D; Corradini, P; Cuttica, A; Gavarotti, P; Ladetto, M; Novero, D; Pileri, A; Rossi, G; Tarella, C; Zallio, F | 1 |
| Balcerzak, SP; Dana, BW; Fisher, RI; Forman, JD; Gaynor, ER; Kjeldsberg, C; LeBlanc, M; Miller, T; Roy, V; Unger, JM | 1 |
| Cairo, MS; Finlay, JL; Gururangan, S; Meadows, AT; Sposto, R | 1 |
| Fujisawa, S; Fujita, H; Fukawa, H; Harano, H; Hattori, M; Ishigatsubo, Y; Kanamori, H; Kodama, F; Koharasawa, H; Maruta, A; Matsuzaki, M; Miyashita, H; Motomura, S; Ogawa, K; Sakai, R; Taguchi, J; Tanabe, J; Tomita, N | 1 |
| Chabot, F; Delorme, N; Ferry, R; Guerci, O; Lederlin, P; Polu, JM; Renaudier, P; Witz, B; Witz, F | 1 |
| De Palo, G; Ditto, A; Fontanelli, R; Gallino, G; Massone, PB; Raspagliesi, F | 1 |
| Luo, Y; Wang, A; Wang, Z | 1 |
| Hasegawa, M; Hayabuchi, N; Hirota, S; Ikeda, H; Isobe, K; Nakamura, K; Oguchi, M; Sasai, K | 1 |
| Hochberg, FH; Kim, L; Shaeffer, P | 1 |
| Bollen, P; Bourgain, C; Duville, L; Van Berlaer, G; Vandenplas, Y | 1 |
| Attal, M; Besson, C; Brière, J; Haioun, C; Lederlin, P; Lepage, E; Reyes, F; Rose, C; Simon, D; Sonet, A; Thieblemont, C; Tilly, H | 1 |
| Bosly, A; Brice, P; Brière, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Lederlin, P; Lepage, E; Morel, P; Nouvel, C; Reyes, F; Salles, G; Sebban, C; Tilly, H | 1 |
| Abrey, LE; DeAngelis, LM; Yahalom, J | 1 |
| Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
| Cabanillas, F | 2 |
| Apostolidis, J; Foran, JM; Gupta, RK; Kelsey, SM; Lister, TA; Rohatiner, AZ; Shamash, J; Walewski, J; Wilson, AM | 1 |
| Fukawa, H; Harano, H; Hattori, M; Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Ogawa, K; Takemura, S; Tanabe, J; Tomita, N; Yamazaki, E; Yoshida, M | 1 |
| Anami, K; Asami, K; Fujimoto, T; Horikoshi, Y; Iwai, A; Katano, N; Kawano, Y; Kikuchi, M; Kikuta, A; Koizumi, S; Matsushita, T; Miyake, M; Mugishima, H; Sekine, I; Tsurusawa, M; Watanabe, A; Yamamura, Y | 1 |
| Blume, KG; Hoppe, RT; Horning, SJ; Hu, WW; Johnston, LJ; Negrin, RS; Stockerl-Goldstein, KE | 1 |
| Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M | 1 |
| Arnold, R; Bartram, CR; Böhme, A; Freund, M; Ganser, A; Gökbuget, N; Hoelzer, D; Kneba, M; Langer, W; Lipp, T; Ludwig, WD; Maschmeyer, G; Messerer, D; Rieder, H; Thiel, E; Weiss, A | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Jerkeman, M; Longo, G; Messori, A; Rigacci, L; Trippoli, S; Vaiani, M | 1 |
| Fenstad, GU; Skovlund, E | 1 |
| Aranoff, GS; Feldstein, NA; Garvin, JH; Hays, AP; Levine, LS; Oberfield, SE; Silfen, ME; Starkman, HS; Wong, B | 1 |
| Azzarà, A; Capochiani, E; Carulli, G; Petrini, M; Rizzuti-Gullaci, A | 1 |
| Bessell, EM; Byrne, P; Graus, F; Holland, I; López-Guillermo, A; Petit, J; Verger, E; Villá, S | 1 |
| Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
| Angelopoulou, MK; Kalovidouris, A; Mitropoulos, FA; Pangalis, GA; Papalampros, E; Rassidakis, G; Siakantaris, MP; Vayiopoulos, GA | 1 |
| Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ | 1 |
| Barbui, T; Benedetti, F; Cavalli, F; Cortelazzo, S; Di Nicola, M; Ghielmini, M; Gianni, AM; Oldani, E; Pogliani, E; Rambaldi, A; Rossi, A; Tarella, C; Vitolo, U; Zaglio, F | 1 |
| Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
| Batchelor, T; Kaufman, D; Leahy, N | 1 |
| Chilcote, RR; Kadin, ME; Kjeldsberg, C; Krailo, MD; Meadows, AT; Morse, M; Siegel, SE; Sposto, R; Steinherz, PG; Termuhlen, AM | 1 |
| Bacilieri, M; Campioni, D; Castoldi, G; Dabusti, M; De Angeli, C; Dominici, M; Focarile, E; Galluccio, L; Lanza, F; Moretti, S; Pauli, S; Punturieri, M; Scapoli, C; Tieghi, A | 1 |
| Hochberg, FH; Tabatabai, G | 1 |
| Ferreri, AJ; Reni, M | 1 |
| Bergui, L; Boccadoro, M; Caracciolo, D; Cuttica, A; de Crescenzo, A; Gavarotti, P; Ladetto, M; Marinone, C; Pagano, M; Pileri, A; Ricca, I; Rossi, G; Salomone, A; Tarella, C; Zallio, F | 1 |
| Finke, J; Korfel, A; Schmidt-Wolf, I; Thiel, E | 1 |
| Cavallin-Stahl, E; Hjermstad, M; Jerkeman, M; Kaasa, S; Kvaløy, S | 1 |
| Baruchel, A; Bertozzi, AI; Boutard, P; Frappaz, D; Laplanche, A; Mechinaud, F; Michon, J; Nelken, B; Patte, C; Schmitt, C | 1 |
| Canfield, PJ; Foster, SF; Gabor, LJ; Malik, R; McCorkell, BE | 1 |
| Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H | 1 |
| Cooney, J; Kaminski, M; Stiff, P | 1 |
| Cairo, MS; Finlay, JL; Harris, RE; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Krailo, MD; Meadows, AT; Morris, E; Morse, M; Radel, E; Steinherz, LJ | 1 |
| Ericsson, SM; Glimelius, BL; Larsson, RL; Nygren, HP; Sundström, C | 1 |
| Bokstein, F; Lossos, A; Lossos, IS; Siegal, T | 1 |
| Balandraud, N; Cazals-Hatem, D; Liote, F; Mariette, X; Sibilia, J; Warszawki, J | 1 |
| Flickinger, JC; Germanwala, A; Kondziolka, D; Schiff, D; Singhal, D; Witham, TF | 1 |
| DeAngelis, LM | 1 |
| Basso, U; Brandes, AA | 1 |
| Anderson, PN; Borgaonkar, DS; Burke, PJ; Klein, DL; Santos, GW; Schacter, B; Sensenbrenner, LL; Slavin, RE | 1 |
| Donner, L; Klener, P | 1 |
| Schmidt, CG | 1 |
| Blom, H; Flaherty, M; Glidewell, O; Hayes, D; Holland, JF; McIntyre, R; Nissen, NI; Pajak, T | 1 |
| Bömer, H; Hübener, KH; Küpper, U; Treuner, J | 1 |
| Bruntsch, U; Passek, S; Reis, HE; Schmidt, CG; Teske, HJ | 1 |
| Andreeva, NA; Ershova, IuA; Nemeriuk, MP; Riabokon', NA; Sokolova, AS | 1 |
| Wehinger, H | 1 |
| Balcarbová, A; Cihar, R; Kubín, M; Motycka, K; Slavík, K; Spacek, P | 1 |
| Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA | 1 |
| Coleman, M; Pasmantier, M; Silver, RT; Turman, S | 1 |
| Brecher, ML; Freeman, AI; Sinks, LF; Thomas, RR | 1 |
| Hackenbruch, W; Oechsler, H; Wündisch, GF | 1 |
| Canellos, GP; Lister, TA; Skarin, AT | 1 |
| Forcier, RJ; Glidewell, O; Holland, JF; McIntyre, OR; Nissen, NI; Pajak, TF | 1 |
| Op de Coul, AA; Slooff, JL | 1 |
| Konchakova, MI; Kruglova, GV | 1 |
| Cihar, R; kocovská, A; Kubín, M; Motycka, K; Spacek, P | 1 |
| Balcarová, A; Cihar, R; Motycka, K; Slavík, K; Slavíková, V; Spacek, P | 1 |
| Kosloski, MJ; Milholland, RJ; Papahadjopoulos, D; Rosen, F | 1 |
| Djerassi, I; Kim, JS | 1 |
| Gang, M; Garibjanian, BT; Goldin, A; Johnson, RK; Kline, I; Vadlamudi, S; Venditti, JM | 1 |
| Op de Coul, AA; Slooff, JL; Vauger, AJ | 1 |
| Wray, EB | 1 |
| Gutteberg, TJ; Moe, PJ | 1 |
| Gálfi, I; Koós, R; Révész, T; Schuler, D; Virág, I | 1 |
| Bishop, Y; Frei, E; Furman, L; Geiser, CF; Jaffe, N; Traggis, D | 1 |
| Bagshawe, KD; Gower, PE; Tasker, PR; Walden, PA | 1 |
| Baccarani, M; Fiacchini, M; Gobbi, M; Lauria, F; Tura, S | 1 |
| Becker, G; Bruntsch, U; Höffken, K; Passek, S; Reis, HE; Schmidt, CG; Teske, HJ | 1 |
| Friedman, M | 1 |
| Dedrick, RL; Hart, MM; Klubes, P; Lutz, RJ; Straw, JA; Zaharko, DS | 1 |
| Jackson, RC; Niethammer, D | 1 |
| Dommann, C; Gebbers, JO; Honegger, HP; Joss, R; Kroner, T; Maurer, R; Peters, J; Pichert, G; Stahel, RA; Sulser, H | 1 |
| Bianconcini, G; Candini, R; Dallasta, A; Gobbi, F; Mazzali, F | 1 |
| Joensuu, H; Turpeenniemi-Hujanen, T | 1 |
| Abe, T; Fujii, H; Kashima, K; Kuzuyama, Y; Misawa, S; Nakagawa, H; Okuda, T; Sonoda, Y; Takashima, T | 1 |
| Dolińska, D; Grzelec, H; Nowacki, P; Stankiewicz, J | 1 |
| Laine, P; Lindqvist, C; Meurman, JH; Murtomaa, H; Pyrhönen, S; Teerenhovi, L; Tenovuo, J | 1 |
| Koivisto, V; Oksanen, K; Sinisalo, M; Vikberg, V | 1 |
| Abdullin, KA; Efimov, ML; Malysheva, LA; Vasil'eva, GS | 1 |
| Dolińska, D; Honczarenko, K; Nowacki, P; Potemkowski, A | 1 |
| Gibson, J; Joshua, DE; Kronenberg, H; Mansberg, R | 1 |
| Ezaki, K; Hirano, M; Ino, T; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Shimizu, K; Shinkai, K; Sobue, R | 1 |
| Bitran, JD; Platanias, LC; Putterman, AM; Recant, W; Vijayakumar, S; Weichselbaum, RR | 1 |
| Dujardin, P; Ferrari, E; Fuzibet, JG; Garnier, G; Taillan, B; Vinti, H | 1 |
| Arnold, H; Bross, K; Heidemann, E; Heim, ME; Hoffman, I; Josten, K; Manegold, C; Reinold, HM; Schalk, KP; Steinke, B | 1 |
| Kawanishi, Y; Kuge, S; Kuriyama, Y; Kuwabara, S; Nakano, M; Toyama, K; Yaguchi, M | 1 |
| Mizoguchi, H; Saito, H | 1 |
| Ashiya, M; Hirano, H; Kouda, K; Kura, Y; Sakuma, A; Satou, Y; Sawada, U; Suzuki, K; Tsuboi, I; Yamazaki, T | 1 |
| Maiche, AG; Muhonen, T; Porkka, K | 1 |
| Andersen, J; Barcos, M; Colgan, J; Glick, J; Gordon, LI; Gottlieb, A; Harrington, D; Mann, R; Neiman, R; Resnick, GD | 1 |
| Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S | 1 |
| Akyar, S; Baskal, N; Dagci, SS; Ekinci, C; Erdogan, G; Kamel, AN | 1 |
| Allen, NB; Caldwell, DS; Hall, BD; Kingsmore, SF; Rice, JR | 1 |
| Adachi, S; Akiyama, Y; Hashimoto, H; Kasai, Y; Kubota, M; Mikawa, H; Sano, H; Shimizu, T | 1 |
| Quah, TC; Siegel, SE; White, L | 1 |
| Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
| Amadori, S; Guglielmi, C; Mandelli, F; Martelli, M; Papa, G | 2 |
| Balcar-Boroń, A; Krzyzanowski, M; Ozyński, T; Pilecki, O; Szadujkis-Szadurski, L; Wysocki, M | 1 |
| Balcar-Boroń, A; Krzyzanowski, M; Nowaczyk-Michalak, A; Ozyński, T; Szadujkis-Szadurski, L; Wysocki, M | 1 |
| Cooper, IA; Ding, JC; Matthews, JP; Matthews, JR | 1 |
| Endo, N; Imai, S; Shimamoto, Y | 1 |
| Horiuti, A; Kakishita, E; Kanamaru, A; Masaoka, T; Miyazaki, E; Nagai, K; Shibata, H; Takemoto, Y; Tsubaki, K; Yonezawa, T | 1 |
| Canellos, GP; Harrington, DP; Jochelson, MS; Klatt, MM; Pinkus, GS; Rosenthal, DS; Shipp, MA; Skarin, AT; Yeap, BY | 1 |
| Clarkson, BD; Koziner, B; Lee, BJ; Lowenthal, DA; Schluger, AE; Schneider, AM; Straus, DJ; Wong, G | 1 |
| Forsthuber, T; Fuhr, HG; Gamm, H; Hennekeuser, HH; Hinterberger, R; Kreiter, H; Lindemann, A; Oster, W; Schmitz, G; Thoenes, W | 1 |
| Golomb, HM; Hoffman, PC; Larson, RA; Mick, R; Olopade, OI; Ultmann, JE; Watson, SM | 1 |
| Nantel, S; Parboosingh, J; Poon, MC | 1 |
| Arimizu, N; Itami, J; Mikata, A; Nemoto, K; Ogata, H; Shimizu, K; Yasuda, S; Yoshida, H | 1 |
| Ambrosetti, A; Benedetti, F; Cetto, GL; Chilosi, M; Meneghini, V; Menestrina, F; Perona, G; Pizzolo, G; Todeschini, G; Veneri, D | 1 |
| Aguilar Ligorit, E; Benet Monforte, I; Escrig Orenga, V; García-Conde Bru, J; Guix García, J | 1 |
| Kaczmarski, R; Mufti, GJ; Pagliuca, A | 1 |
| Arechaga, S; Bellas, C; Berenguer, A; Calleja, JL; García Villanueva, A; Marcos Robles, J; Montalbán, C; Patier, JL | 1 |
| Ajarim, DS; Santhosh-Kumar, CR; Shipkey, FD | 1 |
| Anderson, JR; Barcos, M; Bloomfield, CD; Ginsberg, SJ; Gottlieb, AJ; Henderson, ES; Holland, JF; Nissen, N; Norton, L; Peterson, BA | 1 |
| Diehl, V; Eckert, G; Heitz, W; Hilger, HH; Kirn, E; Krueger, GR; Pothoff, G; Wassermann, K | 1 |
| Dahlberg, S; Eyre, HJ; Files, JC; Fisher, RI; Miller, TP; Pendergrass, KB; Weick, JK | 1 |
| Amadori, S; Gherlinzoni, F; Guglielmi, C; Mandelli, F; Mazza, P; Tura, S | 1 |
| Cossman, J; DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wesley, MN | 1 |
| Avilés, A; Díaz-Maqueo, JC; López Vancell, D; Rodríguez, L; Torras, V | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Hildreth, CR; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| DeAngelis, LM; Gnecco, C; Taylor, L; Warrell, RP | 1 |
| Balcerzak, SP; Dahlberg, S; Dana, B; Fisher, RI; Miller, TP; Pierce, HI; Weick, JK | 1 |
| Dahlberg, S; Fisher, RI; Miller, TP | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Wolff, SN | 1 |
| Anders, CH; Moritz, T; Nagel-Hiemke, M; Niederle, N; Nowrousian, MR; Schmidt, CG; Seeber, S | 1 |
| Armitage, JO | 1 |
| DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Miller, TP; Young, RC | 1 |
| Bennett, JM; Cohen, P; Kahn, J; Kaplan, L; Levine, AM; Metroka, C; Rarick, MU; Rodman, N; Walsh, C; Wernz, JC | 1 |
| Brack, N; Brittinger, G; Dornoff, W; Engelhard, M; Enne, W; Gassmann, W; Gerhartz, H; Hallek, M; Heise, J; Meusers, P | 1 |
| Chan, TK; Chiu, E; Ho, F; Liang, R; Todd, D | 1 |
| Cousar, JB; Flexner, JM; Greco, FA; Greer, JP; Hainsworth, JD; Johnson, DH; McMaster, ML; Stein, RS; Wolff, SN | 1 |
| Canellos, GP; Godleski, J; Jochelson, MS; Shapiro, CL; Shipp, MA; Skarin, AT; Yeap, BY | 1 |
| Capnist, G; Chisesi, T; Contu, A; Coser, P; Porcellini, A; Rancan, L; Rizzoli, V; Salvagno, L; Santini, G; Sertoli, M | 1 |
| Bocchia, M; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Mazza, P; Papa, G; Pileri, S; Tura, S; Zinzani, PL | 1 |
| Abbadessa, V; Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Gobbi, PG; Leone, G; Lombardo, M; Moretti, G; Pitini, V | 1 |
| Bessell, EM; Firth, J; Holland, I; Hope, T; Lowe, J; Punt, J | 1 |
| Mead, GM; Sweetenham, JW; Whitehouse, JM | 1 |
| Smeets, J; Wils, J | 1 |
| Cervos-Navarro, J; Dienemann, D; Jautzke, G; Langford, A; Pohle, HD; Ruf, B; Schürmann, D; Stein, H | 1 |
| Urasiński, I; Zdziarska, B | 1 |
| Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R | 1 |
| Carrión, JR; Delgado, JR; Dominguez, S; Flores, E; Garcia, P; Jaen, J; Santos, JA | 1 |
| Berard, C; Brecher, M; Crist, W; Hvizdala, E; Pullen, J; Ragab, A; Ramirez, I; Shuster, J; Sullivan, MP; Vietti, T | 1 |
| Laine, P; Lindqvist, C; Meurman, JH; Murtomaa, H; Pyrhönen, S; Teerenhovi, L; Torkko, H | 1 |
| Abdel-Azim, H; el-Ghamrawy, KA; Haggag, M; Zawam, HZ | 1 |
| Amadori, S; Coluzzi, S; Guglielmi, C; Mandelli, F; Martelli, M | 1 |
| Hochberg, FH; Loeffler, JS; Prados, M | 1 |
| Amadori, S; Dragoni, F; Guglielmi, C; Mandelli, F; Martelli, M | 1 |
| Nielsen, H | 1 |
| Dunkelman, H; Earl, HM; Twelves, C | 1 |
| Simmons, ED; Somberg, KA | 1 |
| Brincker, H; Mirza, MR | 1 |
| Carey, PJ; Hamilton, PJ; Proctor, SJ; Taylor, P | 1 |
| Fairclough, DL; Furman, WL; Ingram, LC; Kun, LE; Pui, CH; Rivera, GK; Sandlund, JT | 1 |
| Jolivet, J | 1 |
| Matsuhisa, T; Miyoshi, K; Moriwaki, S; Motoi, M; Naruse, R; Okabe, K; Sakamoto, S; Shimokawa, T; Toki, H; Urayama, H | 1 |
| Dhondt, JL; Farriaux, JP; Hayte, JM; Mazingue, F; Millot, F; Taret, S | 1 |
| Mwangemi, PM | 1 |
| Blatt, J | 1 |
| de Andrea, ML; de Camargo, B; Melaragno, R | 1 |
| Nachman, J | 1 |
| Balakirev, SA; Gavrilova, IE; Gordina, GA; Kiselev, AV; Maiakova, SA; Makhonova, LA; Moiseenko, EI; Morozova, OV | 1 |
| Barnes, J; Eden, OB; Hann, IM; Pinkerton, CR | 1 |
| Marwaha, RK; Pritchard, J | 1 |
| Kaito, K; Katayama, T; Kobayashi, M; Masuoka, S; Nishiwaki, K; Ochiai, S; Saito, A; Sakai, O; Shimada, T; Yoshida, M | 1 |
| Cotes, PM; Hellebostad, M; Marstrander, J; Refsum, HE; Slørdahl, SH | 1 |
| Fornasier, V; Keystone, EC; Sturgeon, JF; Thomson, GT | 1 |
| Chessells, JM; Wheeler, K | 1 |
| Enblad, G; Glimelius, B; Hagberg, H; Lindemalm, C | 1 |
| Bostík, J; Bures, L; Lichý, A; Spundová, M | 1 |
| Donhuijsen, K; Günzel, K; Höffken, K; Kath, R; Schmidt, CG | 1 |
| Aubier, F; Bonnay, M; Lemerle, J; Patte, C; Valteau, D; Vassal, G | 1 |
| Jackson, WL; Stephens, RL; Williamson, SK | 1 |
| Canellos, GP; Siegel, RD; Skarin, AT | 1 |
| Brandeis, WE; Burger, R; Kretzmann, R; Ludwig, R | 1 |
| Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP | 1 |
| Canellos, GP; Case, DC; Jochelson, MS; Klatt, MM; Pinkus, GS; Rosenthal, DS; Shipp, MA; Skarin, AT; Yeap, BY | 1 |
| Connors, JM; Klimo, P | 3 |
| Berhardt, B; Chiarieri, D; Coleman, M; Gerstein, G; Lebowicz, J; Pasmantier, MW; Silver, RT; Topilow, A | 1 |
| Connors, JM; Klimo, P; Turhan, A | 1 |
| Anderson, JR; Barcos, M; Bloomfield, CD; Ginsberg, SJ; Gottlieb, AJ; Holland, JF; Norton, L | 1 |
| Cáp, J; Foltinová, A; Misíková, Z | 1 |
| Knecht, H; Odermatt, BF; Rhyner, K; Streuli, RA | 1 |
| Cossman, J; Glatstein, E; Lawrence, TS; Steinberg, SM; Sundeen, JT; Urba, WJ; Young, RC | 1 |
| Brittinger, G; Dörken, B; Engelhard, M; Engert, W; Enne, W; Fuchs, R; Gerhartz, HH; Hagen-Aukamp, CH; Huhn, D; Thiel, E | 1 |
| Brittinger, G; Engelhard, M; Gerhartz, H; Heinz, R; Huhn, D; Meusers, P; Neubauer, A; Siegert, W; Stacher, A; Thiel, E | 1 |
| Arnold, H; Busch, FW; Günther, E; Heim, ME; Kraft, H; Krüger, HU; Steinke, B | 1 |
| Abdel Jabar, A; Abssod, GH; Al-Idrissi, HY; Al-Mulhim, FA; Ibrahim, EM; Satti, MB | 1 |
| DeVita, VT; Glatstein, E; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC | 1 |
| Coltman, CA; Dahlberg, S; Dana, BW; Fisher, RI; Jones, SE; Miller, TP; Weick, JK | 1 |
| Adam, H; Egli, F; Flepp, M; Greminger, P; Lüthy, R; Rhyner, K; Schüler, G | 1 |
| Armitage, JO; Bierman, PJ; Kessinger, A; Klassen, LW; Schouten, HC; Vaughan, WP; Weisenburger, D | 1 |
| Diehl, V; Schaadt, M; von Kalle, AK | 1 |
| Canellos, GP; Jochelson, MS; Klatt, MM; Mauch, PM; Rosenthal, DS; Shipp, MA; Skarin, AT; Yeap, B | 1 |
| Bross, K; Heidemann, E; Heim, ME; Hofmann, I; Josten, K; Kraft, A; Löffler, B; Reinold, HM; Richter, C; Steinke, B | 1 |
| Brittinger, G; Engelhard, M; Gerhartz, HH; Heinz, R; Huhn, D; Meusers, P; Siegert, W; Stacher, A; Thiel, E; Wilmanns, W | 1 |
| Bergerat, JP; Duclos, B; Dufour, P; Garcia, JJ; Herbrecht, R; Oberling, F | 1 |
| Gutkowska, J; Konopka, L; Pakulska, J; Pawelski, S | 1 |
| Eifel, PJ; McClure, S | 1 |
| Anders, C; Höffken, K; Meier, CR; Nowrousian, MR; Osieka, R; Schmidt, CG; Schoetensack, B | 1 |
| Kojima, M; Naito, M; Nara, M; Shinbo, T; Tanahashi, N; Watanabe, K | 1 |
| Frydecka, I; Kotlarek-Haus, S; Kuliczkowski, K; Kuliszkiewicz-Janus, M; Urbaniak-Kujda, D; Wołowiec, D | 1 |
| Cepelák, V; Cetkovský, P; Jungerová, J; Koza, V; Pittrová, H; Skopek, P; Vozobulová, V | 1 |
| Charlesworth, M; Ede, GM; Gawler, J; Green, CR; Jamal, GA; Patel, P; Prior, PF; Stevenson, JF; Thakkar, CM; Tucker, J | 1 |
| Arfeen, S; Carey, PJ; Jackson, G; Proctor, SJ; Stark, AN | 1 |
| Hoppe, RT | 1 |
| Bayle, C; Bergeron, C; Bernard, A; Caillaud, JM; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Luboinski, B; Patte, C | 1 |
| Brodzki, M; Deptala, A; Konopka, L; Krämer, M; Pawelski, S; Swencz-Szczepanik, K | 1 |
| Chilcote, RR; Coccia, PF; Jenkin, RD; Kersey, JH; Meadows, AT; Pringle, KC; Rosenstock, J; Siegel, SE; Sposto, R; Stolar, CJ | 1 |
| Hung, IJ; Yang, CP | 1 |
| Alessandrino, EP; Bernasconi, P; Canevari, A; Inverardi, D; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G; Regazzi Bonora, M; Rondanelli, R | 1 |
| Bagshawe, KD; Begent, RH; Boesen, E; Glaser, MG; Ledermann, JA; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
| Coe, MA; Errington, RD; Green, JA; Nash, JR; Warenius, HM | 1 |
| Abdel-Hadi, S; Adde, M; el-Taneer, O; Gad-el-Mawla, N; Hussein, MH; Magrath, I | 1 |
| Gubareva, AA; Kindzel'skiĭ, LP | 1 |
| Boen-Tan, TN; Rouwen, AJ; Stilma, JS; Wijermans, PW | 1 |
| Begg, EJ; Colls, BM; Jeffery, GM; Robinson, BA; Sharman, JR | 1 |
| Efimov, ML; Kovalenko, VR; Mustafina, RKh; Panina, TG; Vasil'eva, GS | 1 |
| Ichimaru, M; Kikuchi, M; Kimura, I; Konda, S; Ogawa, M; Ota, K; Shimoyama, M; Takatsuki, K; Tominaga, S; Yunoki, K | 1 |
| Grieve, RJ; Harris, RI; Leyland, MJ; Patton, WN; Sangster, G | 1 |
| Kopper, L; Magyarosy, E; Major, J; Nagy, P | 1 |
| Armata, J; Cyklis, R; Dłuzniewska, A | 1 |
| Aarbakke, J; Kolmannskog, S; Moe, PJ; Prytz, PS; Slørdal, L | 1 |
| Kairis, M; Mousatos, G; Pappas, J; Prodromou, N; Tzortzatou-Stathopoulou, F; Zavitsa-Pateli, H | 1 |
| Bernard, A; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C | 1 |
| Burnelli, R; Mancini, AF; Paolucci, G; Paolucci, P; Pession, A; Rosito, P; Serra, L; Vecchi, V; Vivarelli, F | 1 |
| Poburski, R; Wiehler, S | 1 |
| Barrantes, J; García, I; Jiménez, E; Jiménez, R; Lobo-Sanahuja, F; Vargas, G | 1 |
| Antuña García, MJ; Fernández, C; Gudín, G; López Sastre, J; Moro Bayón, C; Rodríguez, R | 1 |
| Badía Torroella, RM; Cubells Riero, J; González Rivero, MA; Illa Sala, J; Melo Valls, M; Pardo García, N; Turmo Martí, J; Vela Ferrer, E | 1 |
| Colly, LP; Peters, WG; Willemze, R | 1 |
| Wollner, N | 1 |
| Castel, V; Ferris, J; Mínguez, JR; Verdeguer, A | 1 |
| Bezanilla Regato, JL; Burgos, J; Moya Calderón, E; Navajas Gutiérrez, A; Zubeldia Sánchez, J | 1 |
| Imura, H; Ino, T; Ito, N; Kojima, H; Maruyama, F; Matsui, T; Shimizu, K; Shinkai, K; Shirakawa, S; Sobue, R | 1 |
| Jurásková, V | 1 |
| Fujii, Y; Hongo, T; Igarashi, Y | 1 |
| Becker, H; Grubbauer, HM; Hauer, C; Urban, C; Zach, M | 1 |
| Armata, J; Dłuzewska, A | 1 |
| Cieślińska, A | 1 |
| Chełkowska, H; Chlebcewicz-Szuba, W; Nowakowska, J; Podraza, W; Skwira, J; Urasiński, T | 1 |
| Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA | 1 |
| Berard, C; Callihan, T; Falletta, J; Hvizdala, EV; Sabio, H; Shuster, JJ; Sullivan, M; Wharam, MD | 1 |
| Bouffet, E; Frappaz, D | 1 |
| Altamirano-Alvarez, E; Ayon-Cardenas, A; Borrego-Roman, R; Cardenas-Cardoz, R; Lanche-Guevara, T; Lopez-Corella, E; Martinez-Avalos, A; Martinez-Guerra, G; Rivera-Luna, R | 1 |
| Armata, J; Bogusławska-Jaworska, J; Cyklis, R; Daszkiewicz, P; Dłuzniewska, A; Kazanowska, B; Matysiak, M; Ochocka, M; Radwańska, U; Rodziewicz, B | 1 |
| Cirrincione, C; Posner, JB; Recht, L; Straus, DJ; Thaler, HT | 1 |
| Bowie, M; Hill, I; Rogers, P; Sinclair-Smith, C | 1 |
| Arai, T; Fujii, Y; Hongo, T; Igarashi, Y; Kino, I; Mizuno, Y; Okamoto, K | 1 |
| Correa Alves, A; de Andrea, ML; de Camargo, B; Franco, EL; Machado, JC | 1 |
| Bostík, J; Bures, L; Motycka, K; Rehák, L; Spundová, M | 1 |
| Blackledge, GR; Child, JA; Ellis, IO; Fletcher, J; Jones, EL; Kavanagh, JA; Kelly, KA; O'Brien, CJ; Perren, TJ; Stuart, NS | 1 |
| Akisawa, M; Ikeda, K; Kamano, H; Kubota, Y; Nagai, M; Ohnishi, H; Sasaki, K; Shimada, Y; Tanaka, T; Taoka, T | 1 |
| Hijiya, N; Ise, T; Kanagawa, S; Kitabayashi, T; Matsushita, T; Yamaguchi, M | 1 |
| Ikeda, N; Ikuno, Y; Kikuchi, M; Nibu, K; Okamura, J; Tasaka, H; Yamada, S | 1 |
| Jurd, J; Milliken, S; Poulgrain, P; Vincent, PC; Young, GA | 1 |
| Schrøder, H | 2 |
| Deville, A; Manassero, J; Milano, G; Renee, N; Schneider, M; Thyss, A | 1 |
| Chang, TT; Chen, TS; Chiou, SS; Perng, JJ | 1 |
| Blackledge, GR; Obeid, ML; Randall, J | 1 |
| Canellos, GP; Skarin, AT | 1 |
| Arlin, Z; Gee, T; Higgins, C; Kempin, S; Koziner, B; McKenzie, S; Mertelsmann, R; Schauer, P; Slater, DE; Straus, D | 1 |
| Baumgarten, E; Buchmann, S; Fengler, R; Grosch-Wörner, I; Henze, G; Schulte-Overberg, U | 1 |
| Fuks, Z; Mandell, LR; Wollner, N | 1 |
| Hayes, AA; Kurzman, I; MacEwen, EG; Matus, RE | 1 |
| Barcos, M; Gomez, GA; Han, T; Henderson, ES | 1 |
| Amadori, S; Guglielmi, C; Mandelli, F; Mantovani, L; Martelli, M; Papa, G; Ruco, LP | 1 |
| Halie, MR; Nieweg, HO; van Imhoff, GW | 1 |
| Dyr, JE; Holý, P; Motycka, K; Pristoupilová, K; Slavík, K; Slavíková, V | 1 |
| Amadori, S; Anselmo, AP; Baroni, CD; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G | 1 |
| Din, GX; He, GF; Sun, ZY; Tang, WY | 1 |
| Abrahamsen, AF; Dahl, IM; Holte, H; Saeter, G | 1 |
| Losonczy, H; Nagy, I | 1 |
| Bukin, IuV; Lukienko, EP | 1 |
| Kruglova, GV; Setdikov, RA | 1 |
| Setdikov, RA | 1 |
| Bostík, J; Bures, L; Jirásek, A; Motycka, K; Slavík, K | 1 |
| Horikoshi, N; Imajo, K; Inagaki, J; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Ueno, K; Yamazaki, H | 1 |
| Gallego Melcón, S; Macía Martí, J; Pérez Payarols, J; Prats Viñas, J; Sánchez de Toledo, J | 1 |
| Adair, SE; Camitta, BM; Casper, JT; Kirchner, PA; Kun, LE; Lauer, SJ; Oechler, HW | 1 |
| Barbet, J; Cano, JP; Gastaut, JA; Imbert, AM; Lejeune, C; Lena, N; Maraninchi, D; Sainty, D; Sebahoun, G; Tubiana, N | 1 |
| Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R | 1 |
| Hartwich, G; Soyka, D; Taghavy, A | 1 |
| Gary-Bobo, J | 1 |
| Keidan, SE | 1 |
| Armstrong, JG | 1 |
| Bukin, IuV; Raushenbakh, MO; Sergeev, AV | 1 |
| Gregory, MC; Hughes, JT | 1 |
| Aghai, E; Hulu, N; Kende, G; Ramot, B; Virag, I | 1 |
| Dedrick, RL; Hart, MM; Klubes, P; Straw, JA; Zaharko, DS | 1 |
| Jacobi, H; Karitzky, D | 1 |
| Gutjahr, P | 1 |
| Galt, RM; Knock, FE; Oester, YT; Sylvester, R | 1 |
| Drings, P; Kölmel, HW; Paal, G | 1 |
| Bertino, JR; DeConti, RC; Farber, LR; Levitt, M; Marsh, JC; Mitchell, MS; Skeel, RT | 1 |
| Durepaire, RM; Eisenmann, D | 1 |
| DeVita, VT; Sherins, RJ | 1 |
| Bagley, CM; Canellos, GP; Chabner, BA; De Vita, VT; Schein, PJ; Young, RC | 1 |
| Arseneau, JC; Canellos, GP; DeVita, VT; Sherins, RJ | 1 |
| Armata, J | 1 |
| Kruglova, GV; Lorie, IuI; Mansurov, AN | 1 |
| Averbukh, LA; Bazhanov, VS; Grinshteĭn, AM; Lepeshkina, GN; Shorin, VA | 1 |
| Chernik, NL; Posner, JB; Shapiro, WR | 1 |
| Armata, J; Cyklis, R; Legutko, L | 1 |
| Gilman, PA; Luddy, RE | 1 |
| Boiron, M; Jacquillat, C; Weil, M | 1 |
| Alberto, P | 1 |
| Glidewell, OJ; Harley, JB; Hoogstraten, B; Lenhard, RE; Leone, LA; Miller, S; Olson, KB; Owens, AH; Spurr, CL; Townsend, SR | 1 |
| Amiel, JL; Cattan, A; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Rosenfeld, C; Schlumberger, JR; Schneider, M; Schwarzenberg, L | 1 |
| Gendelman, S; Mones, RJ; Rizzo, F | 1 |
| Eridani, S; Esposito, R; Giangrande, A; Ponti, GB | 1 |
| Adamson, RH | 1 |
| Cohen, ML; Weiss, EB | 1 |
| Stutzman, L | 1 |
| Becker, H | 1 |
| Block, JB; Carbone, PP; Haskell, CM; Leventhal, BG; Selawry, OS | 1 |
| Aur, RJ; Hustu, HO; Pinkel, D; Pratt, CB; Simone, JV | 1 |
| Kelleter, R; Kuhn, D; Schröter, R | 1 |
| Galton, DA | 1 |
| Blom, J; Burgert, EO; Chevalier, L; Denton, R; Glidewell, O; Hananian, J; Holland, JF; Jones, B; Kung, F; Mills, SD; Nyhan, WL; Sheehe, P; Treat, C; Wolman, IJ | 1 |
| Figueiredo, DG; Martins, JM; Pitombeira, Mda S | 1 |
| Rothenberg, SP | 1 |
| Cottafava, F; Fossati-Guglielmoni, A; Massimo, L; Mori, PG; Pelizza, A | 1 |
| Lorie, IuI; Streliukhina, NV | 1 |
| Brenner, SM; Custodio, D; Miller, SP | 1 |
| Lampkin, BC; Mauer, AM; Nagao, T | 1 |
| Abboud, G; Bertino, JR; Fölsch, E; Gralla, E | 1 |
| Nichol, CA | 1 |
| Ambellan, E; Hollander, VP | 1 |
| Cohen, RA; Glatstein, HR; Rosenbaum, EH | 1 |
100 review(s) available for methotrexate and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neurotoxicity Syndromes; Prognosis | 2021 |
Primary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Tumor Microenvironment | 2022 |
Primary Central Nervous System Lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Stem Cell Transplantation | 2022 |
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Consensus; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Randomized Controlled Trials as Topic | 2022 |
Central Nervous System Lymphoma: Novel Therapies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local | 2022 |
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Consensus; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Positron Emission Tomography Computed Tomography; Retinal Neoplasms; Rituximab; Transplantation, Autologous; Vitreous Body | 2022 |
Treatment Options for Recurrent Primary CNS Lymphoma.
Topics: Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Cytarabine; Humans; Immune Checkpoint Inhibitors; Lenalidomide; Lymphoma, Non-Hodgkin; Methotrexate; Nivolumab; Pemetrexed; Procarbazine; Prospective Studies; Receptors, Chimeric Antigen; Retrospective Studies; Rituximab; Temozolomide; Thiotepa; Vincristine | 2022 |
Review of rituximab in primary CNS lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Rituximab | 2020 |
Advances and challenges in the treatment of primary central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Stem Cell Transplantation | 2020 |
[Primary central nervous system lymphomas].
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis | 2020 |
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Cranial Irradiation; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Transplantation, Autologous | 2020 |
How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration?
Topics: Antidotes; Antimetabolites, Antineoplastic; Hemodiafiltration; Humans; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Treatment Outcome; Young Adult | 2020 |
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2021 |
Central Nervous System Lymphomas.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Tumor Microenvironment | 2020 |
High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Disease-Free Survival; Dose-Response Relationship, Drug; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Remission Induction; Treatment Outcome | 2021 |
Current management of primary central nervous system lymphoma.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Molecular Targeted Therapy; Rituximab | 2017 |
Primary Central Nervous System Lymphoma.
Topics: Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Stem Cell Transplantation | 2017 |
The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Glucose-6-Phosphate; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron-Emission Tomography; Prednisone; Rituximab; Vincristine | 2018 |
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
Topics: Central Nervous System Neoplasms; Cranial Irradiation; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Transplantation, Autologous | 2018 |
Primary intraspinal non-Hodgkin's lymphoma: Case report and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Rituximab; Spinal Cord Neoplasms | 2019 |
Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Killer Cells, Natural; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis; T-Lymphocytes | 2019 |
Primary central nervous system lymphoma: Novel precision therapies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Molecular Targeted Therapy; Precision Medicine; Therapies, Investigational | 2019 |
Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Risk Factors; Stem Cell Transplantation; Treatment Outcome | 2019 |
[High-dose methotrexate plus hematopoietic stem cell transplantation supplemented by rituximab intrathecal injection for primary central nervous system lymphoma:two cases report and literature review].
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Central Nervous System Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Rituximab | 2013 |
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; DNA-Binding Proteins; Humans; Kaplan-Meier Estimate; LIM Domain Proteins; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Proteins; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Treatment Outcome | 2014 |
[Primary central nervous lymphoma: what is the role for radiotherapy?].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Stem Cell Transplantation | 2014 |
Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Thiotepa; Transplantation, Autologous | 2015 |
The Challenge of Primary Central Nervous System Lymphoma.
Topics: Brain Neoplasms; Chemoradiotherapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Rituximab | 2016 |
Extranodal lymphoma: a reappraisal.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Prospective Studies; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2008 |
[Plasmacytoid dendritic cell tumor].
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Disease Progression; Doxorubicin; Humans; Immunophenotyping; Leukemia, Myelomonocytic, Acute; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
Topics: Central Nervous System Neoplasms; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Stem Cell Transplantation | 2011 |
Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Treatment Outcome | 2012 |
Primary CNS lymphoma: a clinician's guide.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Diagnosis, Differential; Evidence-Based Medicine; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis | 2012 |
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Randomized Controlled Trials as Topic | 2012 |
A new approach to the diagnosis and treatment of intravascular lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Gene Rearrangement; Genes, Immunoglobulin; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Spinal Cord Neoplasms; Vascular Neoplasms; Vincristine | 2003 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2004 |
Advances for the treatment of primary central nervous system lymphoma (review).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Quality of Life; Recurrence; Time Factors; Treatment Outcome | 2004 |
Testicular granulocytic sarcoma, a source of diagnostic confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytarabine; Cytoplasmic Granules; Daunorubicin; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Sarcoma, Myeloid; Testicular Neoplasms; Vincristine | 2004 |
Management of primary intraocular lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Eye Neoplasms; Humans; Lymphoma, Non-Hodgkin; Medical Oncology; Methotrexate; Radiotherapy; Recurrence; Retina; Stem Cell Transplantation; Treatment Outcome | 2005 |
Controversies in primary CNS lymphoma.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate | 2005 |
An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chemotherapy, Adjuvant; Humans; Joint Capsule; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Metacarpophalangeal Joint; Methotrexate; Middle Aged; Radiotherapy, Adjuvant | 2006 |
[Link between rheumatoid arthritis and cancer].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Cross-Sectional Studies; Epstein-Barr Virus Infections; Female; Hodgkin Disease; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms; Risk Factors; Tumor Necrosis Factor-alpha | 2006 |
Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Antigens; CD56 Antigen; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dendritic Cells; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Skin Neoplasms; Vincristine | 2006 |
High-dose methotrexate and primary central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Biopsy; Central Nervous System Neoplasms; Drug Administration Schedule; Drug Monitoring; Female; Humans; Incidence; Infection Control; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Nursing Assessment; Patient Care Planning; Rare Diseases; Stereotaxic Techniques; Survival Rate; Treatment Outcome | 2007 |
Primary CNS lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Combined Modality Therapy; HIV Infections; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis; Radiotherapy; Stem Cell Transplantation | 2007 |
Primary central nervous system lymphoma.
Topics: Adrenal Cortex Hormones; Antimetabolites, Antineoplastic; Brain; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Remission Induction; Survival Rate | 2007 |
Advances in adult non-Hodgkin's lymphoma. Current concepts of classification, diagnosis, and management.
Topics: Adult; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Humans; Lymph Nodes; Lymphocytes; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1980 |
Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer.
Topics: Acute Disease; Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Division; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Kinetics; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Mice; Models, Biological | 1984 |
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Vincristine | 1994 |
[Malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine | 1994 |
Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1995 |
Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Retrospective Studies | 1995 |
[Lymphoma induced by low-dose methotrexate in rheumatoid arthritis with severe lymphopenia].
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Lymphopenia; Methotrexate; Middle Aged | 1995 |
Polymyositis-dermatomyositis and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dermatomyositis; Doxorubicin; Fatal Outcome; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Polymyositis; Prednisone; Radiography; Vincristine; Vision Disorders | 1993 |
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Germany, West; Humans; Infant; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Meninges; Methotrexate; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1994 |
[Lymphoma during treatment of rheumatoid arthritis with low-dose methotrexate: a new case].
Topics: Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged | 1994 |
Primary central nervous system involvement of the so called 'peripheral T-cell lymphoma'. Report of a case and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Basal Ganglia; Biopsy; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Female; Humans; Immunophenotyping; Life Tables; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Methotrexate; Methylprednisolone; Middle Aged; Survival Analysis; Vincristine | 1993 |
[Malignant lymphoma in rheumatoid arthritis treated by low doses of methotrexate].
Topics: Aged; Arthritis, Rheumatoid; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1993 |
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms, Second Primary; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1993 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 1995 |
[Disseminated pneumoperitoneum during the therapy of lymphoma with methotrexate and cytosine arabinoside].
Topics: Anemia, Aplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumatosis Cystoides Intestinalis; Pneumoperitoneum; Prognosis | 1996 |
[Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
Topics: Antidotes; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Synergism; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms; Osteosarcoma | 1996 |
Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; France; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms; Retrospective Studies | 1997 |
The emergence of Hodgkin's disease in a patient with long-standing chronic lymphocytic leukemia--case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Disease Progression; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Vincristine | 1997 |
Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Risk Factors | 1997 |
[Primary malignant non-Hodgkin's lymphomas of the central nervous system in immunocompetent patients: diagnostic, prognostic and therapeutic criteria].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Diagnostic Imaging; Female; Humans; Immunocompetence; Immunophenotyping; Incidence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Radioisotope Teletherapy; Survival Analysis | 1997 |
Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Treatment Outcome; Vincristine | 1998 |
[Chylothorax resulting from malignant non Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1998 |
[Chemotherapy for non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine | 1998 |
Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; Retrospective Studies; Vindesine | 1999 |
Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Immunoglobulin E; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged | 1999 |
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Germany; Humans; Immunophenotyping; Injections, Spinal; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Models, Theoretical; Multicenter Studies as Topic; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Risk; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2000 |
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Vincristine | 2001 |
Primary non-Hodgkin's lymphoma of the gall bladder.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gallbladder; Gallbladder Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Ultrasonography; Vincristine | 2000 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Boston; Brain Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Doxorubicin; Eye Neoplasms; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2001 |
Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 2001 |
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Forecasting; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Risk Factors; Rituximab; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vincristine | 2001 |
Primary central nervous system lymphomas.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Combined Modality Therapy; Contraindications; Cranial Irradiation; Craniotomy; Diagnostic Imaging; Eye; Humans; Injections, Spinal; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Meninges; Methotrexate; Middle Aged; Neoplasm Invasiveness; Seizures; Stereotaxic Techniques; Survival Analysis; Treatment Outcome; Vitrectomy | 2001 |
Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Quality of Life; Risk Factors; Survival Analysis | 2002 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lomustine; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission, Spontaneous; Streptonigrin; Time Factors; Vinblastine; Vincristine | 1977 |
Chemotherapy of the non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Burkitt Lymphoma; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Remission, Spontaneous; Time Factors | 1978 |
Localized non-Hodgkin's lymphoma of the adrenal and thyroid glands.
Topics: Addison Disease; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Dexamethasone; Fludrocortisone; Goiter, Nodular; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Thyroid Gland; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, X-Ray Computed; Triiodothyronine; Ultrasonography; Vincristine | 1992 |
Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review.
Topics: Administration, Oral; Adult; Arthritis, Rheumatoid; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Phenotype | 1992 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
The therapy of primary brain lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Evaluation Studies as Topic; Eye Neoplasms; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Life Tables; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Radiotherapy; Spinal Neoplasms; Survival Rate; Transplantation | 1991 |
Methotrexate and leucovorin in malignant blood diseases.
Topics: Humans; Leucovorin; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate | 1991 |
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Doxorubicin; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; United States; Vincristine | 1990 |
European experience with ifosfamide in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Europe; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone | 1989 |
The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Mycosis Fungoides; Palliative Care; Prednisone; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
[Methotrexate in pediatric hemato-oncology].
Topics: Child; Child, Preschool; Humans; Infant; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Methotrexate; Nervous System Diseases; Osteosarcoma | 1987 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinca Alkaloids; Vincristine | 1972 |
Recently recognized complications of cancer chemotherapy.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; Hodgkin Disease; Humans; Hyperkalemia; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Spermatogenesis; Vincristine | 1974 |
[Danger of hyperuricemia in the treatment of acute leukemia, lymphosarcoma and reticulosarcoma].
Topics: Acute Disease; Allopurinol; Antineoplastic Agents; Child; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Uric Acid; Xanthine Oxidase | 1974 |
[Cancerostatic ingredients of higher plants].
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colchicine; Drug Combinations; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Methotrexate; Mice; Plant Extracts; Plant Proteins; Plants, Medicinal; Prednisone; Species Specificity; Terpenes; Vincristine | 1971 |
217 trial(s) available for methotrexate and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Continued-Maintenance Therapy with High-dose Methotrexate Improves Overall Survival of Patients with Primary Central Nervous System Lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Retrospective Studies | 2021 |
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Rituximab; Survival Rate | 2020 |
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma.
Topics: Aged; Aged, 80 and over; Central Nervous System Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Rate | 2018 |
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.
Topics: Acute Kidney Injury; Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Hyperuricemia; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Proteins; Pilot Projects; Prednisone; Prospective Studies; Rituximab; Tumor Lysis Syndrome; Urate Oxidase; Vincristine; Young Adult | 2013 |
Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Combined Modality Therapy; Cross-Over Studies; Female; Fluid Therapy; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Kidney Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Time Factors; Tissue Distribution; Young Adult | 2014 |
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Procarbazine; Prognosis; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Vincristine; Young Adult | 2015 |
Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Combined; Anthracyclines; Autografts; Central Nervous System Neoplasms; Consolidation Chemotherapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Rate | 2015 |
Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
Topics: Antineoplastic Agents; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate | 2015 |
Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Humans; Idarubicin; Immunotherapy; Injections, Spinal; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Rituximab; Treatment Outcome; Young Adult | 2016 |
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous | 2016 |
[Clinical Therapeutic Efficacy of Rituximab Combined with Methotrexate on Primary Central Nervous System Lymphoma].
Topics: Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Quality of Life; Rituximab; Survival Rate; Treatment Outcome | 2016 |
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2016 |
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Rituximab; Transplantation, Autologous; Young Adult | 2017 |
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Karnofsky Performance Status; Leukopenia; Lomustine; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Procarbazine; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome | 2009 |
Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Central Nervous System Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; STAT6 Transcription Factor | 2009 |
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome | 2008 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Recombinant Proteins; Survival Rate; Vincristine; Young Adult | 2010 |
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Drug Administration Schedule; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Proportional Hazards Models; Remission Induction; Treatment Outcome | 2009 |
Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2009 |
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Disease-Free Survival; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prognosis; Pyrazoles; Salvage Therapy; Sulfonamides; Treatment Outcome | 2010 |
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Remission Induction; Vincristine | 2011 |
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Pilot Projects; Procarbazine; Rituximab; Survival Analysis | 2011 |
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intraventricular; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Rituximab | 2013 |
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Time Factors; Treatment Failure; Vincristine | 2002 |
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine | 2003 |
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; CD3 Complex; Cell Separation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.
Topics: Adult; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Risk Factors; Survival Rate; Tacrolimus; Transplantation, Homologous | 2003 |
Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Central Nervous System Neoplasms; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy Dosage; Retrospective Studies; Spinal Cord; Survival Rate; Treatment Outcome | 2003 |
A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Injections, Spinal; Lenograstim; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Prognosis; Recombinant Proteins; Salvage Therapy; Sepsis; Treatment Outcome; Vincristine | 2003 |
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2004 |
Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Lymphoma, Non-Hodgkin; Malabsorption Syndromes; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Protective Agents; Retinol-Binding Proteins; Vitamin A; Xylose | 2004 |
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Infusions, Intravenous; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Radiotherapy, Adjuvant; Treatment Outcome; Vincristine; Viral Load | 2004 |
Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Treatment Outcome; Venezuela; Vincristine | 2004 |
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Infant; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Patient Compliance; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Treatment Outcome | 2005 |
Capacity buffer of the saliva in children and adolescents with cancer: Variations induced by the administration of metotrexate or cyclophosphamide.
Topics: Acid-Base Equilibrium; Adolescent; Antineoplastic Agents, Alkylating; Buffers; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Hydrogen-Ion Concentration; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Saliva | 2005 |
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive mal
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Radiotherapy; Survival Analysis; Survivors; Vincristine | 2005 |
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Pulse Therapy, Drug; Remission Induction; Risk; Survival Rate; Treatment Outcome; Vincristine | 2005 |
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Hematologic Diseases; Humans; Idarubicin; Life Tables; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Remission Induction; Stroke; Survival Analysis; Thiotepa | 2006 |
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Etoposide; Female; Humans; Killer Cells, Natural; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Nose Neoplasms; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Follow-Up Studies; Humans; Karnofsky Performance Status; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2008 |
Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Clinical Trials as Topic; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Random Allocation; Vincristine | 1983 |
Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer.
Topics: Acute Disease; Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Division; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Kinetics; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Mice; Models, Biological | 1984 |
Successful application of a previously derived prognostic index in the analysis of a randomised trial of 281 patients with high grade non-Hodgkin's lymphoma (HIGNHL).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1993 |
Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 1993 |
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1994 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Creatinine; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney; Kidney Neoplasms; L-Lactate Dehydrogenase; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vindesine | 1994 |
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine | 1994 |
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vincristine | 1994 |
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1994 |
Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Risk Factors; Survival Rate; Treatment Failure; United States; Vincristine | 1995 |
Selection of patients for randomised trials: a study based on the MACOP-B vs CHOP in NHL study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Patient Selection; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Salvage Therapy; Treatment Outcome | 1994 |
Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1994 |
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Factors; Treatment Outcome; Vincristine | 1995 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine | 1995 |
[Lymphatic interventional radiology in the treatment of lymphatic neoplasmas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphatic Metastasis; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiography, Interventional; Stomach Neoplasms; Thiotepa | 1995 |
Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Core Protein p24; Humans; Kidney; Leucovorin; Leukocyte Count; Lung; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Remission Induction; Vincristine | 1993 |
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Vincristine | 1993 |
MACOP-B in advanced non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Survival Analysis; Vincristine | 1993 |
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Vincristine | 1993 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine | 1993 |
[MMIP chemotherapy for the treatment of the relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Recurrence | 1995 |
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Japan; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisolone; Remission Induction; Vincristine | 1995 |
Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Thioguanine; Treatment Failure; Vincristine | 1995 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Recurrence; Transplantation, Autologous | 1993 |
A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine | 1994 |
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Treatment Outcome; Vincristine | 1994 |
[Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 1993 |
Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate.
Topics: Administration, Oral; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Administration Schedule; Humans; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1994 |
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Costa Rica; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Life Tables; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1994 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1993 |
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1993 |
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Survival Rate; Vincristine | 1993 |
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1995 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1995 |
P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisolone; Prognosis; Remission Induction; Vincristine | 1995 |
Administration of rhG-CSF increases complete remission rates after CHOP and ProMACE/CytaBOM for non-Hodgkin's lymphoma: a pilot study. Hokkaido Study Group of Malignant Lymphoma and rhG-CSF.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1995 |
A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vincristine | 1996 |
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Foot Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Pain; Peripheral Nervous System Diseases; Vincristine | 1996 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Vincristine | 1996 |
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1996 |
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Vincristine | 1996 |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prognosis; Survival Rate; Transplantation, Autologous; Vincristine | 1996 |
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine | 1996 |
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Treatment Outcome; Vincristine | 1996 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1996 |
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gallium Radioisotopes; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prednisone; Radioimmunodetection; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 1996 |
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Leucovorin; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 1996 |
A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies | 1996 |
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Survival Analysis; Thrombocytopenia; Vincristine | 1997 |
Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Time Factors; Vincristine | 1997 |
Multiple cycles of aggressive chemotherapy prior to autologous peripheral stem cell transplantation for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome | 1997 |
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Survival Rate; Vincristine; Vindesine | 1997 |
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prognosis; Prospective Studies; Survival Analysis | 1997 |
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Research Design; Survival Analysis; Vincristine | 1997 |
A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Topics: Adult; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Filgrastim; Follow-Up Studies; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leucovorin; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Treatment Outcome; Vincristine | 1997 |
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.
Topics: Allopurinol; Antimetabolites; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Urate Oxidase; Uric Acid | 1997 |
Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS.
Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Humans; Injections, Intravenous; Karnofsky Performance Status; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies | 1997 |
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Prospective Studies; Stomach Neoplasms; Vincristine; Vindesine | 1997 |
Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Retrospective Studies; Vincristine | 1997 |
Non-AIDS-related lymphomatous meningitis: combined modality therapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Meningitis; Methotrexate; Middle Aged; Neoplasm Metastasis; Prospective Studies; Survival Analysis; Thiotepa; Treatment Outcome | 1997 |
[Neuropathologic evaluation of intrathecal prophylaxis results in adults with high grade non-Hodgkin's lymphomas].
Topics: Adult; Aged; Arachnoid; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Injections, Spinal; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Pia Mater; Retrospective Studies; Risk Factors; Spinal Nerve Roots | 1997 |
CHOP therapy: has shorter-course therapy had an impact on lymphomas?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Time Factors; Vincristine | 1998 |
Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vincristine | 1998 |
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1998 |
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Ki-1 Antigen; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Phenotype; Prednisone; Prognosis; Survival Analysis; Vincristine | 1998 |
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine | 1998 |
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Prednisolone; Remission Induction; Treatment Outcome; Vincristine | 1998 |
Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Topics: Adolescent; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Interferon-alpha; Karnofsky Performance Status; Leucovorin; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Vinblastine; Vincristine | 1998 |
[Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1998 |
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Vincristine | 1998 |
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prospective Studies; Survival Rate; United Kingdom; Vincristine | 1998 |
Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Cerebellar Neoplasms; Folic Acid Antagonists; Homocysteine; Humans; Lymphoma, Non-Hodgkin; Male; Medulloblastoma; Methotrexate; Middle Aged | 1998 |
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1998 |
[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Transplantation Conditioning | 1998 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Repressor Proteins; Transplantation, Autologous | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine | 1999 |
A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Treatment Failure; Treatment Outcome; Vincristine | 1999 |
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine | 1999 |
Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Surveys and Questionnaires; Survival Analysis | 1999 |
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisolone; Prognosis; Quality of Life; Survival Rate; Time Factors; Treatment Failure; Vincristine | 1999 |
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine | 2000 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Severity of Illness Index; Survival Analysis; United Kingdom; Vincristine | 2000 |
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Vincristine | 2000 |
Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Leukemia, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Proportional Hazards Models; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
[Different chemotherapy protocols for intermediate and high grade malignant non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Remission Induction; Vincristine | 1997 |
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Topics: Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Statistics, Nonparametric; Vindesine | 2000 |
Treatment for primary CNS lymphoma: the next step.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nervous System Diseases; Procarbazine; Radiation Injuries; Survival Analysis; Vincristine | 2000 |
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dexamethasone; Drug Administration Schedule; Female; Hodgkin Disease; Hospitalization; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Sepsis; Treatment Outcome; Vincristine | 2000 |
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Rate; Vincristine | 2001 |
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Prednisone; Recurrence; Stomatitis; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Health Status; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Quality of Life; Social Behavior; Vincristine | 2001 |
Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Morbidity; Neutropenia; Prednisone; Stomatitis; Vincristine | 2002 |
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Prognosis; Treatment Outcome | 2002 |
Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Treatment Outcome | 2002 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lomustine; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission, Spontaneous; Streptonigrin; Time Factors; Vinblastine; Vincristine | 1977 |
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1977 |
Chemotherapy of the non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Burkitt Lymphoma; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Remission, Spontaneous; Time Factors | 1978 |
Combination chemotherapy of non-Hodgkin lymphoma.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission, Spontaneous; Streptonigrin; Vincristine | 1978 |
MACOP-B regimen in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Survival Analysis; Survival Rate; Vincristine | 1992 |
Cytosine arabinoside and etoposide (CARE) in relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged | 1992 |
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Time Factors; Vincristine | 1992 |
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Rate; Vincristine | 1992 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Immunologic Factors; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Prednisolone; Prednisone; Prognosis; Remission Induction; Survival Rate; Vincristine | 1992 |
F-MACHOP in advanced aggressive lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1992 |
Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Teniposide; Treatment Outcome; Vincristine | 1992 |
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone | 1992 |
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Diseases; Clinical Trials as Topic; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine | 1990 |
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Time Factors; Vincristine | 1990 |
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1990 |
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Mouth Mucosa; Neoplasm Staging; Neutropenia; Recurrence; Remission Induction; Stomatitis; Stroke Volume; Survival Rate; Vincristine | 1990 |
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Mexico; Prednisone; Remission Induction; Survival Rate; Vincristine | 1990 |
Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Electrophysiology; Etoposide; Gangliosides; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Motor Activity; Muscular Diseases; Neurologic Examination; Peripheral Nervous System Diseases; Prospective Studies; Random Allocation; Sensory Thresholds; Vincristine | 1991 |
Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine | 1991 |
Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Diseases; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prospective Studies; Vincristine; Zidovudine | 1991 |
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine | 1991 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vincristine | 1991 |
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1991 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoiesis; Humans; Inflammation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucous Membrane; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Analysis; Vincristine | 1991 |
Phase II study of cyclophosphamide (C), epirubicin (E), oncovin (O), prednisone (P), methotrexate (M) + leucovorin and bleomycin (B) (CEOP-MB) in intermediate and high grade non-Hodgkin lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1991 |
ProMACE-C-MOPP in aggressive non-Hodgkin's lymphoma. Long-term results in 45 patients treated in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1991 |
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Infant; Injections, Spinal; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 1991 |
Effect of antiseptic mouthwashes on some clinical and microbiological findings in the mouths of lymphoma patients receiving cytostatic drugs.
Topics: Amines; Antineoplastic Combined Chemotherapy Protocols; Chlorhexidine; Dental Plaque; Dental Plaque Index; Double-Blind Method; Doxorubicin; Female; Fluorides; Gingival Hemorrhage; Gingivitis; Hodgkin Disease; Humans; Lactobacillus; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouthwashes; Periodontal Index; Saliva; Sodium Fluoride; Streptococcus mutans; Tin Fluorides; Yeasts | 1991 |
The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Time Factors; Vincristine | 1991 |
MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Mitoguazone; Prognosis | 1991 |
Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. The Northern Regional Bone Marrow Transplant Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cryopreservation; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Autologous | 1991 |
A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Premedication; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Vincristine | 1990 |
Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Time Factors; Vincristine | 1987 |
Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ketoconazole; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycoses; Nystatin; Prednisone; Prospective Studies; Random Allocation; Time Factors; Vincristine | 1987 |
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1987 |
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1988 |
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Prednisone; Procarbazine; Vincristine | 1988 |
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evaluation Studies as Topic; Humans; Leucovorin; Leukemia; Leukemia, Radiation-Induced; Lymph Nodes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Palliative Care; Prednisone; Procarbazine; Random Allocation; Vincristine | 1988 |
[Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1989 |
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Vincristine | 1989 |
CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Hydroxyurea; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Mycosis Fungoides; Palliative Care; Prednisone; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Vincristine; Whole-Body Irradiation | 1985 |
Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Humans; Infant; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Random Allocation; Vincristine | 1989 |
[Mitoxantrone containing multi-drug chemotherapy in the management of malignancies. Collaborative Group for Clinical Trial of Mitoxantrone].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Digestive System Neoplasms; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Prospective Studies | 1989 |
Evaluation of methotrexate containing chemotherapeutic regimens in the treatment of childhood undifferentiated non-Hodgkin's lymphoma and B cell acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Retrospective Studies | 1989 |
Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Deltaretrovirus Infections; Doxorubicin; Female; Humans; Japan; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Random Allocation; Time Factors; Vincristine | 1988 |
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Random Allocation; Vincristine | 1988 |
Treatment of non-Hodgkin's lymphoma in Mexican children. The effectiveness of chemotherapy during malnutrition.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Female; Humans; Hydrocortisone; Intestinal Perforation; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Prednisone; Vincristine | 1987 |
Progress in treatment of advanced non-Hodgkin's lymphoma in children--report on behalf of the Polish Children's Leukemia/Lymphoma Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine | 1987 |
Lymphoblastic lymphoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Thioguanine; Vincristine | 1986 |
Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Vincristine | 1987 |
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine | 1985 |
Combination sequential chemotherapy in advanced reticulum cell sarcoma.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Combinations; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nervous System Diseases; Radiography, Thoracic; Remission, Spontaneous; Vincristine | 1972 |
Combined radiotherapy and chemotherapy of lymphomas and other cancers.
Topics: Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Fluorouracil; Follow-Up Studies; Hematopoietic System; Hodgkin Disease; Humans; Hydroxyurea; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Placebos; Vincristine | 1971 |
603 other study(ies) available for methotrexate and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-d]pyrimidine based antifolates as antineoplastic and antiarthritic agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthritis, Experimental; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid Antagonists; Glutamates; Guanine; Hydroxymethyl and Formyl Transferases; Leukemia; Lymphoma, Non-Hodgkin; Mice; Pemetrexed; Peptide Synthases; Phosphoribosylglycinamide Formyltransferase; Pyrimidines; Rats; Structure-Activity Relationship; Tetrahydrofolates; Thymidylate Synthase | 1999 |
Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Topics: Central Nervous System Neoplasms; Eye Neoplasms; High-Throughput Nucleotide Sequencing; Humans; Liquid Biopsy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retinal Neoplasms; Rituximab; Vitreous Body | 2021 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2021 |
Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Feasibility Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Rituximab; Vincristine | 2022 |
Parameters of MR perfusion-weighted imaging predict the response and prognosis to high-dose methotrexate-based chemotherapy in immunocompetent patients with primary central nervous system lymphoma.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Perfusion; Prognosis; Vascular Endothelial Growth Factor A | 2022 |
Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Topics: Endophthalmitis; Eye Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Retinal Neoplasms; Retrospective Studies; Rituximab; Vitreous Body | 2022 |
Methotrexate-induced Leukoencephalopathy: A Rare but Life-threatening Toxicity.
Topics: Acute Disease; Female; Humans; Leukoencephalopathies; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2022 |
Experience With Tirabrutinib in the Treatment of Primary Central Nervous System Lymphoma that Is Difficult to Treat With Standard Treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Cranial Irradiation; Female; Humans; Imidazoles; Lymphoma, Non-Hodgkin; Male; Methotrexate; Pyrimidines; Retrospective Studies | 2022 |
Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas.
Topics: Child; Creatinine; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Mucositis | 2022 |
Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Topics: Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Quality of Life; Retrospective Studies; Salvage Therapy | 2022 |
[Molecular pathogenesis and therapeutic development of primary central nervous system lymphoma: update and future perspectives].
Topics: Agammaglobulinaemia Tyrosine Kinase; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Immune Checkpoint Inhibitors; Lymphoma, Non-Hodgkin; Methotrexate; Myeloid Differentiation Factor 88; NF-kappa B; Phosphatidylinositol 3-Kinases; Procarbazine; Receptors, Chimeric Antigen; Rituximab; Thiotepa; Vincristine | 2022 |
Primary Central Nervous System Lymphoma: Clinical Characteristics, Treatment Options and Therapeutic Outcome in 36 Patients. A Single Center Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Treatment Outcome | 2022 |
Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Eye Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Retinal Neoplasms; Retrospective Studies; Treatment Outcome; Vitreous Body | 2023 |
The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience.
Topics: Central Nervous System; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Retrospective Studies | 2023 |
Primary Central Nervous System Lymphoma in an Immunocompetent Young Adult Patient: A Rare Case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Humans; Immunoglobulin G; Immunoglobulin M; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Procarbazine; Young Adult | 2023 |
Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
Topics: Central Nervous System Neoplasms; Corneal Diseases; Eye Neoplasms; Humans; Intravitreal Injections; Lymphoma, Non-Hodgkin; Methotrexate; Retinal Neoplasms; Sodium Chloride; Vitreous Body | 2023 |
Continuous intrathecal injection therapy of methotrexate is a therapeutic option in primary CNS lymphoma.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brain Neoplasms; Chemoradiotherapy; Cranial Irradiation; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prognosis | 2019 |
Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2019 |
Lateral intraventricular primary central nervous system lymphoma (LIPCNSL): a review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; China; Craniotomy; Disease Progression; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Young Adult | 2020 |
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Progression-Free Survival; Proportional Hazards Models; Remission Induction; Retrospective Studies; Rituximab; United Kingdom | 2020 |
Efficacy of salvage therapy with MTX-HOPE for elderly patients with heavily pretreated non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Piperazines; Salvage Therapy; Treatment Outcome; Vincristine | 2020 |
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis; Tumor Cells, Cultured | 2020 |
Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment.
Topics: Central Nervous System; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Methotrexate | 2020 |
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Delayed Diagnosis; Female; Follow-Up Studies; Humans; Immunocompetence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2020 |
Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Humans; India; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Oral plasmablastic lymphoma: A case report.
Topics: Abscess; Adult; Aftercare; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Edema; HIV Infections; HIV Seropositivity; HIV-1; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mouth; Plasma Cells; Plasmablastic Lymphoma; Treatment Outcome | 2020 |
Real-time intracranial pressure monitoring during high-dose methotrexate treatment for primary central nervous system lymphoma.
Topics: Adult; Central Nervous System Neoplasms; Female; Humans; Intracranial Pressure; Lymphoma, Non-Hodgkin; Methotrexate | 2020 |
MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Piperazines; Prognosis; Proportional Hazards Models; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2021 |
Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Humans; Janus Kinases; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Proportional Hazards Models; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinblastine; Vincristine | 2021 |
The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Glucose; Glucose Transport Proteins, Facilitative; Humans; Immunoconjugates; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2021 |
Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma.
Topics: Humans; Intraocular Lymphoma; Intravitreal Injections; Lymphoma, Non-Hodgkin; Methotrexate; Retrospective Studies | 2022 |
Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Topics: Humans; Intravitreal Injections; Lymphoma, Non-Hodgkin; Methotrexate; Retinal Neoplasms; Retrospective Studies; Vitreous Body | 2022 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy | 2021 |
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Cranial Irradiation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Retrospective Studies; Rituximab | 2021 |
Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Hospitals, University; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mortality; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; United Kingdom; Vincristine | 2021 |
Clinical challenges faced in real-world management of moderate-to-severe psoriasis: a personal view.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Disease Management; Humans; Lymphoma, Non-Hodgkin; Mental Disorders; Methotrexate; Photochemotherapy; Psoriasis | 2017 |
Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiation Dosage; Retrospective Studies | 2017 |
Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Temozolomide; Vincristine | 2018 |
SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma.
Topics: Aged; Asian People; Female; Genotype; Humans; Liver-Specific Organic Anion Transporter 1; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide | 2017 |
Neurolymphomatosis in non-Hodgkin lymphoma with cranial multineuritis: A case report.
Topics: Animals; Antimetabolites, Antineoplastic; Cerebrospinal Fluid; Cranial Nerve Diseases; Cranial Nerves; Cytarabine; Fatal Outcome; Humans; Injections, Spinal; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Marek Disease; Methotrexate; Neuroimaging; Positron-Emission Tomography; Radiotherapy; Tomography, X-Ray Computed; Young Adult | 2018 |
Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy.
Topics: Calibration; Central Nervous System Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Monitoring; Folic Acid Antagonists; Humans; Kidney; Liver; Lymphoma, Non-Hodgkin; Male; Methotrexate; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Biomarkers; Case-Control Studies; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neuropsychological Tests; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Survival Rate; Survivors; tau Proteins; Young Adult | 2017 |
Renal Function and Plasma Methotrexate Concentrations Predict Toxicities in Adults Receiving High-Dose Methotrexate.
Topics: Adult; Asian People; China; Female; Humans; Kidney; Kidney Function Tests; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency; Retrospective Studies | 2018 |
Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection.
Topics: Aged; Central Nervous System Neoplasms; Drug Interactions; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Nitrofurantoin; Urinary Tract Infections | 2019 |
Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences.
Topics: Adolescent; Adult; Aged; Central Nervous System Neoplasms; Chemoradiotherapy; Female; Humans; India; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome | 2019 |
Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cell Line, Tumor; Central Nervous System Neoplasms; Drug Resistance, Neoplasm; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Methylenetetrahydrofolate Dehydrogenase (NADP); Minor Histocompatibility Antigens; Molecular Targeted Therapy; Peptide Synthases; Thymidylate Synthase | 2019 |
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Austria; Brain Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Progression-Free Survival; Registries; Rituximab; Survival Analysis; Young Adult | 2019 |
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Hydrocortisone; Infant; Iraq; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2019 |
Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Ambulatory Care Facilities; Diarrhea; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prospective Studies; Sodium Bicarbonate; Vomiting; Young Adult | 2020 |
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Central Nervous System Neoplasms; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Progression-Free Survival; Rituximab; Temozolomide; Vincristine | 2019 |
Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate.
Topics: Antimetabolites, Antineoplastic; Child; Enzyme Inhibitors; Female; Genotype; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Staging; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Toxicogenetics; Treatment Outcome | 2013 |
Remobilization of hematopoietic stem cells with high-dose methotrexate and cytarabine in patients with non-Hodgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines.
Topics: Adult; Antigens, CD34; Blood Component Removal; Cytarabine; Cytokines; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Retrospective Studies | 2014 |
Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Female; Gene Frequency; Genotype; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Staging; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Retrospective Studies | 2014 |
Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Creatinine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
The risk of CNS involvement in aggressive lymphomas in the rituximab era.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Risk Factors; Rituximab; Stem Cell Transplantation; Transplantation, Autologous | 2013 |
Creatinine clearance rate and serum creatinine concentration are related to delayed methotrexate elimination in children with lymphoblastic malignancies.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Creatinine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
High-dose methotrexate in the mobilization of hematopoietic stem cells for patients with non-Hodgkin's lymphoma: a twelve-year study in a single center.
Topics: Adolescent; Adult; Aged; Female; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Receptors, CXCR4 | 2014 |
Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Central Nervous System Neoplasms; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Rituximab; Transplantation, Autologous; Treatment Outcome | 2014 |
Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Central Nervous System Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Oligonucleotide Array Sequence Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Transcriptome; Treatment Outcome | 2014 |
Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brain Neoplasms; Eye Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retinal Neoplasms; Retrospective Studies; Time Factors; Vitreous Body | 2014 |
MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy.
Topics: Adult; Base Sequence; DNA Primers; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Young Adult | 2014 |
Primary central nervous system lymphoma in an immunocompetent 12-year-old boy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Child; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Radiography; Thalamus; Thiotepa; White Matter | 2014 |
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2015 |
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Asian People; Female; Genotype; Hematologic Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Young Adult | 2014 |
Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Chemical and Drug Induced Liver Injury; Female; Humans; Kidney; Liver; Lymphoma, Non-Hodgkin; Male; Methotrexate | 2015 |
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2015 |
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma.
Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents; Busulfan; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2015 |
Spectral-domain Optical Coherence Tomography Patterns in Intraocular Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Eye Neoplasms; Female; Fluorescein Angiography; Gene Rearrangement; Humans; Immunoglobulin Heavy Chains; Interleukin-10; Interleukin-6; Intravitreal Injections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Retinal Neoplasms; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Vitreous Body | 2016 |
Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2015 |
[Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Hemoperfusion; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Renal Dialysis | 2015 |
Rituximab with high-dose methotrexate in primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Rituximab; Young Adult | 2015 |
Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?
Topics: Angiogenesis Inhibitors; Bevacizumab; Brain Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Treatment Outcome | 2015 |
Serum Creatinine Versus Plasma Methotrexate Levels to Predict Toxicities in Children Receiving High-dose Methotrexate.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.
Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Patient Selection; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Female; Humans; Kaplan-Meier Estimate; Lymphocyte Count; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Methotrexate; Middle Aged; Prognosis; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Vincristine | 2016 |
'Real Life' experience in a 'difficult to treat' patient population of non-Hodgkin lymphomas using the R-COMP regimen.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2016 |
Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Brain; Central Nervous System Neoplasms; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Republic of Korea; Retrospective Studies | 2016 |
Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab | 2017 |
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine | 2017 |
Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Methotrexate; Middle Aged; Skin Neoplasms | 2008 |
Successful use of semi-nested PCR for the diagnosis of primary intraocular lymphoma.
Topics: Aged; DNA, Neoplasm; Eye Neoplasms; Female; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Lymphoma, Non-Hodgkin; Methotrexate; Molecular Diagnostic Techniques; Ophthalmoscopes; Polymerase Chain Reaction; Radiotherapy | 2008 |
Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Survival Analysis | 2008 |
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Retrospective Studies; Transplantation, Autologous; Vincristine | 2008 |
[Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mucositis; Retrospective Studies; Young Adult | 2008 |
[Aggressive non-Hodgkin lymphoma in 3 patients with rheumatoid arthritis: discontinue the use of methotrexate].
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Remission, Spontaneous | 2008 |
Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Topics: Adolescent; Alleles; Anemia; Antimetabolites, Antineoplastic; Bone Marrow; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Gene Frequency; Genotype; Humans; Kidney; Liver; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytopenia; Time Factors | 2009 |
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.
Topics: Antimetabolites, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Central Nervous System Neoplasms; Disease-Free Survival; Drug Delivery Systems; Humans; Infusions, Intra-Arterial; Lymphoma, Non-Hodgkin; Methotrexate; Osmosis; Prognosis; Treatment Outcome | 2009 |
Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Facial Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Skin Neoplasms | 2009 |
Potential predisposition for nasal septal perforation with methotrexate use: report of 2 cases and literature review.
Topics: Antimetabolites, Antineoplastic; Antirheumatic Agents; Arthritis, Juvenile; Cartilage; Child; Disease Susceptibility; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nasal Septum; Nose Deformities, Acquired; Rhinoplasty | 2009 |
Epstein-Barr virus negative large B-cell lymphoma during long term immunomodulatory therapy for T-cell large granular lymphocytic leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Disease Progression; Doxorubicin; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2010 |
[Therapeutic management of central nervous system lymphomas in a single hematological institute].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Epidural Space; Female; Humans; Hungary; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2009 |
DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytosol; DNA; Drug Monitoring; Erythrocytes; Female; Guanine Nucleotides; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purines; Thionucleotides | 2010 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
Pulmonary non-Hodgkin's lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Methotrexate | 2012 |
Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Drug Administration Routes; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Invasiveness; Treatment Outcome | 2010 |
Hematology. Individualized methotrexate dosing in primary CNS lymphoma.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Hematologic Tests; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Treatment Outcome | 2010 |
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Recurrence; Salvage Therapy | 2011 |
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisolone; Prednisone; Vinblastine; Vincristine | 2010 |
Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies | 2010 |
Flows and flaws in primary central nervous system lymphoma.
Topics: Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cytarabine; Decision Making; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Treatment Outcome | 2010 |
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Central Nervous System Neoplasms; Combined Modality Therapy; Epidemiologic Methods; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prognosis; Treatment Outcome | 2010 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Drug Therapy, Combination; Eye; Humans; Infliximab; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Risk Factors; Treatment Outcome; Withholding Treatment | 2011 |
Clinical course of Crohn's disease following treatment of lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Crohn Disease; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome | 2011 |
Outcome and haemato-toxicity of two chemotherapy regimens for childhood non-Hodgkin's lymphoma in a Kenyan hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Kenya; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2009 |
Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aqueous Humor; Drug Monitoring; Female; Humans; Interleukin-10; Intravitreal Injections; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Monitoring, Physiologic; Retinal Neoplasms; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitrectomy | 2012 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Rituximab significantly improves complete response rate in patients with primary CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Central Nervous System Neoplasms; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Statistics, Nonparametric; Survival Rate | 2012 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Primary non-Hodgkin's lymphoma of the skull base: a case report and literature review.
Topics: Adolescent; Antimetabolites, Antineoplastic; Combined Modality Therapy; Exophthalmos; Humans; Immunohistochemistry; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Neurosurgical Procedures; Skull Base Neoplasms | 2013 |
Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
Topics: Abdominal Pain; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Colon; Colonic Pseudo-Obstruction; Decompression, Surgical; Dilatation, Pathologic; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neostigmine; Parasympathomimetics; Risk Factors; Treatment Outcome | 2012 |
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Feasibility Studies; Female; Follow-Up Studies; Humans; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Prognosis; Survival Rate; Time Factors; Vincristine | 2012 |
[Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas].
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine | 2012 |
Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Clinical Trials as Topic; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Retrospective Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vinblastine | 2013 |
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2012 |
[Treatment outcome of non-Hodgkin lymphoma in childhood: KYCCSG NHL-89, 96].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2012 |
Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Topics: Adult; Antimalarials; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Glucocorticoids; Hodgkin Disease; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Young Adult | 2014 |
Early relapses in patients with primary CNS lymphoma treated with methotrexate-based chemotherapy without consolidating whole brain irradiation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Rituximab; Survival Rate | 2013 |
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Follow-Up Studies; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2002 |
Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebrospinal Fluid; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Intraventricular; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome | 2002 |
Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Salvage Therapy; Survival Analysis | 2002 |
A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Survival Rate; Vinblastine | 2002 |
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience.
Topics: Antirheumatic Agents; Arthritis, Infectious; Azathioprine; Drug Monitoring; Humans; Hypokalemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Pancytopenia; Pneumonia; Product Surveillance, Postmarketing; Prostatic Neoplasms; Sepsis; Sulfasalazine; United Kingdom | 2002 |
Coeliac disease following high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Diarrhea; Diet; Doxorubicin; Etoposide; Glutens; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Morbidity; Prednisolone; Vincristine | 2002 |
Optimal therapy of primary ocular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Functional Laterality; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Radiotherapy; Vincristine | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Central Nervous System Neoplasms; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2002 |
Use of FISH in an aggressive diffuse large B cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Painting; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiotherapy; Stem Cell Transplantation; Vincristine | 2003 |
Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Eye Neoplasms; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 2003 |
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Linear Models; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Proportional Hazards Models; Retrospective Studies; Selenium; Survival Analysis; Vincristine | 2003 |
Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Time Factors | 2003 |
[Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration].
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cyclophosphamide; Doxorubicin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Spinal; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Recombinant Proteins; Respiratory Distress Syndrome; Steroids; Tomography, X-Ray Computed; Vindesine | 2003 |
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Peripheral Blood Stem Cell Transplantation; Prognosis; Treatment Outcome | 2003 |
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine | 2003 |
Chemotherapy of malignant disease. II. Diseases of lymphoid tissue and bone marrow.
Topics: Adrenal Cortex Hormones; Aged; Bone Marrow; Busulfan; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoid Tissue; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Multiple Myeloma; Neoplasms; Sarcoma | 1962 |
[EXPERIMENTAL STUDIES ON THE MODIFIED ARRANGEMENT OF SULLIVAN'S INTRA-ARTERIAL CYTOSTATIC THERAPY IN THE REGION OF THE HEAD].
Topics: Adenoma, Pleomorphic; Animals; Brain Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Craniopharyngioma; Dogs; Facial Neoplasms; Head and Neck Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Pituitary Neoplasms; Research; Thrombin; Tongue Neoplasms | 1963 |
THE RETICULOSES.
Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Dermatitis, Exfoliative; Genetic Diseases, X-Linked; Geriatrics; Hodgkin Disease; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphatic Diseases; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Mycosis Fungoides; Neoplasms; Pathology; Peptide Nucleic Acids; Physiology; Sarcoma; Severe Combined Immunodeficiency | 1964 |
THE INTRALYMPHATIC ADMINISTRATION OF RADIOACTIVE ISOTOPES AND CANCER CHEMOTHERAPEUTIC DRUGS.
Topics: Abdominal Neoplasms; Angiography; Breast Neoplasms; Geriatrics; Gold; Humans; Injections; Iodine Isotopes; Leukemia; Lymphatic Metastasis; Lymphatic System; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Melphalan; Methotrexate; Neoplasms; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms; Scandium; Thiotepa; Yttrium | 1964 |
DYNAMICS OF ARTERIAL CIRCULATION OF PELVIS AS RELATED TO CHEMOTHERAPY OF BLADDER CANCER: EXPERIMENTAL AND CLINICAL STUDY.
Topics: Facial Neoplasms; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms; Pelvis; Sarcoma; Urinary Bladder Neoplasms | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exfoliative; Equipment and Supplies; Floxuridine; Fluorouracil; Humans; Infusion Pumps; Infusions, Parenteral; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Methotrexate; Mitomycin; Mitomycins; Pancreatic Neoplasms; Stomach Neoplasms; Testicular Neoplasms; Thyroid Neoplasms; Tongue Neoplasms; Toxicology | 1964 |
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Mercaptopurine; Methotrexate; Neoplasms; Palliative Care; Sarcoma; Vinblastine | 1964 |
BRAIN DAMAGE AFTER INTRACAROTID INFUSION OF METHOTREXATE.
Topics: Brain; Brain Diseases; Brain Neoplasms; Carotid Arteries; Cerebrovascular Disorders; Drug Therapy; Facial Paralysis; Injections, Intra-Arterial; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Metastasis; Paresis; Pathology; Seizures; Toxicology | 1964 |
EFFECT OF 5',5',5'-TRIFLUOROLEUCINE ON A NUMBER OF MOUSE LEUKAEMIAS.
Topics: Amino Acids; Animals; Chromatography; Hair; Leucine; Leukemia; Leukemia, Experimental; Leukemia, Lymphoid; Liver; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Pharmacology; Proteins; Research; Skin | 1964 |
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Mercaptopurine; Methotrexate; Multiple Myeloma; Neoplasms; Pathology; Primary Myelofibrosis; Sarcoma; Triethylenemelamine; Tuberculosis; Tuberculosis, Pulmonary; Urethane | 1965 |
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
[Principles of treatment and military medical examination of the patients with indolent Non-Hodgkin's lymphomas].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disability Evaluation; Doxorubicin; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Military Personnel; Neoplasm Staging; Prednisone; Russia; Vincristine | 2003 |
Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Eye Neoplasms; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Visual Acuity; Vitreous Body | 2003 |
Neurocognitive outcomes in primary CNS lymphoma (PCNSL).
Topics: Aged; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Comorbidity; Cranial Irradiation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiation Injuries; Treatment Outcome | 2004 |
Cognitive functions in survivors of primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Attention; Brain; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Memory; Methotrexate; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Remission Induction; Survivors | 2004 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Positive T-Lymphocytes; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Intracellular Fluid; Lymphocyte Count; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Th1 Cells; Th2 Cells; Vincristine | 2004 |
Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Analysis; Vincristine | 2004 |
Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Databases, Factual; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Incidence; Infliximab; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Receptors, Tumor Necrosis Factor; Risk Factors; SEER Program; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2004 |
Primary central nervous system lymphoma with testicular relapse.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Testicular Neoplasms | 2004 |
Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cranial Irradiation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome | 2004 |
A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Carmustine; Central Nervous System; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Paraplegia; Spinal Cord Neoplasms; Teniposide | 2004 |
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Clinical Trials as Topic; Drainage; Drug Overdose; Female; gamma-Glutamyl Hydrolase; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Medication Errors; Methotrexate; Middle Aged; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins | 2004 |
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2004 |
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Survival Rate; Vincristine | 2005 |
Intracerebral hematoma following intrathecal administration of methotrexate in a patient with non-Hodgkin's lymphoma.
Topics: Aged; Cerebral Hemorrhage; Headache; Hematoma, Subdural, Intracranial; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Spinal Puncture | 2005 |
Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vincristine | 2005 |
Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoadjuvant Therapy; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning | 2005 |
Myelopathy due to intrathecal chemotherapy: report of six cases.
Topics: Adolescent; Central Nervous System Neoplasms; Child; Child, Preschool; Female; Folic Acid Antagonists; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases | 2005 |
Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Procarbazine; Temozolomide; Vincristine | 2005 |
[Leucovorin rescue after continuing infusion of high dose methotrexate].
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Humans; Infusions, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2005 |
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2005 |
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Prednisone; Regression Analysis; Sex Factors; Survival Rate; Vincristine | 2005 |
Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Chemoprevention; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Patient Selection; Practice Patterns, Physicians'; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Surveys and Questionnaires; United Kingdom | 2005 |
[Efficacy of different chemotherapy programs, indications for surgery and radiotherapy in primary mediastinal B-cell lymphosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Methotrexate; Prednisone; Remission Induction; Vincristine | 2005 |
[Rheumatoid arthritis, methotrexate and non-Hodgkins lymphoma. A report of 3 patients].
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged | 2005 |
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
Topics: Epstein-Barr Virus Infections; Graft Rejection; Herpesvirus 4, Human; HIV Infections; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Immunotherapy; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Transplantation; Virus Latency | 2005 |
Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Hydroxyurea; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 1989 |
Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Child, Preschool; Contrast Media; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2006 |
Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Dexamethasone; Diplopia; Doxorubicin; Facial Paralysis; Headache; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Prednisolone; Remission Induction; Translocation, Genetic; Vincristine | 2007 |
Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Folic Acid; Homocysteine; Humans; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vitamin B 12; Vitamin B Complex | 2006 |
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Gemcitabine; Humans; In Vitro Techniques; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, SCID; Time Factors; Xenograft Model Antitumor Assays | 2006 |
Ultraviolet recall phenomenon associated with methotrexate and cytarabine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Cytarabine; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Ultraviolet Rays | 2006 |
Intracerebral hematoma as a complication of intrathecal methotrexate administration.
Topics: Antimetabolites, Antineoplastic; Cerebral Hemorrhage; Child; Hematoma; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Spinal Puncture | 2008 |
Methotrexate-induced pulmonary non-Hodgkin lymphoma.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Methotrexate; Radionuclide Imaging | 2006 |
Retroperitoneal fibrosis after chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Retroperitoneal Fibrosis; Retroperitoneal Neoplasms; Vincristine | 2007 |
[IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence | 2006 |
Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord; Spinal Cord Diseases | 2007 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Radiotherapy Dosage; Recurrence; Remission Induction; Vincristine | 2007 |
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy.
Topics: Adult; Antibodies, Monoclonal; Blood-Brain Barrier; Brain; Central Nervous System Neoplasms; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Radioimmunotherapy; Remission Induction | 2006 |
Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Topics: Aged; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Humans; Infliximab; Lymphoma, Non-Hodgkin; Male; Methotrexate; Risk Factors; Sezary Syndrome; Skin Neoplasms; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Kluver-Bucy syndrome in a boy with non-Hodgkin lymphoma.
Topics: Antimetabolites, Antineoplastic; Child; Diagnosis, Differential; Humans; Injections, Spinal; Kluver-Bucy Syndrome; Lymphoma, Non-Hodgkin; Male; Methotrexate | 2007 |
Testicular relapse of primary central nervous system lymphoma.
Topics: Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Testicular Neoplasms; Treatment Outcome | 2007 |
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Piperazines; Salvage Therapy; Survival Rate; Thrombocytopenia; Vincristine | 2007 |
The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 2002 |
Complete remission by chemotherapy in stage IE-IIE primary gastric lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Preoperative Care; Prospective Studies; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Epstein-Barr Virus Infections; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Risk Assessment; Treatment Outcome | 2007 |
Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radioimmunotherapy; Yttrium Radioisotopes | 2007 |
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Central Nervous System Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; HIV Seronegativity; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rituximab | 2007 |
Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children.
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Humans; Liver Transplantation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Postoperative Complications; Tomography, X-Ray Computed | 2008 |
Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruption.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Eye Neoplasms; Female; Humans; Infusions, Intravenous; Injections; Lymphoma, Non-Hodgkin; Macula Lutea; Male; Methotrexate; Middle Aged; Retinal Diseases; Retrospective Studies; Tomography, X-Ray Computed; Vitreous Body | 2008 |
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Clinical Protocols; Drug Administration Schedule; Drug Evaluation; Eye Neoplasms; Female; Follow-Up Studies; Humans; Injections; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
What constitutes "improved prognosis"?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis; Treatment Outcome; Vincristine | 2008 |
Comment on the diagnosis and treatment of leukemia and lymphosarcoma.
Topics: Cyclophosphamide; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate | 1967 |
Cell cycle kinetics of uninfected and feline leukemia virus-infected canine lymphoma cell lines: effects of methotrexate treatment.
Topics: Animals; Autoradiography; Cell Cycle; Cells, Cultured; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Leukemia Virus, Feline; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate | 1980 |
[Therapy of non-Hodgkin lymphomas of a high degree of malignancy].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prognosis; Random Allocation; Vincristine | 1981 |
Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma.
Topics: Adult; Aged; Bleomycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Parenteral; Leucovorin; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Stomatitis; Time Factors; Vincristine | 1982 |
An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prognosis; Recurrence; Stomatitis; United States | 1984 |
Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
Topics: Animals; Bacterial Vaccines; Combined Modality Therapy; Cytarabine; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, Inbred C3H; Propionibacterium acnes; Time Factors | 1984 |
Combined local chemotherapy for a spontaneously occurring intraocular tumour in a cat.
Topics: 17-Hydroxycorticosteroids; Administration, Topical; Animals; Antineoplastic Agents; Cat Diseases; Cats; Drug Therapy, Combination; Eye Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1983 |
[Treatment and prognosis of nervous system lesions in lymphosarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Prognosis; Spinal Cord Neoplasms | 1983 |
[Total body irradiation with linear accelerator for bone marrow transplantation in acute leukemia and lymphosarcoma (author's transl)].
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Radiotherapy, High-Energy; Transplantation, Homologous | 1981 |
Cyclic combination chemotherapy of canine lymphosarcoma.
Topics: Animals; Asparaginase; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lymphoma, Non-Hodgkin; Male; Methotrexate; Vincristine | 1981 |
The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative.
Topics: Animals; Antineoplastic Agents; Cattle; Female; Fibrinogen; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1981 |
Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma.
Topics: Aminopterin; Animals; Bone Marrow; Cell Division; Fibrinogen; Liver; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Sarcoma, Experimental; Spleen | 1982 |
Necrotising leucoencephalopathy associated with intrathecal/intraventricular methotrexate therapy.
Topics: Adolescent; Adult; Brain; Brain Diseases; Female; Humans; Injections, Intraventricular; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Necrosis | 1982 |
A seven year laboratory and clinical experience with lithium carbonate as an adjuvant to cancer chemotherapy.
Topics: Bone Marrow Cells; Cells, Cultured; Cytarabine; Daunorubicin; Drug Therapy, Combination; Granulocytes; Humans; Leukemia, Myeloid, Acute; Leukocytosis; Lithium; Lymphoma, Non-Hodgkin; Methotrexate | 1980 |
Lymphoblastic lymphoma in adults: results of a pilot protocol.
Topics: Adolescent; Adult; Asparaginase; Central Nervous System Diseases; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Vincristine | 1981 |
Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
Topics: Aminopterin; Animals; Drug Implants; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Polymethacrylic Acids; Tetrahydrofolates | 1981 |
COMLA chemotherapy for lymphoma.
Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Vincristine | 1980 |
[Results of chemotherapy with cyclophosphamide, vincristine, methotrexate and prednisone in recurring or disseminated non-Hodgkin lymphomas in the University of Kiel Radiology Clinic].
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine | 1981 |
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine | 1993 |
Lactate dehydrogenase levels during MACOP-B chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine | 1993 |
[Effect of combination chemotherapy for elderly patients with malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prednisone; Retrospective Studies; Vincristine | 1993 |
[Increased blood cell destruction during vigorous regeneration of bone marrow after CAMBO-VIP chemotherapy for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Bone Marrow Cells; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Vincristine | 1994 |
Oculomotor nerve palsy associated with vincristine treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Oculomotor Nerve Diseases; Prednisone; Skin Neoplasms; Vincristine | 1993 |
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Stomach Neoplasms; Vincristine | 1994 |
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Radiotherapy Dosage; Remission Induction; Survival Rate; Vincristine | 1994 |
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Vincristine | 1994 |
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen].
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Tolerance; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1993 |
[VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Procarbazine; Remission Induction; Retrospective Studies; Vincristine | 1994 |
A cooperative study on ProMACE-CytaBOM in aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Feasibility Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine | 1994 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1994 |
Long-term results with MACOP-B in the treatment of aggressive non-Hodgkin's lymphomas. The experience in Brazil.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Socioeconomic Factors; Survival Rate; Vincristine | 1994 |
Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blotting, Southern; CD4 Lymphocyte Count; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; DNA, Viral; Doxorubicin; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Immunoglobulin Variable Region; Immunologic Factors; Leucovorin; Life Tables; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Polymerase Chain Reaction; Prednisone; Proportional Hazards Models; Radiotherapy, Adjuvant; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Adhesion Molecules; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Luminescent Measurements; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Neutrophils; Prednisone; Recombinant Proteins; Respiratory Burst; Vincristine | 1995 |
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Folic Acid; Humans; Hydrocortisone; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Platelet Transfusion; Prognosis; Prospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine | 1995 |
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Time Factors; Transplantation, Autologous | 1995 |
Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis.
Topics: Adolescent; Brain; Brain Damage, Chronic; Child; Child, Preschool; Cranial Irradiation; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Regression Analysis | 1995 |
CHOP versus m-BACOD in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1993 |
Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Vincristine | 1993 |
Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Prognosis; Remission Induction; Vincristine | 1993 |
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; HIV Seropositivity; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Vincristine | 1993 |
[Thyroid lymphoma in a 51-year-old woman].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Postoperative Care; Prednisone; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Vincristine | 1993 |
[Treatment of high risk non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protocols; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission Induction; Risk; Survival Rate; Vincristine | 1993 |
Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Stevens-Johnson Syndrome; Vincristine | 1993 |
CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1993 |
Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lung; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Vincristine | 1993 |
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexamethasone; DNA, Neoplasm; Doxorubicin; Environmental Exposure; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; HIV Infections; Hodgkin Disease; Humans; Incidence; Leucovorin; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Prednisone; Procarbazine; Remission Induction; Vincristine | 1993 |
Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Ovarian Diseases; Prednisone; Retrospective Studies; Testicular Diseases; Vincristine | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1993 |
Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Thyroid Neoplasms; Vincristine | 1995 |
Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Survival Analysis; Thiotepa; Transplantation, Homologous; Whole-Body Irradiation | 1995 |
Urinary N-acetyl-beta-D-glucosaminidase activity in leukaemic children during high-dose methotrexate therapy.
Topics: Acetylglucosaminidase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Burkitt Lymphoma; Child; Creatinine; Diuresis; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Kidney Tubules, Proximal; Leucovorin; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 1995 |
Three-year results of MIM salvage treatment for refractory/relapsed intermediate grade NHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Salvage Therapy; Survival Analysis | 1995 |
[Evaluation of the method of treating non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Teniposide; Vincristine | 1994 |
Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Central Nervous System Neoplasms; Child; Cranial Irradiation; Cross-Sectional Studies; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Injections, Spinal; Italy; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy; Registries; Risk Factors; Wilms Tumor | 1994 |
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer.
Topics: Absenteeism; Adolescent; Analysis of Variance; Central Nervous System Neoplasms; Child; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Humans; Injections, Spinal; Intelligence; Intelligence Tests; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms; Neuropsychological Tests | 1994 |
Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment.
Topics: Administration, Oral; Adult; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Tetrahydrofolates; Time Factors | 1994 |
Extraskeletal localization of MDP in soft tissue secondary to methotrexate infiltration.
Topics: Adolescent; Arm; Bone and Bones; Extravasation of Diagnostic and Therapeutic Materials; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Radionuclide Imaging; Technetium Tc 99m Medronate | 1994 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Excretion of Ascaris lumbricoides during total body irradiation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascariasis; Ascaris lumbricoides; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Contents; Humans; Intestinal Diseases, Parasitic; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine; Vomiting; Whole-Body Irradiation | 1994 |
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Herpesvirus 3, Human; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Recurrence; Vincristine; Virus Activation | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
2,4-diamino-7-hydroxy-pteridines in biological fluids of patients on high-dose methotrexate.
Topics: Adolescent; Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pteridines | 1993 |
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxyglucose; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisone; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 1993 |
Primary malignant lymphoma of the uterus: localization in a cervical polyp.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cervix Uteri; Cyclophosphamide; Doxorubicin; Female; Humans; Hyperplasia; Immunohistochemistry; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 1993 |
[Successful oral administration of etoposide therapy for refractory malignant lymphoma treated with frequent combination chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Recurrence; Salvage Therapy; Vincristine | 1993 |
Long-term effects of vincristine on the peripheral nervous system.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neuromuscular Diseases; Peripheral Nervous System Diseases; Prednisone; Reflex, Abnormal; Sensation Disorders; Surveys and Questionnaires; Treatment Outcome; Vincristine | 1993 |
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Survival Analysis; Vincristine | 1993 |
[Hypersalivation as a leading symptom of neoplastic meningiosis in highly malignant non-Hodgkin's lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cerebrospinal Fluid; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Sialorrhea; Vincristine | 1993 |
Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction | 1993 |
Non-Hodgkin's lymphoma, rheumatoid arthritis and methotrexate.
Topics: Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged | 1993 |
High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 11; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Life Tables; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Risk; Vincristine | 1993 |
Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Dose-Response Relationship, Drug; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1993 |
IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Pilot Projects; Recombinant Proteins | 1993 |
Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Immunocompetence; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Contraindications; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glucocorticoids; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prospective Studies; Vincristine; Virus Activation | 1996 |
Intraocular levels of methotrexate after intravenous administration.
Topics: Anterior Chamber; Antimetabolites, Antineoplastic; Aqueous Humor; Biological Availability; Cerebrospinal Fluid; Eye Neoplasms; Female; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged | 1996 |
Bulky centroblastic non-Hodgkin's lymphoma of the cranium vault mimicking brain involvement managed with chemotherapy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Diagnosis, Differential; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Remission Induction; Skull Neoplasms; Tomography, X-Ray Computed; Vincristine | 1995 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Prospective Studies; Salvage Therapy; Sweden; Transplantation, Autologous; Treatment Outcome | 1996 |
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Dog Diseases; Dogs; Doxorubicin; Female; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplastic Stem Cells; Nucleolus Organizer Region; Predictive Value of Tests; Prednisone; Prognosis; Proliferating Cell Nuclear Antigen; Remission Induction; Silver Staining; Treatment Outcome; Vincristine | 1996 |
Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Disposable Equipment; Doxorubicin; Drug Costs; Etoposide; Fees, Medical; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Models, Economic; Prednisone; Survival Rate; Vincristine | 1996 |
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis.
Topics: Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Fees, Pharmaceutical; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Medicare; Methotrexate; Prednisone; Private Practice; Reimbursement Mechanisms; United States; Vincristine | 1996 |
[Primary cerebral non-Hodgkin's lymphoma. Intensive chemotherapy supported by crania radiotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Tomography, X-Ray Computed | 1996 |
Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1996 |
Lymphomatous infiltrates within leptomeninges and spinal roots in adult patients with non-Hodgkin's lymphomas after intrathecal methotrexate administration.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Female; Humans; Injections, Spinal; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged | 1996 |
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1996 |
Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin's lymphoma in Saudi Arabia: clinical results and analysis of prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Regression Analysis; Saudi Arabia; Survival Analysis; Vincristine | 1996 |
Cervical spontaneous epidural hematoma as a complication of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hematoma, Epidural, Cranial; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Spinal Cord Compression; Thrombocytopenia; Vincristine | 1996 |
Exacerbation of hepatitis in hepatitis B carriers following chemotherapy for haematological malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carrier State; Chronic Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Doxorubicin; Etoposide; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1996 |
F wave studies after intrathecal methotrexate administration.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Drug Therapy, Combination; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Neural Conduction; Prednisolone | 1996 |
3'-Azido 3'-deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus-related non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Zidovudine | 1997 |
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Recurrence; Survival Rate; Vincristine | 1997 |
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Remission Induction; Survival Analysis; Treatment Failure; Vincristine | 1997 |
Tumour inhomogeneities on magnetic resonance imaging, a new factor with prognostic information in non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 1997 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Final height and puberty in 40 patients after antileukaemic treatment during childhood.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Growth; Growth Disorders; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Puberty | 1997 |
Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Salvage Therapy; Survival Rate; Time Factors; Vincristine | 1997 |
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Topics: Adolescent; Adult; Antidotes; Antimetabolites, Antineoplastic; Carboxypeptidases; Child; Child, Preschool; Female; Humans; Infant; Kidney; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Thymidine | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Prognosis; Risk Factors; Thioguanine; Vinblastine; Vincristine | 1996 |
Is methotrexate oncogenic in patients with rheumatoid arthritis?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lymphoma, Non-Hodgkin; Methotrexate | 1997 |
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine | 1996 |
High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoguazone; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Treatment Failure | 1997 |
Delayed elimination of methotrexate associated with piperacillin administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Piperacillin; Vincristine | 1997 |
Chemotherapy for AIDS-related lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Survival Rate; Vincristine | 1997 |
Limiting therapy for limited childhood non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Survival Rate | 1997 |
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
Topics: Adolescent; Adult; Bone Marrow Diseases; Female; Graft Rejection; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation Conditioning; Transplantation, Homologous | 1997 |
[Disturbed neutrophil activation in pneumonia during medicinal immunosuppression].
Topics: Adult; Aged; Arthritis, Rheumatoid; Chemotaxis; Cyclophosphamide; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutrophil Activation; Pneumonia; Postoperative Complications | 1997 |
[Pleural tumor as the only manifestation of lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Pleural Neoplasms; Tomography, X-Ray Computed; Vincristine | 1997 |
Methotrexate induced lymphoma?
Topics: Antirheumatic Agents; Carcinogenicity Tests; Folic Acid Antagonists; Humans; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Mutagenicity Tests; Rheumatic Diseases | 1998 |
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Partial Thromboplastin Time; Plasminogen; Prednisone; Procarbazine; Protein C; Protein S; Thrombophilia; Time Factors; Vinblastine; Vincristine | 1997 |
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Salvage Therapy; Time Factors | 1998 |
Diagnosis and treatment of malignant lymphoma of the parotid gland.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Parotid Neoplasms; Prednisolone; Prednisone; Radiotherapy Dosage; Vincristine | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Prednisolone; Pulmonary Fibrosis; Vascular Neoplasms; Vincristine | 1998 |
Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Radiography; Treatment Outcome | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Remission Induction; Urinary Bladder Neoplasms; Vincristine | 1998 |
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Transient tetraparesis after intrathecal and high-dose systemic methotrexate.
Topics: Adolescent; Antineoplastic Agents; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Quadriplegia | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Cell cycle dependency of 67gallium uptake and cytotoxicity in human cell lines of hematological malignancies.
Topics: Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Gallium Radioisotopes; Hematologic Neoplasms; HL-60 Cells; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Proteins; Neoplastic Stem Cells; Prednisolone; Radiopharmaceuticals; Receptors, Transferrin; Tumor Cells, Cultured | 1998 |
Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Epidural Neoplasms; Fatal Outcome; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Spinal Cord Compression; Syndrome; Treatment Outcome; Vincristine | 1999 |
Chemotherapy is effective as early treatment for primary central nervous system lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Tomography, X-Ray Computed; Vincristine | 1999 |
[Clinical outcomes in low grade follicular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine | 1999 |
Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy.
Topics: Antimetabolites, Antineoplastic; Brain; Brain Diseases; Catheters, Indwelling; Cerebral Ventricles; Equipment Failure; Extravasation of Diagnostic and Therapeutic Materials; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged | 1999 |
Intermediate dose of methotrexate toxicity in non-Hodgkin lymphoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1999 |
Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Granuloma; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Skin Neoplasms | 1999 |
Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin's lymphoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Prednisone; Spinal Cord Neoplasms; Vincristine | 1999 |
Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diabetes Insipidus; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Pituitary Neoplasms; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1999 |
Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate: a kinetic study of lymph node changes.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged | 1999 |
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multiple Myeloma; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1999 |
[Evaluation of the CCNU-COP regimen for primary refractory and recurrent non-Hodgkin's lymphoma].
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hydrocortisone; Leukopenia; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Treatment Outcome; Vincristine | 1999 |
Adult head and neck lymphomas in Papua New Guinea: a retrospective study of 70 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; New Guinea; Prednisone; Procarbazine; Registries; Retrospective Studies; Vincristine | 1999 |
[A case of non-Hodgkin lymphoma in the central nervous system, developing during treatment of galactorrhea amenorrhea syndrome].
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Galactorrhea; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Prednisone; Syndrome; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1999 |
Translocation (1;11)(q23;p15), a novel simple variant of translocation (7;11)(p15;p15), in a patient with AML (M2) accompanied by non-Hodgkin lymphoma and gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Cyclophosphamide; Doxorubicin; Humans; Immunohistochemistry; Karyotyping; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Prednisone; Stomach Neoplasms; Translocation, Genetic; Vincristine | 2000 |
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Italy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Recurrence; Survival Rate; Vincristine | 2000 |
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Failure; Vincristine | 1998 |
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Central Nervous System; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Incidence; L-Lactate Dehydrogenase; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Meninges; Methotrexate; Neoplasm Proteins; Neurologic Examination; Predictive Value of Tests; Prednisolone; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
[Methotrexate pneumonitis arising during the treatment of non-Hodgkin's lymphomas with the m-BACOD protocol].
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Pneumonia; Vincristine | 1995 |
Primary non-Hodgkin's lymphoma of the vagina.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Pregnancy; Pregnancy Outcome; Vaginal Neoplasms; Vincristine | 2000 |
Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Rate; Vincristine | 2000 |
White-matter abnormalities in unirradiated patients cured of primary central nervous system lymphoma.
Topics: Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Treatment Outcome | 2000 |
Non-Hodgkin lymphoma presenting as a solitary rectal polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Colonoscopy; Cyclophosphamide; Doxorubicin; Gastrointestinal Hemorrhage; Humans; Hydrocortisone; Immunophenotyping; Intestinal Mucosa; Intestinal Polyps; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Rectum; Vincristine | 2000 |
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de
Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Female; Humans; Injections, Spinal; Logistic Models; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Risk Factors; Secondary Prevention; Survival Analysis | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Interferon does not prolong progression-free survival after ProMACE-MOPP.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine | 2000 |
[Treatment outcome in elderly patients with aggressive non-Hodgkin's lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome; Vincristine | 2000 |
[Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Vincristine | 2000 |
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Purging; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Cystitis; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Infections; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Salvage Therapy; Survival Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Should we always choose a nonparametric test when comparing two apparently nonnormal distributions?
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Data Interpretation, Statistical; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukocyte Count; Lymphoma, Non-Hodgkin; Methotrexate; Mitoguazone; Models, Statistical; Neutrophils; Numerical Analysis, Computer-Assisted; Sample Size; Software; Statistical Distributions; Statistics, Nonparametric; Stochastic Processes; Time Factors | 2001 |
Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diabetes Insipidus; Disease Progression; Doxorubicin; Dwarfism, Pituitary; False Negative Reactions; Genetic Predisposition to Disease; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Hypothyroidism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Pituitary Hormones; Pituitary Neoplasms; Prednisone; Remission Induction; Vincristine | 2001 |
Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD18 Antigens; Cell Movement; Chemotaxis, Leukocyte; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Glycosylation; Granulocyte Colony-Stimulating Factor; Humans; Image Processing, Computer-Assisted; Lenograstim; Lymphoma, Non-Hodgkin; Methotrexate; Neutrophils; Prednisone; Protein Processing, Post-Translational; Recombinant Proteins; Vincristine | 2001 |
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine | 2001 |
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Regression Analysis; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2001 |
High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Brain; Brain Neoplasms; Central Nervous System Neoplasms; Disease Progression; Disease-Free Survival; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Recurrence; Testicular Neoplasms | 2001 |
CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunophenotyping; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Prednisolone; Reference Values; Transplantation, Autologous; Vincristine | 2001 |
5. Report on workshop: Primary CNS lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Gene Rearrangement; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Methotrexate; Radiation Injuries; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2001 |
Therapy for Australian cats with lymphosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cat Diseases; Cats; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Leukemia Virus, Feline; Lymphoma, Non-Hodgkin; Male; Methotrexate; New South Wales; Patient Satisfaction; Prednisolone; Surveys and Questionnaires; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Transplantation, Autologous; Treatment Outcome; Vincristine | 2002 |
Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunophenotyping; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Methotrexate; Mitotic Index; Neoplasm Staging; Prednisone; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2002 |
Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Female; France; Hodgkin Disease; Humans; Incidence; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies | 2002 |
Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; HIV-1; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Vincristine | 2002 |
HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cyclophosphamide; Graft Rejection; Graft vs Host Reaction; Histocompatibility Antigens; HLA Antigens; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Methotrexate; Transplantation, Homologous | 1976 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
[Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Burkitt Lymphoma; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphatic Diseases; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Mycosis Fungoides; Prednisone; Vincristine | 1977 |
[Unusual CT skull findings after preventive CNS treatment of acute leukemia in children].
Topics: Central Nervous System; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Radiotherapy Dosage; Radiotherapy, High-Energy; Skull; Time Factors; Tomography, X-Ray Computed | 1979 |
[The primary extranodal manifestation of lympho- and reticulosarcoma of the stomach].
Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission, Spontaneous; Stomach Neoplasms; Vincristine | 1975 |
[Tomizine--a new inhibitor of folate metabolism enzymes possessing an antitumor activity].
Topics: Aminopterin; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Folic Acid Antagonists; Leukemia L1210; Leukemia, Experimental; Liver Neoplasms; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Neoplasms, Experimental; Rats; Sarcoma 37; Sarcoma, Experimental; Thiazines | 1975 |
[Meningosis-prophylaxis in the treatment of acute lymphoblastic leukemia and of non-Hodgkin's lymphomas (author's transl)].
Topics: Child; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Meninges; Methotrexate; Neoplasm Metastasis; Remission, Spontaneous | 1977 |
Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
Topics: Animals; Drug Implants; Drug Therapy, Combination; Female; Gels; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methacrylates; Methotrexate; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1978 |
High dose methotrexate with citrovorum factor in adult resistant lymphoma.
Topics: Adolescent; Aged; Antineoplastic Agents; Bone Marrow; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission, Spontaneous; Stomatitis; Time Factors | 1977 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
[Juvenile reticulosarcoma].
Topics: Adolescent; Braces; Child; Cortisone; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Vincristine | 1978 |
Cerebral reticulum cell sarcoma.
Topics: Brain Neoplasms; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Methotrexate | 1979 |
[Neuroleukemia in blast leukemization of hematosarcomas].
Topics: Adolescent; Adult; Brain Neoplasms; Female; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Spinal Cord Neoplasms | 1979 |
Effect of methotrexate sorbed on modified 2-hydroxyethylmethacrylate carriers in mice of C3H strain with a solid Gardner lymphosarcoma.
Topics: Acrylic Resins; Animals; Female; Injections; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Peritoneum; Polymethacrylic Acids; Sarcoma, Experimental | 1977 |
Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma.
Topics: Animals; Drug Implants; Gels; Injections, Intraperitoneal; Kinetics; Lymphoma, Non-Hodgkin; Methacrylates; Methotrexate; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1978 |
Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors.
Topics: Animals; Drug Resistance; Hydrocortisone; In Vitro Techniques; Liposomes; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, Inbred Strains; Rats; Sarcoma, Experimental | 1978 |
Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions.
Topics: Child; Humans; Infusions, Parenteral; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Remission, Spontaneous | 1976 |
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Topics: Animals; Carcinoma; Cell Line; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Melanoma; Methotrexate; Mice; Neoplasms, Experimental; Tegafur | 1976 |
A patient with so-called primary reticulum cell sarcoma of the brain with 6.5 years' survival, treated as 'meningeal leukaemia'.
Topics: Adult; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Humans; Intracranial Pressure; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prognosis; Spinal Puncture | 1976 |
Burkitt's lymphoma.
Topics: Acanthosis Nigricans; Adolescent; Antibodies, Viral; Biopsy, Needle; Blood Cell Count; Blood Cells; Bone Marrow; Burkitt Lymphoma; Cyclophosphamide; Diagnosis, Differential; Gonadotropins; Humans; Hypogonadism; Jaw Neoplasms; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Methotrexate; Vincristine | 1975 |
[High dosage of Methotrexate in childhood malignancy].
Topics: Child, Preschool; Dose-Response Relationship, Drug; Humans; Kidney Neoplasms; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Metastasis | 1976 |
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
Topics: Adolescent; Anaphylaxis; Asparaginase; Child; Child, Preschool; Confusion; Daunorubicin; Female; Hallucinations; Hemorrhage; Humans; Injections, Spinal; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Pancreatitis; Prednisolone; Retroperitoneal Space; Vinblastine; Vincristine | 1976 |
Adverse effects of intrathecal methotrexate in children with acute leukemia in remission.
Topics: Adolescent; Carbohydrates; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Humans; Indicator Dilution Techniques; Injections, Spinal; Leukemia, Lymphoid; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Monocytes; Neutrophils; Osmolar Concentration; Radiation Effects; Remission, Spontaneous; Skull | 1975 |
Reticulosarcoma occurring during long-term hemodialysis.
Topics: Brain Neoplasms; Humans; Kidney Failure, Chronic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Polycystic Kidney Diseases; Renal Dialysis; Time Factors | 1975 |
Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission, Spontaneous; Vincristine | 1975 |
[Cytostatic therapy of primary lympho- and reticulosarcoma of the stomach].
Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Stomach Neoplasms; Vincristine | 1975 |
Aspects of radiation biology and radiation pathology observed during the treatment of cancer in man. The Mackenzie Davidson memorial lecture delivered at the British Institute of Radiology on May 16, 1974.
Topics: Carcinoma, Squamous Cell; Female; Humans; Lip Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Microscopy, Electron; Mitosis; Models, Biological; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Radiobiology; Radiotherapy Dosage; Tonsillar Neoplasms | 1975 |
The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma.
Topics: Animals; Biological Transport; Cell Membrane; Dogs; Extracellular Space; Folic Acid Antagonists; Kinetics; Lymph Nodes; Lymphoma, Non-Hodgkin; Methotrexate; Models, Biological; Neoplasms, Experimental; Regional Blood Flow; Time Factors | 1975 |
Changes of molecular properties associated with the development of resistance against methotrexate in human lymphoblastoid cells.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Folic Acid; Formate-Tetrahydrofolate Ligase; Glycine Hydroxymethyltransferase; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylenetetrahydrofolate Dehydrogenase (NADP); Sarcoma, Experimental; Tetrahydrofolate Dehydrogenase; Tetrahydrofolates; Thymidine Kinase; Thymidylate Synthase | 1975 |
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Vincristine | 1992 |
[Primary non-Hodgkin's lymphoma of paranasal sinuses. Review of the literature and a case report].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Ethmoid Sinus; Etoposide; Female; Frontal Sinus; Humans; Lymphoma, Non-Hodgkin; Maxillary Sinus Neoplasms; Methotrexate; Paranasal Sinus Neoplasms; Prednisone; Vincristine | 1992 |
[Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recombinant Proteins; Vincristine | 1992 |
Impairment of peripheral nervous system in patients with non-Hodgkin's lymphomas treated with CBVPM/AVBP and CHOP schedules.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Median Nerve; Methotrexate; Middle Aged; Neural Conduction; Peroneal Nerve; Prednisone; Reflex, Abnormal; Reflex, Stretch; Ulnar Nerve; Vincristine | 1992 |
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Leucovorin; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Salivation; Secretory Rate; Sex Factors; Vinblastine; Vincristine | 1992 |
[Vibrio cholerae can be encountered even at home].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Immunocompromised Host; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Stomatitis; Vibrio cholerae; Vibrio Infections; Vincristine | 1991 |
[The effect of the time of methotrexate administration over 24 hours on the antitumor activity of the preparation, its concentration in the blood and in the tumor in Pliss' lymphosarcoma in rats].
Topics: Animals; Circadian Rhythm; Drug Screening Assays, Antitumor; Female; Injections, Subcutaneous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Transplantation; Rats; Rats, Wistar; Remission Induction; Time Factors; Tissue Distribution | 1992 |
Impairment of vertebral canal nervous structures after intrathecal prophylaxis in non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Cauda Equina; Demyelinating Diseases; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Myelin Sheath; Spinal Cord; Spinal Cord Neoplasms; Spinal Nerve Roots | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Prednisolone | 1992 |
Treatment and prognosis of orbital non-Hodgkin's lymphomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Prognosis; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Vincristine | 1992 |
[Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1992 |
Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Flow Cytometry; Humans; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Vincristine | 1992 |
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Humans; Immunocompromised Host; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine | 1992 |
Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1992 |
Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neutropenia; Sepsis; Vincristine | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine | 1992 |
Effect of high-dose methotrexate on plasma hypoxanthine and uridine levels in patients with acute leukemia or non-Hodgkin lymphoma in childhood.
Topics: Adolescent; Child; Humans; Hypoxanthine; Hypoxanthines; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uridine | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
[Studies of methotrexate pharmacokinetics in children with neoplasms of the hematopoietic system after administration of different doses of the drug].
Topics: Administration, Oral; Adolescent; Age Factors; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1992 |
[Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Topics: Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1992 |
[Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Nimustine; Prednisone; Remission Induction; Vincristine | 1992 |
MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Vincristine | 1990 |
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Vincristine | 1990 |
Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Infant, Newborn; Infant, Premature; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Multiple; Twins; Vincristine | 1990 |
[M-BACOD in advanced case of non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Evaluation; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Logistic Models; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate; Vincristine | 1990 |
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Sclerosis; Sex Factors; Survival Rate; Vincristine | 1990 |
[Syndrome of persistent generalized lymphadenopathy with development into a gastric lymphoma].
Topics: Adult; AIDS-Related Complex; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Opportunistic Infections; Stomach Neoplasms; Substance-Related Disorders; Tuberculosis, Miliary; Vincristine | 1990 |
Palmar-plantar erythema associated with combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Leucovorin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1990 |
[Intraparenchymal non-neoplastic residual masses after treatment of large-cell non-Hodgkin's lymphoma with intensive chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Fibrosis; Humans; Kidney; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Necrosis; Prednisone; Spleen; Vincristine | 1990 |
Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Hypercalcemia; Leucovorin; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1990 |
[Acute pneumocystosis during polychemotherapy following the MACOP-B protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bronchi; Bronchoalveolar Lavage Fluid; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; HIV Seropositivity; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Pneumocystis; Pneumonia, Pneumocystis; Prednisone; T-Lymphocyte Subsets; Time Factors; Vincristine | 1990 |
A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate | 1991 |
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomycin; Body Height; Body Weight; Child; Child Development; Child, Preschool; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulins; Intelligence; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Sex Characteristics; Vinblastine; Vincristine | 1991 |
A clinical phase II study of ProMACE-CytaBOM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1991 |
Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Survival Rate; Vincristine | 1991 |
Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate | 1991 |
m-BACOD chemotherapy for intermediate- and high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Vincristine | 1991 |
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Vincristine | 1991 |
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Calcium; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1991 |
Primary non-Hodgkin's lymphoma of the central nervous system: phase II study of chemotherapy (BVAM) prior to radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vincristine | 1991 |
Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
Malignant lymphomas in HIV-seropositive patients. Frequency, features, and prognosis. Report on 31 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Female; HIV Seropositivity; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Vincristine | 1991 |
[Indicators of nonspecific immunity in patients with non-Hodgkin's lymphoma of high grade malignancy in the remission phase of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; CD4-CD8 Ratio; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoglobulins; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; T-Lymphocytes; Vincristine | 1991 |
[Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1991 |
Risk factors in intermediate and high-grade non-Hodgkin's lymphomas of adults: a need for a new staging system.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Risk Factors; Vincristine | 1991 |
The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1991 |
Clinical and pathological restaging in aggressive non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prospective Studies; Vincristine | 1991 |
Experience with salvage regimens at M.D. Anderson Hospital.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate | 1991 |
Salvage therapy with PROMACE in relapsed non-Hodgkin malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone | 1991 |
Acute reversible neurological deficit following intrathecal chemotherapy.
Topics: Adult; Cytarabine; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Paralysis; Preservatives, Pharmaceutical | 1991 |
Acute tumor lysis syndrome after intrathecal methotrexate administration.
Topics: Acute Disease; Adult; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Tumor Lysis Syndrome | 1991 |
Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Topics: Child; Child, Preschool; Combined Modality Therapy; Cranial Nerve Diseases; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Radiotherapy Dosage; Sex Factors; Survival Analysis | 1991 |
[Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay
Topics: Adult; Aged; Child, Preschool; Chromatography, High Pressure Liquid; Female; Fluorescence Polarization Immunoassay; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
[High-dose methotrexate and hyperphenylalaninemia].
Topics: Adolescent; Biopterins; Child; Child, Preschool; Humans; Hydroxylation; Lymphoma, Non-Hodgkin; Methotrexate; Phenylalanine; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
Primary non-Hodgkin's lymphoma of the brain revisited.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Combined Modality Therapy; Craniotomy; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; New York; Radiotherapy; Tomography, X-Ray Computed | 1991 |
Excessive chemotherapy-related granulocytopenia in a child with non-Hodgkin's lymphoma and a congenital abnormality of purine salvage.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Pentosyltransferases; Prednisone; Purine-Nucleoside Phosphorylase; Vincristine | 1990 |
[High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Humans; Infant; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Time Factors | 1990 |
'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 1990 |
Primary thyroid lymphoma in childhood: treatment with chemotherapy alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Thyroid Neoplasms | 1990 |
[Fulminant hepatic failure induced by intermediate dose methotrexate in a case of non-Hodgkin's lymphoma].
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Humans; Liver; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1990 |
Serum immunoreactive erythropoietin in children with acute leukaemia at various stages of disease--and the effects of treatment.
Topics: Adolescent; Anemia; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Erythropoietin; Female; Hemoglobins; Humans; Infant; Leukemia, Myeloid, Acute; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Erythema nodosum and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Erythema Nodosum; Etoposide; Female; Humans; Intestinal Obstruction; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Periarthritis; Prednisone | 1990 |
UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Vincristine | 1990 |
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies | 1990 |
The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative.
Topics: Animals; Drug Carriers; Female; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Serum Albumin | 1990 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1990. A 28-year-old man with increasing dyspnea, dry cough, and fever after chemotherapy for lymphoma.
Topics: Adult; B-Lymphocytes; Diagnosis, Differential; Drug Hypersensitivity; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Methotrexate; Pneumonia; Pneumonia, Pneumocystis | 1990 |
[Burkitt's lymphoma in HIV-infected patients].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction | 1990 |
Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma.
Topics: Adolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Time Factors | 1990 |
Methotrexate cerebrospinal fluid pharmacokinetics in a patient with lymphoma treated with methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Kinetics; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Vincristine | 1986 |
Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Vincristine | 1986 |
[Changes in the blood-cerebrospinal fluid barrier for serum proteins in children with acute lymphatic leukemia].
Topics: Adolescent; alpha-Macroglobulins; Blood Proteins; Blood-Brain Barrier; Child; Child, Preschool; Combined Modality Therapy; Humans; Immunoglobulin G; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Methotrexate; Serum Albumin | 1987 |
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Time Factors; Vincristine | 1987 |
Updated clinical experience with MACOP-B.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Time Factors; Vincristine | 1987 |
Advances in chemotherapy for large cell lymphoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Tolerance; Forecasting; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prognosis; Time Factors; Vincristine | 1987 |
Minimizing toxicity of MACOP-B.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Stomatitis; Vincristine | 1987 |
Non-Hodgkin's lymphoma in children. Results of therapy.
Topics: Abdominal Neoplasms; Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1987 |
[Provisional treatment results of intensive combination chemotherapy (m-BACOD) in non-Hodgkin lymphoma of intermediate and high malignancy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; T-Lymphocytes; Vincristine | 1987 |
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Vincristine | 1988 |
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine | 1988 |
Non-Hodgkin's lymphoma in Saudi Arabia: prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Risk Factors; Saudi Arabia; Time Factors; Vincristine | 1988 |
Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Evaluation; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1988 |
MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Vincristine | 1988 |
[Malignant lymphomas in HIV-infected patients].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prognosis; Risk Factors; Vincristine | 1988 |
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Reoperation; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1989 |
Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Remission Induction; Vincristine | 1989 |
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Remission Induction; Vindesine | 1989 |
Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Radiation Injuries; Recurrence; Stomatitis; Tonsillar Neoplasms; Vincristine | 1989 |
Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vincristine | 1989 |
B-cell lymphoma associated with eosinophilia.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; Cyclophosphamide; Doxorubicin; Eosinophilia; Humans; Immunohistochemistry; Leucovorin; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1989 |
[Results of the treatment of non-Hodgkin's lymphoma with 6 cytostatic drug combination].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1989 |
[Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1989 |
Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Combined Modality Therapy; Electroencephalography; Female; Humans; Intelligence Tests; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, High-Energy; Spinal Cord Neoplasms | 1989 |
Severe renal toxicity due to intermediate-dose methotrexate.
Topics: Adult; Aged; Back Pain; Bicarbonates; Fluid Therapy; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mouthwashes; Sodium; Sodium Bicarbonate; Stomatitis | 1989 |
[Clinical, anatomo-pathologic aspects and therapeutic results in 63 malignant ORL non-Hodgkin's lymphomas in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1989 |
Central nervous system involvement in non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Agents; Central Nervous System Diseases; Cytophotometry; DNA, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Protein Binding; Vitamin B 12 | 1989 |
Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy; Cytarabine; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Remission Induction | 1989 |
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Vincristine | 1989 |
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone; Time Factors; Vincristine | 1989 |
Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Drug Evaluation; Egypt; Etoposide; Female; Humans; Ifosfamide; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Remission Induction; Time Factors; Vincristine | 1989 |
[Indirect endolymphatic chemotherapy of patients with lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hodgkin Disease; Humans; Injections, Intralymphatic; Lomustine; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Procarbazine; Prospidium; Remission Induction; Vinblastine; Vincristine | 1989 |
Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Female; Humans; Injections, Spinal; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Retinal Diseases; Uveitis; Vincristine; Visual Acuity; Vitreous Body | 1989 |
Circadian pharmacokinetics of methotrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged | 1989 |
[The prevention of the side effects of cytostatics by administering them at various times of day].
Topics: Animals; Body Temperature; Body Weight; Circadian Rhythm; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Transplantation; Rats; Time Factors | 1989 |
Treatment of refractory and relapsed non-Hodgkin's lymphoma with ifosfamide, methotrexate and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors | 1989 |
Chemotherapy of human non-Hodgkin lymphoma (NHL) xenografts.
Topics: Animals; B-Lymphocytes; Cyclophosphamide; Dianhydrogalactitol; DNA; Humans; Immunoenzyme Techniques; Karyotyping; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Transplantation, Heterologous | 1986 |
The Murphy-Bowman protocol in the treatment of childhood non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1988 |
High-dose methotrexate therapy (6-8 g/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Half-Life; Humans; Infusions, Intravenous; Leucovorin; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stomatitis; Vincristine | 1987 |
Action of intermediate doses of methotrexate on dihydrofolate reductase in malignant diseases.
Topics: Brain Neoplasms; Child; Folic Acid Antagonists; Humans; Leukocytes; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Proteins; Neoplasms; Sarcoma; Tetrahydrofolate Dehydrogenase | 1987 |
High-dose methotrexate and continuous infusion Ara-C in children's non-Hodgkin's lymphoma: phase II studies and their use in further protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Diseases; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Vincristine | 1986 |
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Evaluation Studies as Topic; Humans; Italy; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Rate; Syndrome; Vincristine | 1986 |
[Meningiosis neoplastica--clinical aspects and therapy. Experiences in 78 cases].
Topics: Breast Neoplasms; Combined Modality Therapy; Follow-Up Studies; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Melanoma; Meningeal Neoplasms; Meninges; Methotrexate; Skin Neoplasms | 1988 |
[Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Remission Induction; Vincristine | 1988 |
[Effects of the use of cranial radiotherapy. Findings obtained by computerized axial tomography and intellectual function tests].
Topics: Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Medulloblastoma; Mental Processes; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed | 1988 |
[Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine | 1988 |
Non-Hodgkin's lymphoma in children; diffuse lymphoblastic histology; diffuse non-lymphoblastic histology; LSA2-L2 experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1988 |
[Results of the treatment of 46 non-Hodgkin's lymphomas in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1988 |
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Remission Induction; Vincristine | 1988 |
The cytotoxic effect of methotrexate as evaluated by colony-forming activity of hemopoietic and tumor cells.
Topics: Animals; Colony-Forming Units Assay; Drug Resistance; Hematopoietic Stem Cells; Lethal Dose 50; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, Inbred Strains | 1988 |
[Serial spectral EEG analysis in children treated with intermediate-dose methotrexate (ID-MTX)].
Topics: Brain; Child; Child, Preschool; Electroencephalography; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1988 |
[You make the diagnosis: methotrexate pneumonitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Pulmonary Fibrosis | 1988 |
[Evaluation of the results of treatment of non-Hodgkin's lymphoma in children by the Wollner method].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Time Factors; Vincristine | 1988 |
[A case of lymphoma of a higher stage of malignancy treated with cytostatics and interferon].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans; Interferon Type I; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Vincristine | 1988 |
[Non-Hodgkin's lymphoma among the cases of the Institute of Pediatrics, Polish Academy of Medicine].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Poland; Remission Induction; Vincristine | 1988 |
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Female; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Teniposide; Thrombocytopenia; Vincristine | 1988 |
Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Risk Factors; Spinal Cord Neoplasms | 1988 |
Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1988 |
[Serial spectral EEG analysis in a patient with non-Hodgkin's lymphoma complicated by leukoencephalopathy induced by high-dose methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Child, Preschool; Electroencephalography; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Non-Hodgkin; Methotrexate; Necrosis | 1988 |
Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nutritional Status; Prednisone; Prognosis; Time Factors; Vincristine | 1988 |
The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Topics: Animals; Drug Carriers; Drug Evaluation, Preclinical; Folic Acid; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Serum Albumin; Statistics as Topic | 1988 |
A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Procarbazine; Vincristine | 1988 |
[VAMA salvage regimen (VP-16, ARA-C, MTX and L-asparaginase) in relapsed or resistant non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Drug Resistance; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Podophyllotoxin; Remission Induction | 1988 |
[Clinical effect of prostaglandin E1 on liver dysfunction due to high-dose methotrexate].
Topics: Alprostadil; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Osteosarcoma | 1988 |
[Results of treatment in children with diffuse large cell lymphoma].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
The intraventricular reservoir in the treatment of neurological disease secondary to hematological malignancy: an eight year experience.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Diseases; Female; Humans; Injections, Spinal; Leukemia; Lymphoma, Non-Hodgkin; Male; Meningitis; Methotrexate; Middle Aged | 1986 |
Methotrexate pharmacokinetics in age-fractionated erythrocytes.
Topics: Chemical Fractionation; Erythrocyte Aging; Erythrocyte Count; Erythrocytes; Humans; Infusions, Parenteral; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Methotrexate; Reticulocytes | 1986 |
Effect of dose and repeat intravenous 24 hr infusions of methotrexate on cerebrospinal fluid availability in children with hematological malignancies.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infusions, Intravenous; Kinetics; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate | 1987 |
[non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 1987 |
Haemorrhage and perforation of gastrointestinal neoplasms during chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Intestinal Perforation; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Postoperative Care; Prednisolone; Vincristine | 1986 |
Methotrexate-leucovorin factor rescue regimens in diffuse large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prognosis | 1987 |
Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Vindesine | 1987 |
[Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Radioisotope Teletherapy; Tomography, X-Ray Computed | 1986 |
Is cranial radiation necessary for CNS prophylaxis in pediatric NHL?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Remission Induction | 1987 |
Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
Topics: Age Factors; Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Weight; Cyclophosphamide; Dog Diseases; Dogs; Female; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prognosis; Retrospective Studies; Sex Factors; Vincristine | 1987 |
Combination chemotherapy for the treatment of diffuse aggressive lymphomas: F-MACHOP update.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Vincristine | 1987 |
High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Vincristine | 1987 |
Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
Topics: Animals; Cattle; Fibrinogen; Gardner Syndrome; Lymphoma, Non-Hodgkin; Macromolecular Substances; Methotrexate; Mice; Mice, Inbred C3H; Tissue Distribution | 1987 |
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
[Short-term result of non-Hodgkin's lymphoma treated by the COMP regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1987 |
Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Meningeal Neoplasms; Methotrexate; Optic Neuritis; Prednisone; Vincristine | 1987 |
Activation of haemostasis by combined chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hemostasis; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasms; Prednisone; Vincristine | 1987 |
[Effect of methylglyoxal bis(guanylhydrazone) in combination with antifolic acid preparations on the biochemical indices and growth of Pliss lymphosarcoma in rats].
Topics: Adenosylmethionine Decarboxylase; Animals; Cycloserine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Folic Acid Antagonists; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mitoguazone; Neoplasm Transplantation; Polyamines; Rats; S-Adenosylhomocysteine; Time Factors | 1986 |
[Clinical picture, diagnosis and treatment of the brain lesions in lymphosarcomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Drug Combinations; Female; Gamma Rays; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Time Factors; Vincristine | 1986 |
[Clinical picture and treatment of lesions of the epidural space in lymphosarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Epidural Space; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pain; Prednisolone; Spinal Neoplasms; Vincristine | 1986 |
The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
Topics: Animals; Drug Evaluation, Preclinical; Female; Immunotoxins; Lectins; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Mice, Inbred C3H; Plant Lectins; Sarcoma, Experimental | 1986 |
Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Separation; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cells; Humans; Kinetics; Lymphoma, Non-Hodgkin; Methotrexate; Neutrophils; Prednisone; Vincristine | 1987 |
[Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Vincristine | 1986 |
[Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1987 |
Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1985 |
Methotrexate-vindesine association in leukemia: pharmacokinetic study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Vindesine | 1985 |
[Therapy of leukemic and sarcomatous meningopathies in the adult age].
Topics: Adult; Central Nervous System Diseases; Chemical Phenomena; Chemistry; Humans; Injections, Spinal; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Meninges; Methotrexate; Neoplasms | 1972 |
[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Intestinal Neoplasms; Laryngeal Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melanoma; Methotrexate; Mitomycins; Neoplasms; Palliative Care; Pharyngeal Neoplasms; Sarcoma; Thiotepa; Tongue Neoplasms; Urogenital Neoplasms; Vinblastine | 1971 |
Paraplegia in childhood malignant disease.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Humans; Infant; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Paraplegia; Prednisolone; Retroperitoneal Neoplasms; Sarcoma, Ewing; Spinal Cord Neoplasms; Vinblastine; Vincristine; Wilms Tumor | 1967 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Hydrazines; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mesenchymoma; Methotrexate; Multiple Myeloma; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pregnancy; Prostatic Neoplasms; Steroids; Testicular Neoplasms; Urethane; Vinblastine; Vincristine; Wilms Tumor | 1968 |
[New route of regulating folic acid metabolism in experimental chemotherapy of leukoses and malignant neoplasms].
Topics: Animals; Carcinoma, Hepatocellular; Cycloserine; Female; Folic Acid; Leukemia, Experimental; Liver; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Mice; Neoplasms, Experimental; Pyridoxal Phosphate; Rats; Spleen; Tetrahydrofolate Dehydrogenase; Transferases | 1971 |
Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.
Topics: Adrenocorticotropic Hormone; Brain Neoplasms; Cerebral Ventricles; Cerebrospinal Fluid Proteins; Cranial Nerves; Female; Humans; Hypothalamus; Immunoglobulin A; Immunologic Deficiency Syndromes; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisolone | 1973 |
Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.
Topics: Abdominal Neoplasms; Adolescent; Age Factors; Allopurinol; Antigens, Viral; Arabia; Bone Marrow Diseases; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Ethnicity; Female; Herpesvirus 4, Human; Humans; Israel; Jaw Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1974 |
Distribution of anticancer agents in spontaneous animal tumors. I. Regional blood flow and methotrexate distribution in canine lymphosarcoma.
Topics: Adrenal Glands; Animals; Carbon Radioisotopes; Cerebrovascular Circulation; Dogs; Inulin; Kidney; Kinetics; Lymphoma, Non-Hodgkin; Methotrexate; Regional Blood Flow; Tetrahydrofolate Dehydrogenase; Thyroid Gland; Tritium | 1974 |
[IgM paraproteinaemia in lymphoblastic lymphosarcoma in a child (author's transl)].
Topics: Blood Protein Disorders; Blood Protein Electrophoresis; Chromatography, Gel; Humans; Immunoelectrophoresis; Immunoglobulin M; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Vincristine | 1974 |
[The treatment of lymphosarcoma in childhood (author's transl)].
Topics: Age Factors; Antineoplastic Agents; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Vincristine | 1974 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium | 1974 |
[Leukemic meningosis in adults. Clinical picture--liquor cytology--therapy].
Topics: Adult; Aged; Cerebrospinal Fluid; Female; Headache; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Meningitis; Methotrexate; Middle Aged; Prognosis | 1973 |
[Mycosis fungoides evolving into a reticulosarcoma. Monstrous skin manifestations].
Topics: Alopecia; Cyclophosphamide; Humans; Ichthyosis; Lymphoma, Non-Hodgkin; Male; Methotrexate; Parapsoriasis; Skin Manifestations | 1972 |
Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Germ Cells; Hodgkin Disease; Humans; Libido; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Sertoli Cells; Spermatogenesis; Spermatozoa; Testis; Time Factors; Vincristine | 1973 |
[Complex treatment of reticulosarcoma and lymphosarcoma patients].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Moscow; Prednisolone; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
[Antineoplastic activity of antibiotic 1719 from the group of diazo compounds].
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Azo Compounds; Carcinoma, Ehrlich Tumor; Female; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Lung Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma 37; Stomach Neoplasms; Time Factors; Vaginal Neoplasms | 1972 |
Necrotizing encephalopathy following intraventricular instillation of methotrexate.
Topics: Adolescent; Brain; Brain Diseases; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Cerebral Ventricles; Child; Female; Glioma; Humans; Injections, Spinal; Leukemia; Lymphoma, Non-Hodgkin; Male; Medulloblastoma; Methotrexate; Middle Aged | 1973 |
[Attempt at the prevention of lymphosarcoma penetration into the central nervous system].
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Metastasis; Neoplasms | 1973 |
Paraplegia following intrathecal methotrexate.
Topics: Cerebrospinal Fluid Proteins; Child; Erythrocyte Count; Female; Glucose; Humans; Injections, Spinal; Leukemia; Leukocyte Count; Lymphoma, Non-Hodgkin; Methotrexate; Paraplegia; Remission, Spontaneous | 1973 |
[Treatment of lymphosarcoma by the triple combination vincristine-rubidomycin-prednisone].
Topics: Antibiotics, Antineoplastic; Child; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1967 |
[Progress in chemotherapy of solid tumors and malignant lymphomas (continued)].
Topics: Adult; Antineoplastic Agents; Carcinoma; Choriocarcinoma; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasms; Pregnancy | 1967 |
Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma.
Topics: Adolescent; Adult; Aged; Body Weight; Cyclophosphamide; Drug Synergism; Hemoglobinometry; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Prednisone; Vincristine | 1969 |
[A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
Topics: Agranulocytosis; Antineoplastic Agents; Breast Neoplasms; Female; Hemangiosarcoma; Hodgkin Disease; Humans; Kidney Neoplasms; Leucovorin; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Melanoma; Methotrexate; Osteosarcoma; Pancreatic Neoplasms; Radiography; Rectal Neoplasms; Rhabdomyosarcoma; Testicular Neoplasms; Thrombocytopenia | 1969 |
Central nervous system complications of leukemic conversion of the lymphomas.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Injections, Spinal; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Meningioma; Meningitis; Methotrexate; Middle Aged | 1969 |
[The role of vinblastine in the treatment of malignant lymphomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vinblastine | 1968 |
Metabolism of anticancer agents in man.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Bile; Burkitt Lymphoma; Child; Child, Preschool; Chlorine; Cyclophosphamide; Feces; Half-Life; Humans; Injections, Intravenous; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Radioisotopes; Retinoblastoma; Tritium | 1971 |
Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature.
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Anuria; Azathioprine; Biopsy; Bis-Trimethylammonium Compounds; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Pneumonia, Pneumocystis; Prednisone; Transplantation, Homologous; Vincristine | 1971 |
Clinical experience with L-asparaginase.
Topics: Adolescent; Adult; Aged; Asparaginase; Azaserine; Burkitt Lymphoma; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Drug Hypersensitivity; Escherichia coli; Female; Humans; Leukemia, Lymphoid; Leukopenia; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms; Pancreatitis; Thrombocytopenia | 1970 |
Therapy of localized and regional lymphosarcoma of childhood.
Topics: Adolescent; Child; Child, Preschool; Cobalt Isotopes; Cyclophosphamide; Head and Neck Neoplasms; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Peritoneal Neoplasms; Prednisone; Radioisotope Teletherapy; Remission, Spontaneous; Time Factors; Vincristine | 1971 |
Reticulosis as a long-term side-effect of methotrexate therapy in a patient with generalized psoriasis and psoriatic arthritis.
Topics: Arthritis; Humans; Hyperplasia; Immunosuppressive Agents; Lymphatic Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Organothiophosphorus Compounds; Psoriasis | 1971 |
Some problems in the management of leukaemia and lymphoma.
Topics: Antineoplastic Agents; Busulfan; Cyclophosphamide; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1966 |
Chemotherapy of the leukemic transformation of lymphosarcoma.
Topics: Adolescent; Bone Marrow Examination; Child; Child, Preschool; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone | 1967 |
[Leukosarcomatous meningopathy successfully treated with intrathecal a-methopterin].
Topics: Brain Neoplasms; Child, Preschool; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Meningitis; Methotrexate | 1966 |
Alteration of Methotrexate by leukemic cells: loss of affinity for an anion exchange resin.
Topics: Adult; Histocytochemistry; Humans; Ion Exchange Resins; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphoma, Non-Hodgkin; Methotrexate; Tetrahydrofolate Dehydrogenase; Time Factors; Tritium | 1969 |
[Association of radio- and chemotherapy in a new method of treating leukemic meningopathy].
Topics: Child, Preschool; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Meningitis; Methotrexate; Radiotherapy Dosage | 1969 |
[Modern aspects of treatment of acute leukemia].
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Child; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone | 1968 |
Soft-tissue sarcoma. Treatment with methotrexate and radiation.
Topics: Adult; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Radiotherapy Dosage; Sarcoma | 1970 |
Synchronization and recruitment in acute leukemia.
Topics: Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Bone Marrow Cells; Child; Culture Techniques; Cyclophosphamide; Cytarabine; Deoxyuridine; Depression, Chemical; DNA, Neoplasm; Exchange Transfusion, Whole Blood; Humans; Hydrocortisone; Kinetics; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Mitosis; Thymidine; Tritium; Vincristine | 1971 |
Studies with a 2,4-diamino-5-chloro-quinazoline antifolate: in vitro and invivo correlates in normal and lymphosarcoma dogs.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Deoxyuridine; DNA; DNA, Neoplasm; Dogs; Folic Acid Antagonists; Hydrogen-Ion Concentration; Injections, Intravenous; Leukemia L1210; Lymphoma, Non-Hodgkin; Methotrexate; Quinazolines; Thymine Nucleotides; Time Factors; Tritium | 1971 |
Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cells.
Topics: Animals; Carcinoma 256, Walker; Drug Resistance, Microbial; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms, Experimental; Pediococcus; Rats; Receptors, Drug; Tetrahydrofolate Dehydrogenase | 1968 |
The role of ribonuclease in regression of lymphosarcoma P1798.
Topics: Animals; Chloromercuribenzoates; Chromatography; Corticosterone; Fluorouracil; Freezing; Hydrocortisone; In Vitro Techniques; Lymphocytes; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Neoplasms, Experimental; Prednisolone; Ribonucleases; Vinblastine; Vincristine | 1966 |
Vaccination of a patient receiving immunosuppressive therapy for lymphosarcoma.
Topics: Agammaglobulinemia; Aged; Animals; Autoimmune Diseases; Body Weight; Female; Globulins; Guinea Pigs; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisone; Skin Tests; Smallpox Vaccine; Travel | 1966 |